Stammdaten

Register
Amtsgericht München HRB 262785
Eingetragen
27.1.2021
Branche
Ambulante Betreuungsdienste für ältere MenschenAmbulante PflegediensteStationäre Einrichtungen zur palliativen Pflege
Gegenstand
Kranken-, Alten- und Intensivpflege sowie die Beratung und Schulung im Gesundheitswesen.

Finanzübersicht

Historie

Keine Bekanntmachungen für diesen Filter verfügbar

Management

NameRolle
Daniel Sprenger
seit 31.8.2022
Prokura
Julia Rothe
seit 31.8.2022
Prokura
Giovanni Annoni
seit 27.1.2021
Geschäftsführer
Mirco Dr. Lazzarini
seit 27.1.2021
Prokura

Wirtschaftlich Berechtigte

0.00% identifiziert100.00% ungelöst

Ungelöste Beteiligungen (1)

NameAnteil
AIRSOL S.r.l.ITA
100.00%

Gesellschafter

1 Gesellschafter

GmbH-Struktur

Germany
25.000 €
100.00%

Konzern- und Jahresabschlüsse

SOL S.p.A. Deutschland Zweigniederlassung der SOL S.p.A.

Krefeld

Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022

Registered office

Via Borgazzi, 27

20900 Monza - Italy

Share Capital

Euro 47,164,000.00 fully paid-up

Tax Code and Register of Companies of Milan, Monza Brianza, Lodi under n° 04127270157

R.E.A. n° 991655

C.C.I.A.A. Milano, Monza Brianza, Lodi

BOARD OF DIRECTORS

Chairman and Managing Director

Aldo Fumagalli Romario

Deputy Chairman and Managing Director

Marco Annoni

Director with special powers

Giovanni Annoni

Director with special powers

Giulio Fumagalli Romario

Directors

Alessandra Annoni

Duccio Alberti

Cristina Grieco (Independent)

Anna Gervasoni (Independent)

Antonella Mansi (Independent)

Elli Meleti (Independent)

Erwin Paul Walter Rauhe (Independent)

GENERAL MANAGER

Andrea Monti

BOARD OF STATUTORY AUDITORS

Chairman

Giovanni Maria Alessandro Angelo Garegnani

Regular auditors

Alessandro Danovi

Livia Martinelli

Alternate Auditors Maria

Gabriella Drovandi

Alessandro Manias

AUDITING COMPANY

DELOITTE & TOUCHE Spa

Via Tortona n. 25

20144 Milan

POWERS GRANTED TO THE DIRECTORS

(CONSOB Communication No. 97001574 dated February 20, 1997)

To the Chairman and Deputy Chairman: the legal representation of the Company in dealings with third parties and before the legal authorities; powers of ordinary management acting severally; powers of extraordinary management, acting jointly, it being understood that for the execution of the related acts the signature of one of the two with the written authorisation of the other is sufficient; exception is made for certain specific acts of particular importance reserved for the competence of the Board.

To Directors with special appointments: powers of ordinary administration relevant to Legal and Corporate Business (Giulio Fumagalli Romario) and the Organisation of Information Systems (Giovanni Annoni) with single signature.

MANAGEMENT REPORT SOL GROUP INTRODUCTION

This Annual Financial Report as at December 31, 2022 is drawn up pursuant to Article 154 ter of Italian Legislative Decree 58/1998 and prepared in accordance with the International Accounting Standards (IFRS) issued by the International Accounting Standard Board (IASB) recognised by the European Union pursuant to Regulation (EC) no. 1606/2002 of the European Parliament and of the Council of July 19, 2002, as well as with the implementation regulations set out in Article 9 of Italian Legislative Decree no. 38/2005. These IFRS principles also include all revised international accounting standards ("IAS") and all of the interpretations of the International Financial Reporting Interpretation Committee (IFRIC), previously called Standing Interpretations Committee (SIC). It should be noted that in 2022, as the required conditions were met, IAS 29 - Financial Reporting in Hyperinflationary Economies was applied to the financial statements of the Turkish Group companies.

GENERAL CONTEXT

The SOL Group is primarily engaged in production, applied research and distribution activities pertaining to industrial, pure and medical gases, in door-to-door medical care, as well as in the supply of related medical equipment in Italy, presently active in 24 other European Countries, in Turkey, in Morocco, in India, in Brazil and in China. The products and services of companies belonging to the Group are used in the chemical, electronics, iron and steel, engineering and foodstuff industries, as well as in sectors such as environmental protection, research and health.

2022 started with a new wave of Covid-19 due to the Omicron variant with, however, less severe effects on the population than in the previous two years.

In February, following Russia's invasion of Ukraine, a war began between the two countries that is still ongoing. The conflict led to the gradual reduction of the main natural gas supply channel for many European countries, resulting in abnormally high prices for all energy commodities, which reached unprecedentedly high exchange values.

These increases, together with those caused by a booming global economy un 2021 and in the first half of 2022, caused inflation to rise by as much as 10% in all Western countries in 2022. This level of inflation had never occurred in recent decades.

The spread of inflationary pressures led all Western central banks to embark on a period of raising official interest rates, which in turn led to an increase in the interest rates charged by the credit system to its customers. In the scenario presented, the economic situation was expansionary in the first nine months of the year, with a tendency towards slower growth in the last quarter.

With regard to the technical gas and home care sector, in which the SOL Group operates, we would like to highlight the significant growth in the technical gas sector, due mainly to the recovery of the increase in production costs following the rise in the price of natural gas and, above all, electricity. In terms of quantities sold, there was a slight slowdown in the last few months of the year compared with the previous year.

Growth in the home care services sector showed good growth, partly due to the resumption of prescriptions for new patients, after a slowdown in the previous two years due to the effects of Covid-19, which had reduced the normal operations of hospitals and private laboratories.

With regard to the year 2023, economic growth is expected to be very low in almost all countries and inflation is expected to slow down, partly due to the significant rise in interest rates.

We expect activity in the technical gas sector to continue to grow, albeit much less than in 2022, while the home care sector should confirm pre-pandemic levels of development.

SUMMARY RESULTS

In this context, we believe that the results achieved by the SOL Group in 2022 were extremely positive.

The net sales achieved by the SOL Group in 2022 were equal to Euro 1,379.2 million (+23.9% compared to those of 2021 and +22.3% on a like-for-like basis).

The gross operating margin was Euro 328.3 million, equating to 23.8% of sales, up by 25.9% when compared to 2021 (Euro 260.8 million, or 23.4% of sales).

The operating result came to Euro 192.5 million, equating to 14.0% of sales, up by 41.8 million compared to the figure for the same period of 2021 (Euro 135.8 million, or 12.2% of sales).

The net profit amounted to Euro 133.7 million, up 49.3% from 89.5 million euro in 2021.

The cash flow amounted to Euro 266.5 million (19.3% of sales), up by 25.1% compared to 2021 (equal to Euro 213.1 million).

The technical investments carried out in 2022 amounted to Euro 121.3 million (Euro 123.3 million in 2021). The average number of employees as at December 31, 2022 amounted to 5,374 (4,916 as at December 31, 2021).

The net financial indebtedness was equal to Euro 389.7 million (310.9 million as at December 31, 2021).

The application of IAS 29 had no material impact on the consolidated financial statements of the SOL Group.

MANAGEMENT TREND

During 2022, the technical gas sector showed an increase in sales of 36.5% when compared with the previous year achieving a turnover from third-party customers equating to Euro 762.4 million.

The Technical gas division had to implement a strong action to recover the cost increase as a result of the very high increase in the prices of electricity and natural gas, raw materials in the production of technical gases. The effect of the price adjustment on growth is 70.0%.

The home-care business reported a growth by 11.2%, both in Italy and abroad, with sales to third-party customers of Euro 616.7 million.

The growth in the sector is due to the resumption of new patient prescriptions, which had been severely slowed in the 2020 and 2021 due to reduced activity in hospitals and laboratories as a result of the Covid-19 pandemic. Overall, in the healthcare sector, the Group's sales amounted to Euro 777 million, or 56.3% of total turnover. The gross operating margin increased by Euro 67.5 million or 25.9% compared to 2021.

The operating result increased by Euro 56.7 million compared to 2021, up 41.8%.

The Group's net indebtedness increased by only Euro 78.9 million, compared to December 31, 2021, against technical and intangible investments and acquisitions of Euro 219.4 million made in 2022.

The debt ratios remain very solid, with a debt/equity ratio of 0.45 and a cash flow cover of 1.19. During 2022, technical gas reserves remained within the safety levels.

In 2022, the SOL Group's work force increased by 650 people, from 5,101 to 5,751. Personnel training and qualification activities, aimed at improving the qualities of our people committed to pursuing the Group's development objectives, continued on a regular basis.

SHARE PERFORMANCE ON THE STOCK EXCHANGE

SOL stock opened 2022 with a price of Euro 20.95 and closed as at December 30, 2022 at Euro 17.70. During the year, the stock achieved a maximum price of Euro 21.35, while the minimum came to Euro 15.12.

QUALITY, SAFETY, HEALTH AND ENVIRONMENT

The focus on issues of quality, health, safety and environment was constantly high throughout 2022 with an intense internal auditing activity and with checks by third parties, both by Notified Bodies for Certification and by the Auditing Bodies of the Public Administration.

All of these checks have always had a positive outcome.

Overall, the certifications obtained over the years pursuant to international standards ISO 9001, ISO 14001, ISO 13485, OHSAS 18001/ISO 45001, ISO 22000 - FSSC 22000, ISO 50001, ISO 27001, ISO 22301, ISO 17025 were not only renewed, but extended to new activities (ISO 9001) as well as other new operational sites of the Group. An example from outside Italy is the new production site of SOL BRANCH BELGIUM WANZE, which in 2022 obtained certification according to ISO 9001, ISO 22000 and FSSC 22000.

With regard to the ISO 9001 certification for the technical gases area, the scope was extended to include 6 new services, provided in the area of marketing/technical customer management.

The certification status was also confirmed to the Group for the enforcement of the PED directive in the internal production of vaporisers and of the 93/42 Directive for the production of medical devices.

Always during 2022, the accreditation according to ISO 17025 was confirmed for the analytical methods applied in the laboratory of GAS PURI MONZA, of GTS (Albania), of SOL SERBIA and of STERIMED (Italy - company specialised in services and solutions for health and the environment), companies that therefore maintained the status of a Testing Laboratory approved and accredited by the ACCREDIA accreditation body.

In 2022, the GAS PURI MONZA unit received the first surveillance visit for ISO 17034 accreditation again from ACCREDIA as a producer of certified environmental mixtures.

In the field of technical gases and biotechnology, ISO 9001 certification status of the individual sites stands at 42 sites in Italy and 50 outside of Italy (one of which belongs to the German company CT BIOCARBONIC, a jointly controlled company consolidated using the equity method).

In the area of food safety, the number of sites outside of Italy certified to ISO 22000 is 29 (of which one belongs to the German company CT BIOCARBONIC), while in Italy, the sites are 2.

The FSSC 22000 certified sites among those certified to ISO 22000 are 24 sites outside Italy (of which 1 belonging to the German company CT BIOCARBONIC) and 2 in Italy.

As part of the activities related to technical gas, ISO 14001 certification was confirmed for the environmental management system for 11 sites in Italy and 11 sites outside of Italy.

The certification of the safety management system according to the ISO 45001/OHSAS 18001 standard is applied in 40 sites in Italy and 8 sites outside of Italy.

The excellence certification status (ISO 9001, ISO 14001, ISO 45001/OHSAS 18001) was confirmed, maintaining European EMAS Registration for the Verona, Mantua (Italy) and Jesenice (Slovenia) plants. It is also worth mentioning that SOL Spa obtained the European EMAS Registration for its activities at its headquarters in Monza. As part of home care activities, the certification status (ISO 9001) of the VIVISOL premises was 22 sites in Italy and 43 sites outside of Italy.

The ISO 14001 certification of the environmental management system of VIVISOL Srl Registered office and 8 sites outside Italy was confirmed, as well as the certification of the safety management system according to the ISO 45001/OHSAS 18001 standard, applied at 21 sites in Italy and 9 sites outside Italy.

The Sustainability Report will accompany the Financial Statements this year as well, which was prepared in accordance with the requirements of Articles 3 and 4 of Italian Legislative Decree no. 254 of 30 December 2016 and the "Global Reporting Initiative Sustainability Reporting Standards" defined by the GRI - Global Reporting Initiative.

Work also continued on the implementation of the Responsible Care Programme and in accordance with the principles of corporate Social Responsibility.

CONSOLIDATED NON-FINANCIAL STATEMENT

The consolidated non-financial statement of SOL Spa for the year 2022, prepared in accordance with Italian Legislative Decree 254/16, constitutes a separate report ("Sustainability Report") with respect to this management report, as provided for by Article 5 paragraph 3, letter b) of Italian Legislative Decree 254/16, and is available on the company's website http://www.solgroup.com/, in the "Sustainability" section.

PHARMACEUTICAL-REGULATORY ACTIVITIES AND MEDICAL DEVICES

The Group's regulatory activities, both in Italy and abroad, continued in 2022 as well.

At the end of 2022, the Group had 147 Marketing Authorisations for medical gases filed in 25 countries (18 EU and 7 non-EU).

It also has 64 pharmaceutical workshops, of which 62 are gas production workshops, plus SITEX (production of galenic drugs) and DIATHEVA (production of APIs from biotechnology).

There are 15 gas production workshops in the home care area (of which 5 in Italy), and 47 in the technical gas area (of which 17 in Italy).

In 2022, 20 GMP inspections of gas production workshops were carried out by the relevant national agencies. Medical regulatory activity focused on changes to the oxygen and medical air dossiers to include the sites of the Greek company TAE HELLAS. Moreover, at the end of 2022, the decentralised registration process for peritoneal dialysis solutions containing icodextrin, for which VIVISOL is the owner, came to an end; the "national phase" of granting national marketing authorisations is underway.

The year 2022 saw a strong commitment of the medical device regulatory service in the conversion to Regulation and submission to the Notified Body (DNV) of the 4 gas technical files and in the follow-up of the evaluation to MDR of the 3 F.T.'s (gas and vacuum distribution systems, anaesthetic gas evacuation systems and cryobanks) of which SOL Spa is the manufacturer.

SOL GROUP INVESTMENTS

During the 2022 financial year, investments were made for Euro 58.2 million in the "technical gases" sector, of which Euro 20.4 million by the parent company SOL Spa, and Euro 73.0 million in the "home care" sector. The main investments made were as follows:

in Verona, Italy, at IL POINT, work was completed on modernising the entire site with the creation of the new area dedicated to orthopaedics and the creation of the new centre for orthopaedic prostheses;

in Burago, Italy, work began on the construction of VIVISOL Srl's new logistics centre;

in Cremona, the work to upgrade the storage and compression of gaseous helium was completed;

in Tilburg, the Netherlands, the modernisation of the nitrous oxide production plant was completed;

in Slovenia, the new TPJ company headquarters were built in Jesenice;

in Florina, Greece, work began on upgrading TAE's carbon dioxide production plant;

in India, work began on the construction of a new air fractionation plant for the production of oxygen, nitrogen and argon in Ranipet (Tamil Nadu);

the programme for the improvement, modernisation and rationalisation of primary production plants of technical gases continued. This activity concerned in particular the units at Tanagra in Greece and Trichy in India;

the programme for the improvement, modernisation and rationalisation of secondary production plants of technical and medical gases continued. This activity concerned in particular the units in Catania in Italy, Aspropyrgos in Greece and Sisak in Croatia;

a number of on-site industrial and medical systems were built and launched in Italy as well as abroad, and means of transport, distribution and product sales have been enhanced with the purchase of cryogenic tanks, cryogenic liquid distribution reservoirs, cylinders, dewars and electrical medical devices, all to sustain the group's development in all sectors of activity and geographic areas;

investments continued to improve IT systems for both the technical gas and home-care sectors.

MAJOR CORPORATE TRANSACTIONS

During 2022, several acquisitions were made, both in Italy and abroad. The most important ones are highlighted below:

the Brazilian subsidiary P PAR Ltda acquired 60% of BLA SERVIÇOS HOSPITALARES Ltda e JML SERVIÇOS HOSPITALARES Ltda, companies located in São Paulo (Brazil) and operating in the hospital business;

the subsidiary company VIVISOL DEUTSCHLAND GmbH acquired 100% of the German company PROFI GESUNDHEITS - SERVICE GmbH, operating in the home-care sector;

the subsidiary AIRSOL Srl acquired 51% of the company ITOP Spa OFFICINE ORTOPEDICHE, a company operating in the design, production, research and innovation of ortho-prosthetic devices for orthopaedic and neuromuscular pathologies;

the subsidiary AIRSOL Srl acquired 61% of the Irish company POLAR ICE Ltd active in the production and marketing of dry ice;

the parent company SOL Spa, with the support of SIMEST, acquired 100% of the Indian company GREEN ASU PLANT PRIVATE Ltd, which is active in the production and marketing of technical and medical gases and the production of renewable wind energy; moreover, again with the support of SIMEST, SOL Spa acquired 51% of the Indian company BHORUKA SPECIALTY GASES PRIVATE Ltd, which is engaged in the production and marketing of pure, very pure and specialty gases.

RESEARCH AND DEVELOPMENT ACTIVITIES

Research activities, which characterise and support the Group's development, continued during the year; these activities mainly comprise research associated with the development of new production and distribution technologies, with the promotion of new applications for technical gases and with the development of new services in health and home care.

SHARES OF THE PARENT COMPANY HELD BY GROUP COMPANIES

As at December 31, 2022, the Parent Company SOL Spa did not own treasury shares. The other companies of the Group did not own shares of the parent company SOL Spa.

During the 2022 reporting year, no SOL shares were purchased or sold either by the Parent Company itself or by other Group Companies.

INTRA-GROUP TRANSACTIONS AND TRANSACTIONS WITH RELATED PARTIES

Transactions carried out with related parties, including intra-group transactions, cannot be considered as atypical or unusual, as they are part of the normal activities of Group companies. These transactions are settled at arm's length, taking into account the characteristics of the supplied goods and services.

Information concerning relations with related parties, including those requested by the Consob communication dated July 28, 2006, is presented in our Consolidated Financial Statements as at December 31, 2022.

MAIN RISKS AND UNCERTAINTIES TO WHICH THE SOL GROUP IS EXPOSED RISKS RELATED TO THE GENERAL ECONOMIC TREND

The Group performance is affected by the increase or decrease of the gross national product and industrial production, cost of energy products and health expense policies adopted in the different European countries in which the Group works.

The economic trend in the post-pandemic period and the consequences of the recent Ukrainian crisis could cause a slowdown in various sectors of the economy in the countries where the SOL Group operates.

RISKS RELATING TO THE GROUP'S RESULTS

The SOL Group partially operates in sectors considerably regulated by economic cycles related to the trend in industrial production, such as the steel, metal working, engineering, chemical and glass manufacturing industries. In the case of an extended decline in business, the growth and profitability of the Group could be partially affected.

Moreover, government policies for reducing healthcare expenses could reduce margins in the home-care and medical gas and service sectors.

RISKS RELATED TO FUND REQUIREMENTS

The SOL Group carries on an activity that entails considerable investments both in production and in commercial equipment and expects to face up to requirements through the flows deriving from the operational management and from new loans.

Operational management should continue to generate sufficient financial resources, while the use of new loans, notwithstanding the Group's excellent capital and financial structure, may show higher interest rates and spreads than in the past.

OTHER FINANCIAL RISKS

The Group is exposed to financial risks associated with its business operations:

credit risk in relation to normal trade transactions with customers;

liquidity risk, with particular reference to the raising of financial resources associated with investments and with the financing of working capital;

market risks (mainly relating to exchange and interest rates and to commodity costs), in that the Group operates internationally in different currency areas and uses interest-bearing financial instruments.

Credit risk

The granting of credit to end customers is subject to specific assessments by means of structured credit facility systems.

Positions amongst trade receivables for which objective partial or total non-recoverability is ascertained, are subject to individual write-down. Provisions are made on a collective basis for receivables that are not subject to individual write-down, taking into account the historic experience, the statistical data and, as a result of the introduction of the new accounting standard IFRS 9, on the basis of a predictive approach, based on the counterparty's probability of default, the ability to recover in case of loss given default and also of expected future losses.

Liquidity risk

The liquidity risk may arise with the inability to raise, under good financial conditions, the financial resources necessary for the anticipated investments and the financing of working capital.

The Group has adopted a series of policies and processes aimed at optimising the management of financial resources, reducing liquidity risk, such as the maintenance of an adequate level of available liquidity, the obtaining of appropriate credit facilities and the systematic monitoring of the forecast liquidity conditions, in relation to the corporate planning process.

Management believes that the funds and the credit facilities currently available, in addition to those that will be generated by operating and financing activities, will permit the Group to satisfy its requirements resulting from investment activities, working capital management and debt repayments on their natural maturity dates.

Exchange rate risk

In relation to sales activities, the Group companies may find themselves with trade receivables or payables denominated in currencies other than the reporting currency of the company that holds them.

A number of Group subsidiary companies are located in countries outside the Eurozone, in particular Switzerland, Bosnia, Serbia, Albania, North Macedonia, Bulgaria, Hungary, Romania, the UK, Morocco, Poland, Czech Republic, India, Turkey, Brazil and China. Since the reference currency for the Group is the Euro, the income statements of these companies are translated into Euro using the average exchange rate for the period and, revenues and margins in local currency being equal, changes in interest rates may have an effect on the equivalent value in Euro of revenues, costs and economic results.

Assets and liabilities of the consolidated companies whose reporting currency is not the Euro can adopt equivalent values in Euro that differ depending on the exchange rate trend. As envisaged by the accounting standards adopted, the effects of these changes are booked directly to shareholders' equity, under the item "Other reserves". Some Group companies purchase electricity that is used for the primary production of technical gasses. The price of electricity is affected by the Euro/dollar exchange rate and by the price trend of energy commodities. The risk related to their fluctuations is mitigated by signing, as much as possible, fixed price purchase contracts or with a variation measured over a longer time period. Moreover, almost all supply contracts to customers are index-linked in such a way as to cover the fluctuation risks shown above.

The Parent Company has two bond loans outstanding for a total of USD 22.5 million. To hedge the exchange rate risk, two cross currency swaps were made in Euros on the total loan amount and for the entire duration (12 years). The fair value of the CCSs as at December 31, 2022 was positive in the amount of Euro 3,143 thousand. With regard to the currency weakness involving the Turkish lira, note that Group companies resident in Turkey operate only within the country, but there could be a negative effect on their profitability as a result of the higher cost of products purchased from third countries.

As the conditions were met, IAS 29 - Hyperinflation to Financial Statements was applied to the financial statements of Turkish companies in 2022.

Interest rate risk

The interest rate risk is managed by the parent company by centralising most of the medium/long-term debt and by appropriately dividing the loans between fixed rate and floating rate, favouring, when possible and convenient, medium/long-term debt with fixed rates, also through specific Interest Rate Swap agreements.

Some Group companies have entered into a number of Interest Rate Swap agreements linked to two floating rate medium-term loans with the aim of guaranteeing a fixed rate on said loans. The nominal value as at December 31, 2022 is equal to Euro 133,909 thousand and the positive fair value is equal to Euro 9,851 thousand.

RISKS RELATING TO PERSONNEL

In various countries in which the Group operates, employees are protected by different laws and/or collective labour contracts that guarantee them the right to be consulted on specific issues - including the downsizing and closing of departments and the reduction of staff numbers - through representations. This could affect the Group's flexibility in strategically redefining its own organisations and activities.

The management of the Group consists of persons of proven expertise who normally have long-standing experience in the sectors in which the Group operates. The replacement of any person in management may require a long period of time.

There are potential risks to the health and safety of workers as well as to compliance with occupational health and safety regulations that are mitigated by the adoption of an integrated management system compliant with ISO 45001.

RISKS RELATED TO THE ENVIRONMENT AND CLIMATE CHANGE

The products and the activities of the SOL Group are subject to increasingly complex and strict authorisation and environmental rules and regulations. This concerns manufacturing plants subject to regulations on atmospheric emissions, waste disposal and waste water disposal and the ban on land contamination.

High charges should be shouldered in order to observe such regulations.

During 2022, the Group further deepened its previous assessments of the significance of climate changerelated risks, both physical and transitional, and their economic/financial implications.

With particular reference to transition risks, which depend on an overall scenario of change in the economic context with a view to limiting the increase in global temperature to 1.5-2°C, as per the agreement signed in Paris, the Board considers that factors related to changes in market demand (increased sensitivity of customers and, more generally, of the Group's stakeholders to sustainability issues), technological evolution (risks related to the necessary technological innovations) and regulatory evolution (i.e. risks arising from legislative or political impositions aimed at triggering change) are of greater importance to the Group.

In this context, in the industrial gas sector, which is characterised by a high energy content in production costs, the Group is constantly monitoring possible regulatory changes in order to meet the expectations of the market and the Group's stakeholders, and has planned investments in photovoltaic and wind power plants in order to increase the share of energy from renewable sources. Although there are currently no circumstances in which the Group's production processes are at risk of becoming obsolete as a result of the transition to a low-carbon economy, the Group intends to reaffirm its commitment to continue with the planned renewal and rationalisation of its plants, taking advantage of the opportunities offered by technological developments to reduce energy consumption and greenhouse gas emissions.

On the other hand, the Group is already active in the home care sector, continuously streamlining equipment and introducing new, less polluting technologies.

The common objective of both activities is to limit the fuel consumption and related greenhouse gas emissions generated directly and indirectly by the Group in connection with transport, which is mainly carried out by third-party suppliers. To this end, the Group has already experimented with electric vehicles and intends to encourage its suppliers to replace diesel-powered tractors with other lower-emission vehicles, in line with the expected evolution of the market offer of lower-emission alternatives. In this context, these measures will have no direct impact on SOL investments and costs.

It should also be noted that all of the above initiatives to limit energy consumption and emissions, as well as the procurement of energy from renewable sources, have already been outlined in the Group Sustainability Plan. With regard to the exposure of tangible assets (plants, buildings) to physical risks related to climate change and the business continuity risk resulting from these factors, the Group considers that the overall risk is medium/ low and has not identified any need for urgent action or significant investment.

Please refer to the Non-Financial Statement for a more detailed discussion of the initiatives implemented by the Group.

RISKS RELATING TO IT MANAGEMENT AND DATA SECURITY

The increasing use of IT tools in the management of company activities and the interconnection of company systems with external IT infrastructures expose these systems to potential risks with regard to the availability, integrity and confidentiality of data, as well as the efficiency of the IT tools themselves.

To ensure effective business continuity, the Group adopted a disaster recovery and business continuity system to ensure immediate replication of the main legacy system workstations. The choice of these systems to be managed in business continuity was made on the basis of a risk analysis.

Moreover, multiple levels of physical and logical protection, at the level of servers and at the level of clients, ensure the active security of data and business applications. The SOL Group also has innovative artificial intelligence-based products to protect the digital identity of its employees.

Vulnerability analyses and audits on the security of information systems are periodically carried out by independent technicians to check the adequacy of the company's IT systems.

Finally, with regard to the problem of fraud through the use of IT resources by external parties, all employees are periodically informed and trained on the correct use of the resources and IT applications available to them.

TAX RISKS

The SOL Group is subject to taxation in Italy and in several other foreign jurisdictions.

The various companies of the Group are subject to the assessment of the income tax returns by the competent tax authorities of the countries in which they operate.

As already occurred in the past, any findings reported in the tax audits are carefully assessed and, when necessary, challenged in the appropriate venues.

At present, a dispute is in progress in Italy for findings - considered groundless - on Transfer pricing.

The opening of the MAP (Mutual Agreement Procedure) between Italy and four other European countries has been requested and has not yet been completed.

However, at Group level, this should not have a significant effect on profitability, given that the level of taxation in the countries involved is very similar.

RISKS DERIVING FROM THE WAR IN UKRAINE

The risks to which the SOL Group is exposed in connection with the war between Russia and Ukraine that broke out in February 2022 are essentially indirect, in that there are no activities carried out directly by subsidiaries in the two countries involved.

In fact, the likely negative effects caused by the current conflict on the economic growth of European countries could lead to a lower rate of development of the sales of the SOL Group.

Moreover, the war is contributing to keeping the cost of energy products at high levels, resulting in the continued high cost of purchasing electricity and fuel; this could mean the risk of not being able to fully transfer these costs to the sales prices of technical gases and services on the market, with a consequent negative effect on the Group's margins. The continuation of the war is also contributing to the inflationary effects of high energy commodity prices, with the consequent negative impact on investment costs and operating expenses.

In particular, a significant effect on home care activities is on the supply chain of medical equipment, for which there are delays and difficulties in deliveries and consequent shortages to meet growing demand, as well as an increase in purchase prices.

OTHER RISKS

It is stated that on October 21, 2022 the subsidiary VIVISOL Srl was notified of the interim measure prohibiting it from contracting with the Public Administration pursuant to Article 25, paragraph 2, of Italian Legislative Decree No. 231/2001 in connection with criminal suit No. 6036/2022 GEN. CRIM. REG. - No. 4500/2022 RGGIP pending before the Court of Palermo, which involves several natural and legal persons including a manager and a former manager of the Company, who are under investigation for the offences provided for and punished by Articles 319 and 321 of the Italian Penal Code, which were allegedly committed in connection with a tender dating back to 2017 called by the ASP of Palermo and from which, inter alia, no profit was made. An appeal was immediately lodged against the aforesaid precautionary measure pursuant to Article 299 of the Code of Criminal Procedure and on November 2, 2022, with the favourable opinion of the Prosecutors in charge of the investigation, the Investigating Magistrate suspended the aforesaid measure with immediate effect, allowing the company to continue its operations. The measure was lifted on February 10, 2023.

As stated in the press releases immediately issued by the company, VIVISOL reiterates that it is not involved in this matter and firmly believes that this will be confirmed by the ongoing judicial investigations.

That being said, as an immediate self-cleaning activity, the VIVISOL Board of Directors promptly suspended the manager involved and revoked all delegations and powers of attorney assigned, and the necessary internal checks were initiated. It should also be noted that since 2006 VIVISOL has had a Code of Ethics and an Organisation, Management and Control Model pursuant to Italian Legislative Decree 231/2001 that is periodically updated and effectively implemented through the implementation of ad hoc protocols and procedures.

On December 15, 2022, the Public Prosecutor's Office of the Court of Milan served a notice of conclusion of the investigation into the criminal proceedings following the double fatal accident that occurred on September 28, 2021 on the Humanitas Mirasole Spa university campus involving two drivers of the transport company Pè Giuseppe Srl, which was entrusted by SOL Spa with the delivery of nitrogen, according to which, inter alia, the former General Manager and employer of SOL Spa is being investigated pursuant to Articles 113 and 589, paragraphs I, II and IV of the Italian Penal Code and the company SOL Spa is being prosecuted for the administrative offence referred to in Articles 5, 9 and 25 septies of Italian Legislative Decree no. 231/2001; on the other hand, it appears that the Chairman and Vice-Chairman of SOL Spa, who were initially under investigation, have been dismissed. Both the company and its former employer are confident that they will be able to prove their innocence in the subsequent proceedings.

MANAGEMENT AND CO-ORDINATION ACTIVITIES (PURSUANT TO ARTICLE 37, SUB-PARAGRAPH 2, MARKET REGULATION ISSUED BY CONSOB)

The body of shareholders of SOL Spa consists of a controlling shareholder, GAS AND TECHNOLOGIES WORLD Bv, (in turn controlled by STICHTING AIRVISION, a Dutch foundation), which holds 59.978 % of the share capital. Neither GAS AND TECHNOLOGIES WORLD BV nor STICHTING AIRVISION exercise the activity of direction and coordination of SOL Spa pursuant to art. 2497 of the Italian Civil Code, as the majority shareholder, a holding company, is limited to exercising the rights and prerogatives of each shareholder and does not get involved, with the management of the Company (fully entrusted to the autonomous decisions of the Board of Directors of SOL Spa).

IMPORTANT FACTS OCCURRING AFTER THE 2022 REPORTING PERIOD AND BUSINESS OUTLOOK

The ongoing war in Ukraine, which started in February 2022 with the invasion by Russia, is economically causing continuous changes in the prices of oil, gas, electricity and other products.

This is reflected in the production and purchase costs of technical gases and, due to inflationary effects, also in investment and operating costs.

However, the SOL Group will continue with its investment programmes and, where possible, acquisitions, with the aim of achieving good sales growth and maintaining profitability at appreciable levels.

 

Monza, March 30, 2023

The Chairman of the Board of Directors

Aldo Fumagalli Romario

CONSOLIDATED FINANCIAL STATEMENTS AND EXPLANATORY NOTES SOL GROUP

SOL GROUP CONSOLIDATED INCOME STATEMENT

(amounts in thousands of Euro)

Notes 12.31.2022 % 12.31.2021 %
Net sales 1 1,379,187 100.0% 1,112,909 100.0%
Other revenues and income Internal 2 83,904 6.1% 11,060 1.0%
works and collections 3 26,718 1.9% 18,933 1.7%
Revenues 1,489,809 108.0% 1,142,901 102.7%
Purchase of materials 520,650 37.8% 306,023 27.5%
Services rendered Change 366,030 26.5% 319,511 28.7%
in inventories (13,232) -1.0% (2,380) -0.2%
Other costs 28,446 2.1% 24,761 2.2%
Total costs 4 901,894 65.4% 647,915 58.2%
Added value 587,915 42.6% 494,987 44.5%
Payroll and related costs 5 259,657 18.8% 234,209 21.0%
Gross operating margin 328,259 23.8% 260,778 23.4%
Depreciation/amortisation 6 128,950 9.3% 119,296 10.7%
Provisions and write-downs 6 6,847 0.5% 5,711 0.5%
Non-recurring (income)/expenses 6 - - - -
Operating result 192,462 14.0% 135,771 12.2%
Financial income 2,930 0.2% 2,406 0.2%
Financial expense (15,891) -1.2% (11,472) -1.0%
Results from equity investments 368 - (777) -0.1%
Total financial income/(expense) 7 (12.593) -0,9% (9.843) -0,9%
Profit (Loss) before income taxes 179,869 13.0% 125,928 11.3%
Income taxes 8 42,294 3.1% 32,170 2.9%
Net result from business activities 137,574 10.0% 93,757 8.4%
Net result from discontinued operations - - - -
(Profit)/Loss pertaining to minority interests (3,882) -0.3% (4,208) -0.4%
Net Profit/(Loss) 133,693 9.7% 89,549 8.0%
Earnings per share 1.474 - 0.987 -

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME SOL GROUP

(amounts in thousands of Euro)

12.31.2022 12.31.2021
Profit/(Loss) for the year (A) 137,574 93,757
Components that will never be reclassified to the Income Statement
Actuarial gains/(losses) 3,111 550
Tax effect (762) (126)
Total components that will never be reclassified to the Income Statement (B1) 2,349 424
Components that may be reclassified to the Income Statement
Profits/(losses) on cash flow hedging instruments 11,717 5,071
Profits/(losses) deriving from conversion of financial statements of foreign companies (3,181) 1,522
Tax effect related to other profits (losses) (2,803) (1,206)
Total components that may be reclassified to the Income Statement (B2) 5,733 5,387
Total other profits/(losses) net of the tax effect (B1) + (B2) = (B) 8,082 5,811
Overall result for the period (A +/- B) 145,656 99,569
Attributable to:
- shareholders of the parent company 142,036 95,373
- minority interest 3,620 4,195

CONSOLIDATED STATEMENT OF FINANCIAL POSITION SOL GROUP

(amounts in thousands of Euro)

Notes 12.31.2022 12.31.2021
Tangible fixed assets 9 694,164 615,329
Goodwill and consolidation differences 10 216,811 170,313
Other intangible fixed assets 11 26,550 22,752
Equity investments 12 13,082 12,704
Other financial assets 13 22,015 10,484
Deferred tax assets 14 18,557 21,031
Non-current assets 991,179 852,612
Non-current assets held for sale Inventories 15 84,144 67,303
Trade receivables 16 431,054 340,023
Other current assets 17 64,377 36,197
Current financial assets 18 13,187 8,671
Cash and cash at bank 19 134,642 139,642
Current assets 727,403 591,835
TOTAL ASSETS 1,718,583 1,444,448
Share capital 47,164 47,164
Share premium reserve 63,335 63,335
Legal reserve 10,459 10,459
Reserve for treasury shares in portfolio 0 0
Other reserves 565,261 486,904
Retained earnings (accumulated loss) 704 845
Net Profit 133,693 89,549
Shareholders' equity - Group 820,615 698,257
Shareholders' equity - Minority interests 38,134 18,987
Profit pertaining to minority interests 3,882 4,208
Shareholders' equity - Minority interests 42,015 23,194
Shareholders' equity 20 862,630 721,452
Employee severance indemnities and benefits 21 15,143 18,696
Provision for deferred taxes 22 12,163 7,362
Provisions for risks and charges 23 3,309 3,070
Payables and other financial liabilities 24 454,496 378,471
Non-current liabilities 485,111 407,598
Non-current liabilities held for sale Amounts due to banks 6,860 1,643
Trade accounts payable 175,114 150,290
Other financial liabilities 84,814 82,098
Tax payables 32,552 19,216
Other current liabilities 71,502 62,150
Current liabilities 25 370,842 315,398
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 1,718,583 1,444,448

CONSOLIDATED CASH FLOW STATEMENT SOL GROUP

(amounts in thousands of Euro)

Notes 12.31.2022 12.31.2021
CASH FLOW GENERATED BY OPERATING ACTIVITIES
Profit for the year 133,693 89,549
Minority interests in profit/loss 3,882 4,208
Adjustments to items not affecting liquidity
Depreciation/amortisation 6 128,950 119,296
Interest on loans and on bonds 7 8,192 7,982
Employee severance indemnities and benefits accrued 5 1,702 1,307
Provisions/Use of provisions for risks and charges 22 - 23 5,040 3,825
Taxes for the period 8 37,533 29,072
Cash flow before changes in nwc 318,992 255,239
Changes in current assets and liabilities
Inventories 15 (13,758) (1,825)
Trade receivables 16 (80,521) (20,112)
Other assets 14 - 17 (25,386) (5,619)
Suppliers 25 20,367 17,854
Other liabilities 11,776 (4,387)
Tax payables 4,466 5,230
Total changes in current assets and liabilities (83,056) (8,859)
Other adjustments for non-monetary items 7,647 (16,607)
Taxes paid (28,664) (37,209)
Cash flow generated by operating activities 214,919 192,564
CASH FLOWS GENERATED BY INVESTMENT ACTIVITIES
Acquisition of tangible fixed assets 9 (121,329) (123,298)
Revaluations and other changes in tangible fixed assets 9 (30,020) (15,305)
Increases in intangible assets (9,829) (9,149)
(Increase) decrease in long-term investments 13 (11,177) (2,409)
(Increase) decrease of equity investments and business units (75,426) (78,137)
(Increase) decrease in current financial assets 18 (4,516) (1,222)
Total (252,297) (229,520)
CASH FLOWS GENERATED BY FINANCING ACTIVITIES
Repayment of loans (49,559) (47,715)
Raising of new loans 32,758 279
Redemption of bonds (12.039) (11.937)
Undertaking bonds 75,000 -
Change in leases 16,181 (1,925)
Raising (repayment) of shareholders' loans - (224)
Dividends paid 20 (24,259) (23,857)
Interest on loans and on bonds paid (7,737) (8,153)
Total 30,345 (93,532)
Effect of exchange rate fluctuations 20 (3,183) 1,522
INCREASE (DECREASE) IN CASH IN HAND AND AT BANK (10,216) (128,966)
CASH IN HAND AND AT BANK AT BEGINNING OF YEAR 19 137,998 266,964
CASH IN HAND AND AT BANK AT END OF YEAR 19 127,782 137,998

Flows are shown net of the effect of acquisitions on the Group's assets and liabilities, as indicated in Chapter 10 -Goodwill and consolidation differences.

STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY SOL GROUP

(amounts in thousands of Euro)

Share capital Share premium reserve Legal reserve Other reserves Net profit Total Group shareholders' equity
Balance as at 01.01.2021 47,164 63,335 10,459 411,669 103,047 635,674
Allocation of 2020 profit - - - 83,093 (83,093) -
Dividend distribution - - - - (19,954) (15,873)
Other consolidation changes - - - (12,836) - (16,917)
Profit (loss) for the financial year - - - 5,824 89,549 95,373
Balance as at 12.31.2021 47,164 63,335 10,459 487,750 89,549 698,257
Allocation of 2021 profit - - - 67,781 (67,781) -
Dividend distribution - - - - (21,768) (21,768)
Other consolidation changes - - - 2,089 - 2,089
Profit (loss) for the financial year - - - 8,344 133,693 142,037
Balance as at 12.31.2022 47,164 63,335 10,459 565,965 133,693 820,615
Total shareholders' equity pertaining to minority interests Total shareholders' equity
Balance as at 01.01.2021 27,174 662,848
Allocation of 2020 profit - -
Dividend distribution (3,903) (19,776)
Other consolidation changes (4,272) (21,189)
Profit (loss) for the financial year 4,195 99,569
Balance as at 12.31.2021 23,194 721,452
Allocation of 2021 profit - -
Dividend distribution (2,491) (24,259)
Other consolidation changes 17,692 19,781
Profit (loss) for the financial year 3,620 145,656
Balance as at 12.31.2022 42,015 862,630

EXPLANATORY NOTES

The 2022 consolidated financial statements have been drawn up in accordance with the International Accounting Standards (IFRS) established by the International Accounting Standards Board and approved by the European Union. The IFRS are understood to also be all the international accounting standards reviewed (IAS), all the interpretations of the International Financial Reporting Interpretations Committee (IFRIC), previously known as the Standing Interpretations Committee (SIC), approved by the European Union and contained in the relevant EU Regulations.

The financial statements are prepared on the basis of the historical cost principle, amended as requested for the valuation of various financial instruments, as well as on a going concern basis. The SOL Group, in fact, evaluated that no significant uncertainties exist (as defined by paragraph 25 of accounting standard IAS 1) on the principle of going concern The income statement has been drawn up with the allocation of the costs by nature; the Balance Sheet has been prepared in accordance with the format that highlights the separation of the "current/non-current" assets and liabilities, while the indirect method was adopted for the statement of cash flows, adjusting the profit for the period of non-monetary components. Statement of changes in shareholders' equity shows comprehensive income (expenses) for the year and other changes in Shareholders' Equity.

In the Income statement, income and costs deriving from non-recurring operations have been shown separately. The analysis of the income statement and the consolidated statement of financial position and cash flow statement has also been carried out in accordance with the provisions of IFRS 8, highlighting the contribution of the technical gases and home-care service activity sectors taken as primary sectors and providing the most important data relating to the activities by geographic area, Italy and other countries, identified as secondary sectors. Further to the enforcement of Legislative Decree no. 38 of February 28, 2005, implementing in the Italian regulations the European Regulation No. 1606/2002, companies with securities admitted for trading on Member European Union States' regulated markets must from 2006 draw up their financial statements in accordance with the international accounting standards (IAS/IFRS) issued by the International Accounting Standard Board (IASB), as approved by the EU Commission.

The financial statements and the notes to the financial statements have been prepared supplying also the additional information on diagrams and budget disclosure provided by Consob resolution no. 15519 and by Consob notification no. 6064293 issued on July 28, 2006.

GROUP COMPOSITION AND SCOPE OF CONSOLIDATION

The consolidated financial statements comprise the financial statements as at December 31, 2022 of the SOL Spa Parent Company and of the following companies, which are, pursuant to Article 38, paragraph 2 of Italian Legislative Decree No. 127/91 as amended by the provisions of Italian legislative decree no. 139 of 18 August 2015 "Implementation of directive 2013/34/EU related to the financial statements, consolidated financial statements and related reports of certain types of companies, amending directive 2006/43/EC and repealing directives 78/660/EEC and 83/349/EEC, for the part related to the regulations of the financial statements and consolidated financial statements".

a) directly or indirectly controlled subsidiaries, consolidated on a line-by-line basis

Ownership percentage
Company name and registered office Notes Share capital Direct Indirect Total
AIRSOL S.r.l. - Monza EUR 7,750,000 100.00% 100.00%
ALLERSHAUSEN CARE GmbH - Neufahrn bei Freising EUR 25,000 100.00% 100.00%
BTG Bvba - Lessines EUR 5,508,625 100.00% 100.00%
BEHRINGER FRANCE Sarl - Saint Andre Lez Lille EUR 10,000 51.00% 51.00%
BEHRINGER Srl - Genoa EUR 102,000 2.00% 49.00% 51.00%
BHORUKA SPECIALTY GASES PRIVATE Ltd - Bangalore 1 INR 204,080 51.00% 51.00%
BIOTECHSOL Srl - Monza EUR 110,000 51.00% 49.00% 100.00%
BLA SERVICOS HOSPITALARES Ltda - San Paolo BRL 15,000,000 51.00% 51.00%
CTS Srl - Monza EUR 156,000 100.00% 100.00%
CRYOLAB Srl - Rome EUR 509,021 85.00% 85.00%
CRYOS Srl - Peveragno EUR 40,000 70.00% 70.00%
DIATHEVA Srl - Cartoceto EUR 260,000 82.00% 82.00%
DIRECT MEDICAL Ltd - Athlone EUR 100 100.00% 100.00%
DN GLOBAL HOMECARE Ltda - Salvador BRL 1,968,130 46.75% 46.75%
DOLBY HEALTHCARE Ltd- Stirling GBP 300,100 100.00% 100.00%
DOLBY MEDICAL HOME RESPIRATORY CARE Ltd - Stirling GBP 15,100 100.00% 100.00%
ENERGETIKA ZJ doo - Jesenice EUR 999,602 100.00% 100.00%
FLOSIT Sas - Casablanca MAD 12,000,000 99.97% 0.03% 100.00%
FRANCE OXYGENE Sarl - Templemars EUR 1,300,000 100.00% 100.00%
GEBZE GAZ As - Gebze TRY 5,503,000 85.00% 85.00%
GLOBAL CARE Ltda - San Paolo BRL 10,736,528 85.00% 85.00%
GREEN ASU PLANT PRIVATE Ltd - Bangalore 2 INR 9,900,000 100.00% 100.00%
GTH GAZE INDUSTRIALE Sa - Bucharest RON 14,228,583 99.99% 99.99%
GTS Shpk - Tirana ALL 292,164,000 100.00% 100.00%
HYDROENERGY Shpk - Tirana ALL 1,444,108,950 96.04% 96.04%
ICOA Srl - Vibo Valentia EUR 45,760 97.60% 97.60%
IL POINT Srl - Verona EUR 98,800 81.00% 81.00%
Kompass GmbH - Munich EUR 25,000 100.00% 100.00%
Irish Oxygen Company - Cork EUR 697,802 50.01% 50.01%
ITOP Spa OFFICINE ORTOPEDICHE - Rome EUR 400,000 51.00% 51.00%
ITOP SICILIA Srl - Rome EUR 50,000 51.00% 51.00%
ITOP ORTOPEDIE ASSOCIATE Srl - Rome EUR 10,400 51.00% 51.00%
ITOP SERVIZI Srl - Rome EUR 10,000 51.00% 51.00%
ORTHOHUB Srl - Rome EUR 10,000 51.00% 51.00%
JML SERVICOS HOSPITALARES Ltda - San Paolo BRL 19,597,590 51.00% 51.00%
KSD KOHLENSÄURE-DIENST GmbH - Bretzfeld EUR 30,000 100.00% 100.00%
MBAR ASSISTANCE RESPIRATOIRE Sas - Ballan Mire EUR 7,622 100.00% 100.00%
MEDES Srl - Settimo Milanese EUR 10,400 51.00% 51.00%
MEDSEVEN spzoo - Osielsko PLN 646,000 100.00% 100.00%
MEDTEK MEDIZINTECHNIK GmbH - Grunstadt EUR 75,000 100.00% 100.00%
MEL Ad - Trn BAM 2,005,830 80.00% 80.00%
P PAR Ltda - San Paolo BRL 31,233,045 85.00% 85.00%
PALLMED spzoo - Bydgoszcz PLN 800,802 100.00% 100.00%
PERSONAL GENOMICS Srl - Verona EUR 500,000 84.71% 84.71%
PIELMEIER MEDIZINTECHNIK GmbH - Taufkirchen EUR 25,000 100.00% 100.00%
POLAR ICE Ltd - Portarlington EUR 3,672 61.00% 61.00%
PORTARE Ltda- San Paolo BRL 2,000,000 85.00% 85.00%
PROFI GESUNDHEITS - SERVICE GmbH - Weiler bei Bingen EUR 25,000 100.00% 100.00%
REVI Srl - Surbo EUR 52,000 100.00% 100.00%
RESPITEK As - Istanbul TRY 4,390,000 70.00% 70.00%
SHANGHAI MU KANG MEDICAL DEVICE DISTRIBUTION SERVICE Co. Ltd - Shanghai CNY 5,000,000 70.00% 70.00%
SHANGHAI SHENWEI MEDICAL GAS Co. Ltd - Shanghai CNY 10,000,000 70.00% 70.00%
SITEX MAD Sa - Plan-les-Ouates CHF 110,000 100.00% 100.00%
SITEX Sa - Plan-les-Ouates CHF 400,000 100.00% 100.00%
SOL BULGARIA Ead - Sofia BGN 19,305,720 100.00% 100.00%
SOL CROATIA doo (ex KISIKANA) - Sisak HRK 30,771,300 100.00% 100.00%
SOL DEUTSCHLAND GmbH - Krefeld EUR 7,000,000 100.00% 100.00%
SOL FRANCE Sas - Eragny EUR 13,000,000 100.00% 100.00%
SOL GAS PRIMARI Srl - Monza EUR 500,000 100.00% 100.00%
SG - LAB Srl - Costabissara EUR 100,000 100.00% 100.00%
SOL HELLAS Sa - Magoula EUR 4,947,429 99.72% 99.72%
SOL HUNGARY Kft - Dunaharaszti HUF 50,020,000 100.00% 100.00%
SOL HYDROPOWER doo - Skopje MKD 2,460,200 100.00% 100.00%
SOL INDIA PRIVATE Ltd - Chennai INR 703,991,650 86.37% 86.37%
SOL KOHLENSÄURE GmbH & Co. KG - Burgbrohl EUR 20,000 100.00% 100.00%
SOL KOHLENSÄURE VERWALTUNGS GmbH - Burgbrohl EUR 25,000 100.00% 100.00%
SOL KOHLENSÄURE WERK GmbH & Co. KG - Burgbrohl EUR 10,000 100.00% 100.00%
SOL NEDERLAND Bv - Tilburg EUR 2,295,000 100.00% 100.00%
SOL REAL ESTATE DEUTSCHLAND GmbH - Neufahrn bei Freising EUR 25,000 100.00% 100.00%
SOL SEE doo - Skopje MKD 497,554,300 97.16% 2.84% 100.00%
SOL SLOVAKIA Sro - Bratislava EUR 75,000 100.00% 100.00%
SOL SRBIJA doo - Nova Pazova RSD 317,193,834 67.16% 32.84% 100.00%
SOL TG GmbH - Wiener Neustadt EUR 5,726,728 100.00% 100.00%
SOL TK As - Istanbul TRY 28,374,000 100.00% 100.00%
SOL-K ShpK - Pristina EUR 2,010,000 99.72% 0.28% 100.00%
SPG - SOL PLIN GORENJSKA doo - Jesenice EUR 8,220,664 54.85% 45.15% 100.00%
SPITEX PERSPECTA - Basel CHF 100,000 100.00% 100.00%
STERIMED Srl - Milan EUR 100,000 100.00% 100.00%
TPJ doo - Jesenice EUR 2,643,487 64.11% 35.89% 100.00%
TAE HELLAS - Maroussi EUR 6,422,227 99.78% 99.78%
TESI Srl TECNOLOGIA & SICUREZZA Srl - Milan EUR 14,489 89.63% 89.63%
TGP Ad - Petrovo BAM 1,177,999 61.38% 26.04% 87.42%
TGS doo - Skopje MKD 419,220,422 100.00% 100.00%
TGT Ad - Trn BAM 970,081 75.18% 75.18%
UTP doo - Pula HRK 17,543,800 100.00% 100.00%
UNIT CARE Ltda - San Paolo BRL 2,084,000 89.50% 89.50%
VIVICARE GmbH - Neufahrn bei Freising EUR 25,000 100.00% 100.00%
VIVICARE HOLDING GmbH - Neufahrn bei Freising EUR 25,000 100.00% 100.00%
VIVISOL ADRIA doo - Mengeš EUR 7,500 100.00% 100.00%
VIVISOL B Sprl - Lessines EUR 162,500 0.08% 99.92% 100.00%
VIVISOL BRASIL Ltda - San Paolo BRL 11,662,772 94.00% 94.00%
VIVISOL CALABRIA Srl - Vibo Valentia EUR 10,400 98.32% 98.32%
VIVISOL CZECHIA Sro - Prague CZK 100,000 100.00% 100.00%
VIVISOL DEUTSCHLAND GmbH - Neufahrn bei Freising EUR 2,500,000 100.00% 100.00%
VIVISOL FRANCE Sarl - Vaux le Penil EUR 3,503,600 100.00% 100.00%
VIVISOL HEIMBEHANDLUNGSGERÄTE GmbH - Vienna EUR 726,728 100.00% 100.00%
VIVISOL HELLAS Sa - Athens EUR 1,053,981 99.89% 99.89%
VIVISOL IBERICA Slu - Arganda del Rey EUR 5,500,000 100.00% 100.00%
VIVISOL Intensivservice GmbH - Regensburg EUR 40,000 100.00% 100.00%
VIVISOL NAPOLI Srl - Marcianise EUR 98,800 81.00% 81.00%
VIVISOL NEDERLAND Bv - Tilburg EUR 500,000 100.00% 100.00%
VIVISOL PORTUGAL Lda - Condeixa-a-Nova EUR 100,000 100.00% 100.00%
VIVISOL SILARUS Srl - Battipaglia EUR 18,200 56.70% 56.70%
VIVISOL Srl - Monza EUR 2,600,000 51.00% 49.00% 100.00%
WIP WEITERBILDUNG IN DER PFLEGE GmbH - Neufahrn bei Freising EUR 25,000 100.00% 100.00%

1) The Group's share as at December 31, 2022 includes a 5.40 % equity investment of SIMEST Spa; under an agreement entered into between SOL Spa and SIMEST Spa on November 25, 2022, SOL Spa is under obligation to repurchase the entire SIMEST Spa share by November 30, 2030.

2) The Group's share as at December 31, 2022 includes a 47.44 % equity investment of SIMEST Spa; under an agreement entered into between SOL Spa. and SIMEST Spa on November 25, 2022, SOL Spa is under obligation to repurchase the entire SIMEST Spa share by November 30, 2030.

b) jointly controlled companies, consolidated by adopting the equity method

Company name and registered office Share capital Ownership percentage
CONSORZIO ECODUE - Monza EUR 800,000 50.00%
CT BIOCARBONIC GmbH - Zeitz EUR 50,000 50.00%

c) non-consolidated subsidiary and associated companies

Company name and registered office Share capital Ownership percentage
FLOSIT PHARMA Sas - Casablanca MAD 5,000,000 100.00%
GTE Sl - Barcelona EUR 12,020 100.00%
NIPPON SANSO SHENWEI GASES Co. Ltd - Shanghai CNY 18,224,460 31.62%
SHANGHAI SHENWEI GAS FILLING Co. Ltd - Shanghai CNY 1,000,000 37.00%
ZDS JESENICE doo - Jesenice EUR 10,000 75.00%

The companies FLOSIT PHARMA Sa and GTE Sl were not consolidated in that inactive and not relevant for the purposes of giving a true and fair view of the financial position, the results of the operations and of the cash flows of the Group.

The companies NIPPON SANSO SHENWEI GASES Co. Ltd and SHANGHAI SHENWEI GAS FILLING Co. Ltd were not consolidated in that they are minority interests.

ZDS JESENICE doo was not consolidated since it is administered by a minority shareholder.

d) associated companies, consolidated by adopting the equity method

Company name and registered office Share capital Ownership percentage
CONSORGAS Srl - Milan EUR 500,000 25.79%
NEMO LAB Srl - Milan EUR 14,286 30.00%
SHANGHAI JIAWEI MEDICAL GAS Co. Ltd - Shanghai CNY 1,000,000 30.00%

Finally, equity investments in other companies were carried at fair value through profit and loss, as they cannot be included among subsidiary and associated companies.

The scope of consolidation between December 31, 2022 and December 31, 2021 underwent the following changes:

with the inclusion of the Company BLA SERVICOS HOSPITALARES Ltda acquired in April 2022,

with the inclusion of the Company JML SERVICOS HOSPITALARES Ltda acquired in April 2022,

with the inclusion of the Company PROFI GESUNDHEITS - SERVICE GmbH acquired in July 2022,

with the inclusion of the Company WIP WEITERBILDUNG IN DER PFLEGE GmbH acquired in August 2022,

with the inclusion of the Company ITOP Spa OFFICINE ORTOPEDICHE and its subsidiaries ITOP ORTOPEDIE ASSOCIATE Srl, ITOP SERVIZI Srl, ITOP SICILIA Srl and ORTHOHUB Srl, acquired in September 2022,

with the inclusion of the Company POLAR ICE Ltd acquired in November 2022,

with the inclusion of the Company BHORUKA SPECIALTY GASES PRIVATE Ltd acquired in December 2022,

with the inclusion of the Company GREEN ASU PLANT PRIVATE Ltd, acquired in December 2022,

with the increase in shareholdings in the Company GLOBAL CARE Ltda from 84.83% to 85%,

with the increase in the shareholdings in the Company REVI Srl from 80 % to 100%,

with the increase in the shareholdings in the Company STERIMED Srl from 80 % to 100%,

with the increase in shareholdings in the Company UNIT CARE Ltda from 85% to 89.50%,

with the increase in the shareholdings in the Company INTENSIVPFLEGEDIENST KOMPASS GmbH from 70 % to 100%,

with the increase in the shareholdings in the Company ALLERSHAUSEN CARE GmbH from 70 % to 100%,

with the decrease in shareholdings in the Company VIVISOL HELLAS Sa from 100 % to 99.89%,

with the exclusion of the Company SICGILSOL GASES PRIVATE Ltd Srl, merged by incorporation into the Company SOL INDIA PRIVATE Ltd on January 19, 2022,

with the exclusion of the Company VIVICARE HELLAS Sa, merged by incorporation into the Company VIVISOL HELLAS Sa on January 17, 2022,

with the exclusion of ISIMED Srl merged into VIVISOL Srl on May 2, 2022.

According to paragraph 264 Section 3 of the German Commercial Code, German subsidiaries:

ALLERSHAUSEN CARE GmbH - Neufahrn bei Freising

INTENSIVPFLEGEDIENST KOMPASS GmbH - Munich

KSD KOHLENSÄURE-DIENST GmbH - Bretzfeld

MEDTEK MEDIZINTECHNIK GmbH - Grunstadt

PIELMEIER MEDIZINTECHNIK GmbH - Taufkirchen

PROFI GESUNDHEITS - SERVICE GmbH - Weiler bei Bingen

SOL DEUTSCHLAND GmbH - Krefeld

SOL KOHLENSÄURE GmbH & Co. KG - Burgbrohl

SOL KOHLENSÄURE VERWALTUNGS GmbH - Burgbrohl

SOL KOHLENSÄure Werk GmbH & Co. KG - Burgbrohl

SOL REAL ESTATE DEUTSCHLAND GmbH - Neufahrn bei Freising

VIVICARE GmbH - Neufahrn bei Freising

VIVICARE HOLDING GmbH - Neufahrn bei Freising

VIVISOL DEUTSCHLAND GmbH - Neufahrn bei Freising

VIVISOL INTENSIVSERVICE GmbH - Regensburg

WIP WEITERBILDUNG IN DER PFLEGE GmbH - Neufahrn bei Freising

are exempted from the obligation to prepare and publish in Germany both the financial statements in accordance with generally accepted German accounting standards and the report on management and to allow the audit of those financial statements.

ACCOUNTING AND CONSOLIDATION PRINCIPLES

GENERAL PRINCIPLES

The consolidated financial statements of the SOL Group have been drawn up in Euro since this is the legal tender of the economies in the countries where the Group operates. The balances of the consolidated financial statement items, taking into account their importance, are expressed in thousands of Euro. Foreign subsidiaries are included in accordance with the principles described in the section "Consolidation principles - Consolidation of foreign companies".

CONSOLIDATION STANDARDS

Subsidiary companies

These are companies over which the Group exercises control. Such control exists when the Group has the power, directly or indirectly, to determine the financial and operating policies of a company, for the purpose of obtaining the benefits from its activities. The financial statements of the subsidiary companies are included in the consolidated financial statements as from the date when control over the company was taken up until the moment said control ceases to exist. The portions of shareholders' equity and the result attributable to minority shareholders are indicated separately in the consolidated balance sheet and income statement, respectively. Subsidiaries are enterprises over which SOL has the power to determine autonomously the strategic choices of the enterprise in order to obtain the related benefits. In general, the existence of control is presumed when more than half of the voting rights in the ordinary Shareholders' Meeting are directly or indirectly held also considering the potential votes i.e. voting rights deriving from convertible instruments.

Dormant subsidiaries are not included in the consolidated financial statements.

Jointly controlled companies

These are companies over whose activities the Group has joint control, as defined by IFRS 11 - Joint Arrangements. The consolidated financial statements include the portion pertaining to the Group of the results of the jointly controlled companies, recorded using the equity method, as from the date on which the significant influence started and until it ceases to exist.

Associated companies

These are companies in which the Group does not exercise control or joint control over the financial and operating policies (joint ventures that do not qualify as joint operations and associated companies) over which SOL exercises significant influence in determining their strategic decisions, albeit without having control over them, also considering the potential votes i.e. voting rights deriving from convertible instruments; significant influence is presumed when SOL holds, directly or indirectly, more than 20% of the voting rights in the ordinary Shareholders' Meeting.

The consolidated financial statements include the portion pertaining to the Group of the results of the associated companies, recorded using the equity method, as from the date on which the significant influence started and until it ceases to exist.

Equity investments in other companies

Equity investments in other companies (normally involving a percentage ownership of less than 20%) are carried at fair value and possibly written down to reflect any permanent losses in value. Subsequently, gains and losses deriving from changes in fair value are recognised directly in profit or loss for the period as permitted by IFRS 9.

Transactions eliminated during the consolidation process

All the balances and the significant transactions between Group companies, as well as unrealised gains and losses on inter company transactions, are eliminated during the preparation of the consolidated financial statements. Any unrealised gains or losses generated on transactions with associated companies are eliminated in relation to the value of the Group's shareholding in said companies.

The criteria applied for consolidation are as follows:

Assets and liabilities, income and costs in financial statements consolidated on a line-by-line basis are entered into the Group financial statements, regardless of the entity of the equity interest concerned. Moreover, the carrying value of equity interests is derecognised against the shareholders' equity relating to investee companies;

payable/receivable and cost/revenue items between consolidated companies and profits/losses arising from intercompany transactions are derecognised. Similarly, dividends and write-downs of equity investments recognised in the financial statements are eliminated;

closing inventories for products purchased from Group companies are adjusted for the intra-group margins included therein, as these have not yet been realised with third parties.

Capital gains realised on intra-group sales of intangible and tangible fixed assets are eliminated net of the amortisation/depreciation recorded on those gains.

If minority shareholders exist, the portion of shareholders' equity and net profit for the period pertaining thereto is posted in specific items of the balance sheet and income statement;

upon the sale of an investee that results in the loss of control, any goodwill attributable to the investee is taken into account in determining the gain or loss on disposal;

in case of shareholdings acquired after control has been obtained, any difference between the purchase cost and the corresponding portion of shareholders' equity is recognised in equity; Similarly, the effects of the sale of minority interests without loss of control are recognised in equity.

Foreign currency transactions

Transactions in foreign currencies are recorded at the exchange rate in force as of the date of the transaction. Monetary assets and liabilities in foreign currencies at the reporting date are translated at the exchange rate in force at that date. Exchange differences arising from the settlement of monetary items or from their translation at exchange rates different from those used at the time of initial recording during the year or in previous financial statements, are booked to the income statement.

Consolidation of foreign companies

All the assets and liabilities of foreign companies denominated in currency other than the Euro that are included within the scope of consolidation are converted using the exchange rates in force at the reporting date (current exchange rate method). Income and costs are translated using the average rate for the year. The exchange differences emerging from the application of this method are classified as an equity account until the equity investment is disposed of.

Goodwill and adjustments to the fair value generated by the acquisition of a foreign company are stated in the relevant currency and translated using the period-end exchange rate.

The exchange rates used for converting the financial statements not expressed in Euro are indicated in the table below:

Currency Exchange rate on 12.31.2022 Average exchange rate 2022 Exchange rate on 12.31.2021
Czech Koruna Euro 0.04147 Euro 0.04071 Euro 0.04023
Macedonian dinar Euro 0.01624 Euro 0.01623 Euro 0.01623
Serbian dinar Euro 0.00852 Euro 0.00852 Euro 0.00850
Moroccan dirham Euro 0.08962 Euro 0.09365 Euro 0.09539
Hungarian forint Euro 0.00249 Euro 0.00256 Euro 0.00271
Swiss franc Euro 1.01554 Euro 0.99532 Euro 0.96796
Croatian Kuna Euro 0.13269 Euro 0.13272 Euro 0.13306
Albanian lek Euro 0.00874 Euro 0.00841 Euro 0.00828
Bulgarian lev Euro 0.51130 Euro 0.51130 Euro 0.51130
Turkish Lira Euro 0.05009 Euro 0.05009 Euro 0.06564
Convertible mark Euro 0.51129 Euro 0.51129 Euro 0.51129
New Romanian leu Euro 0.20204 Euro 0.20279 Euro 0.20206
Brazilian real Euro 0.17735 Euro 0.18383 Euro 0.15848
Indian rupee Euro 0.01134 Euro 0.01209 Euro 0.01187
British pound Euro 1.12748 Euro 1.17266 Euro 1.19008
Yuan renminbi Euro 0.13590 Euro 0.14127 Euro 0.13899
Polish Zloty Euro 0.21364 Euro 0.21340 Euro 0.21754
Currency Average exchange rate 2021
Czech Koruna Euro 0.03900
Macedonian dinar Euro 0.01623
Serbian dinar Euro 0.00851
Moroccan dirham Euro 0.09411
Hungarian forint Euro 0.00279
Swiss franc Euro 0.92498
Croatian Kuna Euro 0.13283
Albanian lek Euro 0.00817
Bulgarian lev Euro 0.51130
Turkish Lira Euro 0.09513
Convertible mark Euro 0.51129
New Romanian leu Euro 0.20319
Brazilian real Euro 0.15679
Indian rupee Euro 0.01144
British pound Euro 1.16333
Yuan renminbi Euro 0.13109
Polish Zloty Euro 0.21905

Business combinations

The business combinations are accounted for in accordance with the acquisition method in accordance with IFRS 3. According to this method, the consideration transferred in a business combination is measured at fair value, calculated as the sum of the fair value of the assets transferred and liabilities undertaken by the Group at the date of acquisition and of the equity instruments issued in exchange for the control of the acquired company. The expenses related to the transaction are generally recognised in the income statement when they are incurred. The goodwill is determined as the surplus between the sum of the amounts transferred in the business combination, the value of shareholders' equity attributable to minority interests and the fair value of any equity investment previously held in the acquired company compared to the fair value of net assets acquired and liabilities undertaken at the date of acquisition. If the value of the net assets acquired and liabilities undertaken at the date of acquisition exceeds the sum of the amounts transferred, the value of shareholders' equity attributable to minority interests and the fair value of any equity investment previously held in the acquired company, this surplus is immediately recognised in the income statement as income arising from the concluded transaction.

The portions of shareholders' equity attributable to minority interests, at the date of acquisition, can be measured at fair value or at the pro-rata value of net assets recognised for the acquired company. The choice of the measurement method is carried out for each transaction.

Any amount subject to conditions stipulated by the contract of business combination are measured at fair value at the date of acquisition and included in the value of the amounts transferred in the business combination for the purposes of determining the goodwill.

In the case of business combinations that occurred in stages, the equity investment previously held by the Group in the acquired company is revalued at fair value at the date of acquisition of control and any ensuing gain or loss is recognised in the income statement. Any value arising from the equity investment previously held and recorded in Other profits (losses) are reclassified in the income statement as if the equity investment had been transferred.

The business combinations that occurred before January 1, 2010 were recognised according to the previous version of IFRS 3.

Minority shareholders

The portion of capital and reserves pertaining to minority shareholders in subsidiaries and the portion pertaining to minority shareholders of profit or loss for the year of consolidated subsidiaries are separately identified in the consolidated income statement and balance sheet. Changes in ownership shares of subsidiaries that do not involve acquisition/loss of control are accounted for under changes in shareholders' equity.

Acquisition of minority shares

After obtaining the control of a company, transactions in which the parent company acquires or transfers more minority interests without modifying the control over the subsidiary are to be considered transactions with shareholders and therefore must be recognised under shareholders' equity. It follows that the book value of the controlling interest and minority interests must be adjusted to reflect the change in interest in the subsidiary and any difference between the amount of the adjustment made to minority interests and the fair value of the price paid or received in respect of that transaction is recognised directly in the shareholders' equity and is attributed to the shareholders of the parent company. There will be no adjustment to the value of goodwill and profits or losses will be recognised in the income statement. The expenses arising from such transactions must also be recognised in equity in accordance with the requirements of IAS 32 in paragraph 35.

Under common control transactions

A business combination involving enterprises or groups under common control (transaction under common control) is a combination in which all of the enterprises or businesses are ultimately controlled by the same person or persons both before and after the business combination and the control is not temporary.

If a significant influence on future cash flows after the transfer is demonstrated for all parties involved, these transactions are treated as described under "Business combinations and goodwill".

If, however, this cannot be demonstrated, such transactions are recognised according to the principle of continuity of values.

In particular, the accounting recognition criteria, in application of the principle of continuity of values, falling within the scope of what is indicated in IAS 8.10, in line with international practice and the orientations of the Italian accounting profession on the subject of business combinations under common control, envisage that the purchaser recognises the assets acquired on the basis of their historical book values determined on a cost basis. If the transfer values are higher than the historic values, the excess is reversed, reducing the shareholders' equity of the acquiring Group, with the recording of a special reserve in its financial statements.

Similarly, the accounting standard adopted in preparing the financial statements of the transferring Group provides that any difference between the transaction price and the pre-existing book value of the transferred assets is not recognised in the income statement, but is instead recognised as a credit to shareholders' equity.

ACCOUNTING STANDARDS TANGIBLE FIXED ASSETS

Cost

Real estate property, plant and machinery are stated at purchase or production cost, inclusive of any related charges. For assets that justify capitalisation, the cost also includes the financial expenses that are directly attributable to the acquisition, construction or production of said assets.

The costs incurred subsequent to purchase are capitalised only if they increase the future economic benefits inherent to the assets to which they refer.

Gains and losses from sale or disposal of assets are calculated as the difference between the sales revenue and the net book value of the asset and are recognised in profit or loss of the financial year.

All the other costs are recorded in the income statement when incurred.

Assets held under financial lease agreements, via which all the risks and benefits associated with the ownership are essentially transferred to the Group, are recorded as Group assets at their current value or, if lower, at the net current value of minimum lease payments due. The corresponding liability owed to the lessor is recorded in the financial statements under financial payables. The assets are depreciated by applying the following method and rates. The recoverability of their value is ascertained in accordance with the approach envisaged by IAS 36 illustrated in the following paragraph "Impairment of assets". Write-downs made may be reversed in the context of the original cost incurred.

The costs capitalised for leasehold improvements are attributable to the classes of assets to which they refer and depreciated over the residual duration of the rental contract or the residual useful life of the improvement, whichever period is shorter.

If the individual components of the compound fixed asset are characterised by different useful lives, they are recorded separately so as to be depreciated on a consistent basis with their duration ("component approach). Specifically, according to this approach, the value of land and the value of the buildings on it are separated and just the building is depreciated.

Depreciation

Depreciation is calculated on a straight-line basis over the estimated useful life of the assets, as follows:

Land -
Buildings 2% - 10 %
Plant and machinery 7,5% - 20 %
Industrial and commercial equipment 5.5% - 25 %
Other assets 10% - 30 %

Lease agreements

The Group must assess whether the agreement is, or contains, a lease at the date it is entered into. The Group recognises the Right of Use and the related lease liability for all lease arrangements as lessee, except for short- term leases (i.e. leases of 12 months or less) and leases of low-value assets (by Group policy, such assets are those with a value of less than Euro 10,000 when new). For the latter, the Group recognises the related payments as operating expenses on a straight-line basis over the term of the contract unless another method is more representative. The agreements for which this last exemption was applied fell mainly within the following categories:

computers, phones and tablets;

printers;

equipment;

other electronic devices;

other assets.

With reference to these exemptions, the Group recognises the related payments as operating expenses recognised on a straight-line basis over the term of the agreement

The lease payments included in the value of the lease liability include:

the fixed component of the lease payments, net of any incentives received;

variable lease payments based on an index or rate, initially measured using the index or rate at the effective date of the agreement;

the amount of guarantees for the residual value that the lessee expects to pay;

the exercise price of the purchase option, which must be included only if the exercise of that option is considered reasonably certain;

penalties for early termination of the lease if the lease term provides for an option to terminate the lease and the exercise of that option is reasonably certain.

Subsequent to initial recognition, the book value of the lease liability increases due to accrued interest (using the effective interest method) and decreases due to payments made under the lease agreement.

The Group recalculates the lease liability (and adjusts the corresponding right-of-use value) if:

the duration of the lease changes or there is a change in the valuation of the exercise of the option right; in which case the lease liability is restated by discounting the new lease payments at the revised discount rate.

changes in the value of the lease payments as a result of changes in indices or rates, in such cases the lease liability is restated by discounting the new lease payments at the original discount rate (unless the lease payments change as a result of fluctuations in interest rates, in which case a revised discount rate shall be used).

a lease agreement has been amended and the amendment does not qualify for separate recognition of the lease agreement. In such cases, the lease liability is restated by discounting the new lease payments at the revised discount rate.

The right-of-use asset comprises the initial measurement of the lease liability, lease payments made before or on the effective date of the lease and any other initial direct costs. The right of use is recognised in the financial statements net of depreciation and any impairment losses.

Lease-related incentives (e.g. rent-free periods) are recognised as part of the initial value of the right-of-use and lease liability over the contractual period.

The right of use is depreciated on a systematic basis at the lower of the lease term and the residual useful life of the underlying asset. If the lease agreement transfers ownership of the related asset or the cost of the right of use reflects the Group's intention to exercise the purchase option, the related right of use is amortised over the useful life of the asset in question. Depreciation starts from the commencement of the lease term.

The Group applies IAS 36 Impairment of Assets in order to identify the presence of any impairment losses.

Public grants

Public grants are recognised in the financial statements when there exists a reasonable certainty that the company will meet all the conditions for receiving the contributions and that the contributions will be received. When the contributions are related to cost components, they are recognised as revenues, but are allocated systematically across the financial periods in order to be proportionate to the costs that they intend to compensate. If a contribution is related to an asset, the asset and the contribution are recognised for their nominal values and they are gradually discharged to the income statement, on a straight-line basis, along the expected useful life of the asset of reference.

If the Group receives a non-monetary contribution, the asset and contribution are recognised at their nominal value and discharged to the income statement, on a straight-line basis, along the expected useful life of the asset of reference. In case of loans or similar forms of assistance supplied by government entities or similar institutions that have an interest rate lower than the current market rate, the effect related to the favourable interest rate is considered as an additional public grant.

INTANGIBLE ASSETS

Goodwill and consolidation differences

In the event of the acquisition of businesses, the assets, liabilities and potential liabilities acquired and identifiable are stated at their current value (fair value) as of the date of acquisition. The positive difference between the purchase cost and the portion of the current value of these assets and liabilities pertaining to the Group is classified as goodwill and recorded in the financial statements as an intangible asset. Any negative difference ("negative goodwill") is by contrast stated in the income statement at the time of acquisition.

Goodwill is not amortised, but is subject annually (or more frequently if specific events or changed circumstances indicate the possibility of having suffered an impairment) to checks in order to identify any reduction in value, carried out at Cash Generating Unit level to which the Company's management charges said goodwill, in accordance with the matters anticipated by IAS 36 - Impairment of assets. After initial recognition, goodwill is valued at cost, net of any accumulated impairment losses.

Any write-downs made are not subject to subsequent reinstatement.

At the time of the disposal of a portion or of the whole of a company previously acquired, whose acquisition gave rise to goodwill, account is taken of the corresponding residual value of the goodwill when determining the capital gain or loss on the disposal.

At the time of initial adoption of the IFRS, the Group chose not to retroactively apply IFRS 3 - Business Combinations, to the acquisitions of businesses that took place prior to January 1, 2004; consequently, the goodwill generated on the acquisitions prior to the date of transition to the IFRS is maintained at the previous value, as are the consolidation reserves recorded under the shareholders' equity, determined in accordance with Italian accounting standards, subject to assessment and recognition of any impairment losses at that date.

Other intangible fixed assets

The other intangible fixed assets purchased or produced internally are identifiable assets lacking physical consistence and are recorded under assets, in accordance with the matters laid down by IAS 38 - Intangible assets, when the company has control over said assets and it is probable that the use of the same will generate future economic benefit and when the cost of the assets can be reliably determined.

These assets are measured at purchase or production cost and amortised on a straight-line basis over their estimated useful lives, if the same have a definite useful life. Intangible fixed assets with an indefinite useful life are not amortised, but are subject annually (or more frequently if there is indication that the asset may have suffered an impairment) to assessment in order to identify any reductions in value.

Other intangible fixed assets recorded following the acquisition of a company are recorded separately from the goodwill, if their current value can be determined reliably.

IMPAIRMENT OF ASSETS

IAS 36 requires the company to test tangible and intangible and fixed assets for impairment where indicators that such problem may persist are present. In the case of other intangible assets with an indefinite useful life or assets not available for use (in progress), this assessment is made at least annually.

The Group periodically assesses the recoverability of the book value of the Intangible assets and the Real estate property, plant and machinery, so as to determine if there is any indication that said assets have suffered an impairment loss. If such indication occurs, it is necessary to estimate the recoverable amount of the assets in order to establish the entity of the possible impairment loss. An intangible asset with an indefinite useful life is tested for impairment annually or more frequently, whenever there is an indication that the asset may be impaired.

When it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the unit generating the financial flows to which the asset belongs.

The recoverability of the recognised amounts is tested by comparing the book value recognised in the financial statements with the fair value net sale price, if an active market exists, or the value in use of the asset, whichever is greater.

In calculating the usage value, the estimated future cash flows are discounted to their current value using a rate that reflects the current market valuations of the current value of cash and the asset's specific risks. The main assumptions used for calculating the value of use concern the discount rate, growth rate, expected changes in selling prices and cost trends during the period used for the calculation. The growth rates adopted are based on future market expectations in the relevant sector. Changes in the sales prices are based on past experience and on the expected future changes in the market. The Group prepares operating cash flow fore- casts resulting from the business plan prepared by the Directors and approved by the Board of Directors of the parent company and determines the terminal value (current value of perpetual income), based on a medium- and long-term growth rate in line with that of the specific sector to which it belongs.

If the recoverable amount of an asset (or CGU) is estimated to be lower than its book value, the latter is reduced to the lower recoverable amount, immediately recognising impairment in the income statement.

When there is no longer any reason for a write-down to be maintained, the book value of the asset (or of the cashgenerating unit) - with the exception of goodwill - is increased to the new value resulting from the estimate of its recoverable amount, but not beyond the net book value that the asset would have had if it had not been written down for impairment. Reversal of impairment loss is recognised immediately in the income statement.

FINANCIAL INSTRUMENTS

Financial assets and financial liabilities are recognised in the Group's statement of financial position when the Group becomes a party to the contractual provisions governing the instrument.

The Equity investments and other non-current financial assets item includes the equity investments in non-consolidated companies and other non-current financial assets (securities held with the intention of maintaining them in the portfolio until maturity, non-current receivables and loans and other non-current financial assets available for sale).

Current financial instruments include trade receivables, current securities, other current financial assets and liquid funds and equivalents.

Financial liabilities include financial payables and trade payables.

Equity investments in non-consolidated companies are stated in accordance with the matters established by IAS 28 -Investments in associated and Joint Ventures , as described in the previous section entitled "Consolidation principles"; equity investments in other companies are stated at cost net of any write-downs. Other non-current financial assets, as well as current financial assets and financial liabilities, are stated in accordance with the approach established by IAS 39 - Financial instruments: recognition and measurement.

Current financial assets and securities held with the intention of maintaining them in the portfolio until maturity are recorded in the accounts with reference to the date of trading and, at the time of initial recognition in the financial statements, are measured at acquisition cost, including any costs related to the transaction.

Subsequent to initial recognition, the financial instruments at FVTOCI and those available for trading are measured at fair value. If the market price is not available, the fair value of the financial instruments at FVTOCI available for sale is measured by means of the most appropriate measurement techniques, such as, for example, the analysis of the discounted back cash flows, made with the market information available at the end of the reporting period.

When an investment in a debt instrument measured as FVTOCI is derecognised, the cumulative gain (loss) previously recognised in other comprehensive income is reclassified from equity to profit or loss through a reclassification adjustment.

Conversely, when an investment in an equity instrument designated as measured at FVTOCI is derecognised, the cumulative gain (loss) previously recognised in other comprehensive income is subsequently transferred to retained earnings without passing through profit or loss.

Current assets denominated in foreign currencies for which hedging transactions through derivative instruments are undertaken are measured in accordance with hedge accounting, where applicable.

Gains and losses on financial assets available for sale are recorded directly under shareholders' equity until the financial asset is sold or is written down; then, the accumulated gains or losses, including those previously recorded under shareholders' equity, are recorded in the income statement for the period.

Loans and receivables that the Group does not hold for trading purposes (loans and receivables originated during core business activities), securities held with the intention of being maintained in the portfolio until maturity and all the financial assets for which listings on an active market are not available and whose fair value cannot be determined reliably, are calculated at amortised cost, if they have a pre-established maturity, using the effective interest method. When the financial assets do not have a pre-established maturity, they are measured at purchase cost.

Measurements are regularly carried out so as to check if objective evidence exists whether a financial asset or a group of assets have suffered an impairment loss. If objective evidence exists, the impairment loss will have to be recorded as a cost in the income statement for the period.

The financial liabilities hedged by derivative instruments are valued in accordance with the formalities established by IAS 39 for hedge accounting applying the following accounting treatments:

fair value hedge: the profits or losses deriving from fair value measurements of the hedged instrument are recorded in the income statement;

cash flow hedge: the effective portion of profits or losses deriving from fair value measurements of the hedged instrument are recorded in the income statement.

IMPAIRMENT OF FINANCIAL ASSETS

The recoverability of financial assets not measured at fair value through profit or loss is measured on the basis of the Expected Credit Loss (ECL) model introduced by IFRS 9.

Expected losses are generally determined by multiplying: (i) the exposure to the counterparty by (ii) the probability of default (PD) of the counterparty; (iii) the estimate, in percentage terms, of the amount of credit that will not be recovered in the event of a defined loss given default (LGD), as well as past experience and possible recovery actions available.

DERECOGNITION OF FINANCIAL ASSETS AND LIABILITIES

Financial assets are derecognised whenever one of the following conditions occurs:

the contractual right to receive cash flows from the asset has expired;

the Group has transferred substantially all the risks and benefits related to the asset, either by transferring its rights to receive cash flows from the asset or by assuming a contractual obligation to return the cash flows received to one or more recipients under a contract that meets the requirements of IFRS 9;

the Group has neither transferred nor retained substantially all the risks and benefits related to the financial asset but has transferred control of it.

The financial liabilities are derecognised when they are extinguished, i.e. when the contractual obligation is discharged, cancelled or expired.

When an existing financial liability is replaced by another to the same creditor on substantially different terms, or the terms of an existing liability are substantially changed, such replacement or change is treated as derecognition of the original liability and recognition of a new liability. The difference between the respective book values is recognised in the income statement.

DERIVATIVE INSTRUMENTS

The financial liabilities hedged by derivative instruments are valued in accordance with the formalities established by IAS 39 for Hedge accounting applying the following accounting treatments:

fair value hedge: the profits or losses deriving from fair value measurements of the hedged instrument are recorded in the income statement;

cash flow hedge: the effective portion of profits or losses deriving from fair value measurements of the hedged instrument are recorded in the income statement.

The Group decided to continue to use the hedge accounting rules set out in IAS 39 for all hedges already designated in hedge accounting in previous years and for new hedges designated in 2020.

DISCLOSURE

IFRS 7 requests additional information aimed at appreciating the importance of the financial instruments in relation to economic performances and to the financial position of a company. The accounting principle requires a description of the targets, policies and procedures carried out by the Management for the different types of financial risk (liquidity market and credit risk) to which the subject is exposed, including sensitivity analysis for each type of market risk (exchange rate, interest rate, equity, commodity) and report on the concentration and average, minimum and maximum exposure to the different types of risk during the period of reference, if the existing exposure at the end of the period is not sufficiently representative.

IAS 1 regulates among other things report obligations to be supplied on the targets, policies and management processes of the share capital, specifying, in case of capital requirements imposed by third parties, the management nature and method and any consequence of lack of compliance. For qualitative and quantitative analysis, refer to Note 25 "Financial Instruments".

INVENTORIES

Inventories of raw materials, semi-finished and finished products are valued at the lower of cost and market value, cost being determined using the weighted average cost method. The measurement of the inventories includes the direct costs of the materials and the labour and the indirect costs (variable and fixed). Write-down allowances are calculated for materials, finished products and other supplies considered obsolete or slow-moving, taking into account their future expected usefulness or their realisable value.

Contract work in progress is measured on the basis of the stage of completion, net of any advance payments invoiced to customers.

Any losses on these contracts are booked to the income statement in full at the time they become known.

LOANS

Loans are initially measured at cost, corresponding to the fair value of the amount received, net of additional charges incurred to obtain the loan.

After initial recognition, loans are recognised at amortised cost calculated by applying the effective interest rate. The effective interest method is the method of calculating the amortised cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that discounts future payments (including all fees, transaction costs and other premiums or discounts) over the term of the financial liability or, if more appropriate, over a shorter period. Loans are classified among current liabilities unless the Group has the unconditional right to defer discharge of a liability by at least 12 months after the reporting period.

EMPLOYEE BENEFITS

Post-employment benefits are defined on the basis of plans, even if not yet formalised, which, based on their nature, are classified as "defined contribution" and "defined benefit". In defined contribution plans, the company's obligation is limited to the payment of contributions to the State or to a legally separate entity (so called Fund), and is determined on the basis of contributions due, reduced by amounts already paid over, if any.

The liability for defined benefit plans, net of any assets serving the plan, is determined on the basis of actuarial calculations and is recognised on an accrual basis on a consistent basis with the period of employment necessary to obtain the benefit.

The severance indemnity is classified as a defined benefit plan-type post-employment benefit, whose accrued sum must be projected so as to estimate the amount to be paid out on termination of the employment relationship and subsequently discounted back, using the projected unit credit method, which is based on demographic and financial type hypothesis in order to make a reasonable estimate of the sum total of the benefits that each employee has already accrued against their employment services.

By means of the actuarial measurement, the current service cost that defines the sum total of the rights accrued during the year by the employees is charged to the income statement item "payroll and related costs" and the interest cost which represents the figurative liability that the company would incur by requesting the market for a loan for the same amount as the severance indemnity is booked under "financial income/expense". The remeasurement components of the net liabilities, which include the actuarial profits and losses, are immediately recorded in the Statement of Comprehensive Income. Such components need not be reclassified in the Income Statement.

PROVISIONS FOR RISKS AND CHARGES

The Group records provisions for risks and charges when it has a legal or implied obligation vis-à-vis third parties, and it is probable that it will become necessary to use Group resources in order to fulfil the obligation and when a reliable estimate of the sum total of said obligation can be made.

The estimate changes are reflected in the income statement in the period when the change took place.

TREASURY SHARES

Treasury shares, if present, are stated as a decrease to the shareholders' equity. The original cost of the treasury shares and the revenues deriving from any subsequent sales are recorded as changes in shareholders' equity.

FOREIGN CURRENCY TRANSACTIONS

Transactions in foreign currencies are recorded at the exchange rate in force as of the date of the transaction. Monetary assets and liabilities in foreign currency are translated at the exchange rate in force at the reporting date. Exchange differences arising from the settlement of monetary items or from their translation at exchange rates different from those used at the time of initial recording during the year or in previous financial statements, are booked to the income statement.

HYPERINFLATIONARY ECONOMIES

The SOL Group controls companies based in Turkey, a country that has been defined as having high inflation in 2022, as the cumulative inflation rate over the last three years has exceeded 100 %. According to the accounting standard IAS 29 Financial Reporting in Hyperinflationary Economies, the financial statements of Turkish companies must be restated according to specific procedures and a valuation process, in order to eliminate the distorting effects of the loss of the purchasing power of money.

In the income statement, costs and revenues are revalued by applying the change in the general consumer price index. With regard to the balance sheet, monetary items are not revalued as they are already expressed in the current unit of measurement at the end of the reporting period; On the other hand, non-monetary assets and liabilities are revalued from the date of initial recognition to the end of the reporting period.

The financial statements are translated into Euro by applying the period-end exchange rate for both balance sheet and income statement items.

REVENUE RECOGNITION

Revenues are recognised to the extent that control is transferred so that it is probable that the Group will receive the economic benefits and their amount can be reliably measured.

Revenues are stated net of any adjusting entries.

Revenue from contracts with customers are recognised on the basis of the following five steps:

(i) identifying the contract with a customer;

(ii) identifying the performance obligations, represented by promises in a contract to transfer to a customer goods or services;

(iii) determining the transaction price;

(iv) allocating the transaction price to each performance obligation on the basis of the relative selling prices of each distinct good or service;

(v) recognising revenue when a performance obligation is satisfied by transferring a promised good or service to a customer. The transfer is considered completed when the customer obtains control of the good or service, which can take place continuously (over time) or at a specific time (at a point in time).

Revenue is recognised at the fair value of the amount of consideration to which the company believes it is entitled in exchange for the goods and/or services promised to the customer, excluding amounts collected on behalf of third parties. In the presence of a variable consideration, the company estimates the amount of the consideration to which it will be entitled in exchange for the transfer of the goods and/or services promised to the customer; in particular, the amount of the consideration may vary where there are discounts, rebates or bonuses or where the price itself depends on the occurrence or non-occurrence of certain future events. Exchanges between goods or services of a similar nature and value, since they do not represent sales transactions, do not result in the recognition of revenues.

Revenue from sales is recognised upon the transfer of ownership, which generally coincides with the shipment or delivery of the goods. Grants related to income are fully recognised in the income statement when the recognition requirements are met. Financial income and expense are recognised on an accrual basis.

COST RECOGNITION

Costs and expenses are recognised in the financial statements on an accrual basis.

FINANCIAL INCOME AND EXPENSE

Financial income and expense are recognised in the income statement on an accrual basis.

In particular, interest income and expense are recognised on an accrual basis, according to the amount of the loan and the effective interest rate, which represents the rate used to discount estimated future cash receipts/ payments over the expected life of the financial asset/liability to the book value.

TAX

Income taxes include all the taxation calculated on the Group's taxable income. Income taxes are recorded in the income statement, with the exception of those relating to items directly debited against or credited to shareholders' equity, in which case the tax effect is booked directly to shareholders' equity. Provisions for taxation that might be generated by the transfer of the non-distributable profit of subsidiary companies, are made solely when there is the real intention to transfer said profit.

Other taxes not linked to income, such as taxes on property and on capital, are included under Operating expense. Deferred taxes are provided for according to the method of the overall provision of the liability. They are calculated on all the timing differences that emerge between the taxable base of an asset or liability and the book value in the consolidated financial statements, with the exception of goodwill not deductible for tax purposes. Deferred tax assets on tax losses and unused tax credits carried forward, are recognised to the extent that future taxable income may be available against which they can be recovered.

Current and deferred tax assets and liabilities are offset when the income taxes are applied by the same tax authority and when there is a legal right to offset. Deferred tax assets and liabilities are determined using the tax rates that are expected to be applicable, within the respective legal systems of the countries where the Group operates, during the accounting period when the timing differences will be realised or cancelled.

Pursuant to Italian Enabling Act no. 80 of April 7, 2003, as amended, from the current financial year, the parent company SOL Spa is the consolidating company; in addition to SOL Spa, the scope of consolidation also includes AIRSOL Srl, BIOTECHSOL Srl and DIATHEVA Srl.

DIVIDENDS

Dividends payable are represented as changes in shareholders' equity during the accounting period when they are approved by the shareholders' meeting.

EARNINGS PER SHARE

The basic earnings per share are calculated by dividing the Group's economic result by the weighted average of the shares in circulation during the year, excluding treasury shares.

CASH FLOW STATEMENT

The cash flow statement is drawn up by applying the indirect method via which the pre-tax result is adjusted by the effects of the non-monetary transactions, by any deferral or provision of previous or future operative collections or payments.

USE OF ESTIMATES

The preparation of the financial statements and the related notes in accordance with the IFRS requires management to make estimates and assumptions that have an effect on the values of the financial statement assets and liabilities and on the disclosures relating to the potential assets and liabilities at the end of the reporting period. The results that will make up the final balances may differ from said estimates. The estimates are used to obtain provisions for risks and charges, asset write-downs, employee benefits, taxation, other provisions, determining the lease term and funds. The estimates and assumptions are periodically reviewed and the effects of each change are immediately reflected in the income statement.

In general, the use of estimates is particularly important for depreciation/amortisation, measurement of derivative instruments, calculation of risk provisions and write-down provisions or other assets, calculation of revenue as well as impairment test.

RIGHTS OF USE

The new standard IFRS 16 provides a new definition of lease and introduces a criterion based on the control (right of use) of an asset to distinguish lease agreements from service contracts, identifying the following as discriminating: the identification of the asset, the right to replace it, the right to substantially obtain all of the economic benefits resulting from the use of the asset and, most recently, the right to direct the use of the asset underlying the contract.

As a result of the introduction of the new standard in the income statement as from January 1, 2019, the depreciation charges of rights of use determined on the basis of the defined lease terms, based on the assessments made regarding the probability of renewal, and the accrued portion of financial expense related to the liabilities are recognised. This process implies a high degree of judgement by the management.

ALLOWANCE FOR DOUBTFUL ACCOUNTS

The allowance for doubtful accounts reflects the Group's estimate of losses on receivables from customers. The estimate of the allowance for doubtful accounts is based on expected losses, calculated on the basis of past experience for similar receivables, current and historical past dues, losses and payments received, the careful monitoring of credit quality, and projections of economic and market conditions.

RECOVERABLE AMOUNT OF NON-CURRENT ASSETS

Non-current assets include property, plant and equipment, intangible assets, equity investments and other financial assets. The Management periodically reviews the book value of non-current assets held and used and of the assets that must be disposed of, when events and circumstances require such a review. This activity is carried out using estimates of cash flows expected from the use or sale of the asset and appropriate discount rates to calculate the current value. When the book value of a non-current asset is impaired, the company recognises an impairment loss for the amount by which the book value of the asset exceeds its recoverable amount through use or sale, calculated by reference to the most recent plans.

DEFERRED TAX ASSETS AND DEFERRED TAX LIABILITIES

The company recognises current taxes, deferred tax assets/liabilities in accordance with the regulations in force. The recognition of taxes requires the use of estimates and assumptions as to how to read the applicable rules and their effect on the company's taxation in relation to transactions during the year. Moreover, the recognition of deferred tax assets/liabilities requires the use of estimates of future taxable income and its changes as well as the actual applicable tax rates. These activities are carried out by analysing transactions and their tax profiles, also with the support, where necessary, of external consultants for the various issues addressed and through simulations of future income and their sensitivity analyses.

PENSION PLANS

Some Group companies can participate in pension plans; in Italy, the Employee Severance Indemnity fund is configured as a defined-benefit plan (with the exception of the portions of Employee Severance Indemnities accrued from January 1, 2007, which are configured as defined contribution plans). The Group uses various statistical assumptions and assessment factors in order to anticipate future events for the calculation of expenses, liabilities and assets related to these plans. The assumptions concern the discount rate, the expected return on plan assets and the rates of future salary increases. Moreover, the Group's consulting actuaries also use subjective factors, such as mortality and resignation rates or assumptions about the expected return on plan assets.

POTENTIAL LIABILITIES

The Group is subject to legal and tax disputes regarding a wide range of issues that are within the jurisdiction of various countries. Given the uncertainties surrounding these issues, it is difficult to predict whether and to what extent they will give rise to a payout.

Cases and disputes against the Group can derive from complex and difficult legal issues, which may be subject to varying degrees of uncertainty, including the facts and circumstances surrounding each case, jurisdiction and different applicable laws. In the ordinary course of business, the Group consults as necessary with its legal advisors and experts in tax or regulatory matters. The Group recognises a liability for disputes when it considers it probable that a financial outlay will be made and when the amount of resulting losses can be reasonably estimated. If a financial outlay becomes possible but the amount cannot be determined, that fact is reported in the explanatory notes.

All the amounts represented in the diagrams and tables are expressed in thousands of Euro.

ACCOUNTING STANDARDS, AMENDMENTS AND INTERPRETATIONS

OF THE IFRS APPLIED AS FROM JANUARY 1, 2022

The Group applied the following accounting standards, amendments and IFRS interpretations for the first time as from January 1, 2022:

On May 14, 2020, the IASB published the following amendments called:

Amendments to IFRS 3 Business Combinations: the purpose of the amendments is to update the reference in IFRS 3 to the Conceptual Framework in the revised version, without changing the requirements.

Amendments to IAS 16 Property, Plant and Equipment: the purpose of the amendments is not to allow the deduction of the amount received from the sale of goods produced during the testing phase of the asset from the cost of tangible assets. These sales revenues and related costs will therefore be recognised in the income statement.

Amendments to IAS 37 Provisions, Contingent Liabilities and Contingent Assets: the amendment clarifies that all costs directly attributable to the contract must be taken into account when estimating the possible onerousness of a contract. Accordingly, the assessment of whether a contract is onerous includes not only incremental costs (such as the cost of direct material used in processing), but also all costs that the enterprise cannot avoid because it has entered into the contract (such as, for example, the share of depreciation of machinery used for the performance of the contract).

Annual Improvements 2018-2020: amendments were made to IFRS 1 First-time Adoption of International Financial Reporting Standards, IFRS 9 Financial Instruments, IAS 41 Agriculture and to Illustrative Examples of IFRS 16 Leases.

The adoption of these amendments had no impact on the consolidated financial statements of the Group.

ACCOUNTING PRINCIPLES, AMENDMENTS AND IFRS AND IFRIC INTERPRETATIONS APPROVED BY THE EUROPEAN UNION THAT ARE NOT YET OBLIGATORY AND THAT THE COMPANY HAS NOT APPLIED IN ADVANCE AS AT DECEMBER 31, 2022

On February 12, 2021, the IASB published two amendments called Disclosure of Accounting Policies - Amendments to IAS 1 and IFRS Practice Statement 2 and Definition of Accounting Estimates - Amendments to IAS 8. The amendments are intended to improve the disclosure of accounting policies so as to provide more useful information to investors and other primary users of financial statements and to help companies distinguish changes in accounting estimates from changes in accounting policies. The amendments apply beginning on January 1, 2023, but earlier application is permitted. The directors do not expect a significant effect on the Group's consolidated financial statements through the adoption of these amendments.

On May 7, 2021, the IASB published an amendment called "Amendments to IAS 12 Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transaction. The document clarifies how deferred taxes should be accounted for on certain transactions that may generate assets and liabilities of equal amounts, such as leases and decommissioning obligations. The amendments apply beginning on January 1, 2023, but earlier application is permitted. The directors do not expect a significant effect on the Group's consolidated financial statements through the adoption of this amendment.

ACCOUNTING STANDARDS, AMENDMENTS AND IFRS AND IFRIC INTERPRETATIONS NOT YET APPROVED BY THE EUROPEAN UNION

At the end of the reporting period, the competent bodies of the European Union have not yet completed the approval process required to adopt the amendments and standards described below:

On January 23, 2020, the IASB published an amendment called Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Non-current and on October 31, 2022, the IASB published an amendment called Amendments to IAS 1 Presentation of Financial Statements: Non-Current Liabilities with Covenants. The purpose of the documents is to clarify how to classify debts and other short or long term liabilities. The amendments are effective beginning on January 1, 2024; however, companies may opt for earlier application. The directors do not expect a significant effect on the Group's consolidated financial statements through the adoption of this amendment.

On September 22, 2022, the IASB published an amendment called Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback. The document requires the seller-lessee to measure the lease liability arising from a sale and leaseback transaction in such a way that no income or loss is recognised in respect of the retained right of use. The amendments apply beginning on January 1, 2024, but earlier application is permitted. The directors do not expect a significant effect on the Group's consolidated financial statements through the adoption of this amendment.

On January 30, 2014, the IASB published IFRS 14 - Regulatory Deferral Accounts , which allows only those who adopt IFRS for the first time to continue to recognise amounts relating to Rate Regulation Activities in accordance with the previously adopted accounting standards. Since the Company is not a first-time adopter, this principle is not applicable.

INFORMATION ON RISKS

RISKS RELATED TO THE GENERAL ECONOMIC TREND

The Group performance is affected by the increase or decrease of the gross national product and industrial production, cost of energy products and health expense policies adopted in the different European countries in which the Group works.

The economic trend in the post-pandemic period and the consequences of the recent Ukrainian crisis could cause a slowdown in various sectors of the economy in the countries where the SOL Group operates.

RISKS RELATING TO THE GROUP'S RESULTS

The SOL Group partially operates in sectors considerably regulated by economic cycles related to the trend in industrial production, such as the steel, metal working, engineering, chemical and glass manufacturing industries. In the case of an extended decline in business, the growth and profitability of the Group could be partially affected.

Moreover, government policies for reducing healthcare expenses could reduce margins in the home-care and medical gas and service sectors.

RISKS RELATED TO FUND REQUIREMENTS

The SOL Group carries on an activity that entails considerable investments both in production and in commercial equipment and expects to face up to requirements through the flows deriving from the operational management and from new loans.

Operational management should continue to generate sufficient financial resources, while the use of new loans, notwithstanding the Group's excellent capital and financial structure, may show higher interest rates and spreads than in the past.

OTHER FINANCIAL RISKS

The Group is exposed to financial risks associated with its business operations:

credit risk in relation to normal trade transactions with customers;

liquidity risk, with particular reference to the raising of financial resources associated with investments and with the financing of working capital;

market risks (mainly relating to exchange and interest rates and to commodity costs), in that the Group operates internationally in different currency areas and uses interest-bearing financial instruments.

Credit risk

The granting of credit to end customers is subject to specific assessments by means of structured credit facility systems.

Positions amongst trade receivables for which objective partial or total non-recoverability is ascertained, are subject to individual write-down. Provisions are made on a collective basis for receivables that are not subject to individual write-down, taking into account the historic experience, the statistical data and, as a result of the introduction of the new accounting standard IFRS 9, on the basis of a predictive approach, based on the counterparty's probability of default, the ability to recover in case of loss given default and also of expected future losses.

Liquidity risk

The liquidity risk may arise with the inability to raise, under good financial conditions, the financial resources necessary for the anticipated investments and the financing of working capital.

The Group has adopted a series of policies and processes aimed at optimising the management of the financial resources, reducing the liquidity risk, such as the maintenance of an adequate level of available liquidity, the obtaining of adequate credit facilities and the systematic monitoring of the forecast liquidity conditions, in relation to the corporate planning process.

Management believes that the funds and the credit facilities currently available, in addition to those that will be generated by operating and financing activities, will permit the Group to satisfy its requirements resulting from investment activities, working capital management and debt repayments on their natural maturity dates.

Exchange rate risk

In relation to sales activities, the Group companies may find themselves with trade receivables or payables denominated in currencies other than the reporting currency of the company that holds them.

A number of Group subsidiary companies are located in countries outside the Eurozone, in particular Switzerland, Bosnia, Serbia, Albania, North Macedonia, Bulgaria, Hungary, Romania, the UK, Morocco, Poland, Czech Republic, India, Turkey, Brazil and China. Since the reference currency for the Group is the Euro, the income statements of these companies are translated into Euro using the average exchange rate for the period and, revenues and margins in local currency being equal, changes in interest rates may have an effect on the equivalent value in Euro of revenues, costs and economic results.

Assets and liabilities of the consolidated companies whose reporting currency is not the Euro can adopt equivalent values in Euro that differ depending on the exchange rate trend. As envisaged by the accounting standards adopted, the effects of these changes are booked directly to shareholders' equity, under the item "Other reserves". Some Group companies purchase electricity that is used for the primary production of technical gasses. The price of electricity is affected by the Euro/dollar exchange rate and by the price trend of energy commodities. The risk related to their fluctuations is mitigated by signing, as much as possible, fixed price purchase contracts or with a variation measured over a longer time period. Moreover, almost all supply contracts to customers are index-linked in such a way as to cover the fluctuation risks shown above.

The Parent Company has two bond loans outstanding for a total of USD 22.5 million. To hedge the exchange rate risk, two cross currency swaps were made in Euros on the total loan amount and for the entire duration (12 years). The fair value of the CCSs as at December 31, 2022 was positive in the amount of Euro 3,143 thousand. With regard to the currency weakness involving the Turkish lira, note that Group companies resident in Turkey operate only within the country, but there could be a negative effect on their profitability as a result of the higher cost of products purchased from third countries.

As the conditions were met, IAS 29 - Hyperinflation to Financial Statements was applied to the financial statements of Turkish companies in 2022.

Interest rate risk

The interest rate risk is managed by the parent company by centralising most of the medium/long-term debt and by appropriately dividing the loans between fixed rate and floating rate, favouring, when possible and convenient, medium/long-term debt with fixed rates, also through specific Interest Rate Swap agreements.

Some Group companies have entered into a number of Interest Rate Swap agreements linked to two floating rate medium-term loans with the aim of guaranteeing a fixed rate on said loans. The nominal value as at December 31, 2022 is equal to Euro 133,909 thousand and the positive fair value is equal to Euro 9,851 thousand.

RISKS RELATING TO PERSONNEL

In various countries in which the Group operates, employees are protected by different laws and/or collective labour contracts that guarantee them the right to be consulted on specific issues - including the downsizing and closing of departments and the reduction of staff numbers - through representations. This could affect the Group's flexibility in strategically redefining its own organisations and activities.

The management of the Group consists of persons of proven expertise who normally have long-standing experience in the sectors in which the Group operates. The replacement of any person in management may require a long period of time.

RISKS RELATED TO THE ENVIRONMENT AND CLIMATE CHANGE

The products and the activities of the SOL Group are subject to increasingly complex and strict authorisation and environmental rules and regulations. This concerns manufacturing plants subject to regulations on atmospheric emissions, waste disposal and waste water disposal and the ban on land contamination.

High charges should be shouldered in order to observe such regulations.

The SOL Group considers the most significant risks to be those related to customer demands regarding the sustainability of its supply chain and purchased products, as well as those related to the increase in the cost of raw materials (in particular, the electricity used in main plants). In this context, and in line with the implementation of its Sustainability Plan, the SOL Group has identified specific actions to manage these risk factors in order to minimise their potential impact on the company's business in the foreseeable future.

Please refer to the Non-Financial Statement for a more detailed discussion of the initiatives implemented by the Group.

RISKS RELATING TO IT MANAGEMENT AND DATA SECURITY

The increasing use of IT tools in the management of company activities and the interconnection of company systems with external IT infrastructures expose these systems to potential risks with regard to the availability, integrity and confidentiality of data, as well as the efficiency of the IT tools themselves.

To ensure effective business continuity, the Group adopted a disaster recovery and business continuity system to ensure immediate replication of the main legacy system workstations. The choice of these systems to be managed in business continuity was made on the basis of a risk analysis.

Moreover, multiple levels of physical and logical protection, at the level of servers and at the level of clients, ensure the active security of data and business applications. The SOL Group also has innovative artificial intelligence-based products to protect the digital identity of its employees.

Vulnerability analyses and audits on the security of information systems are periodically carried out by independent technicians to check the adequacy of the company's IT systems.

Finally, with regard to the problem of fraud through the use of IT resources by external parties, all employees are periodically informed and trained on the correct use of the resources and IT applications available to them.

TAX RISKS

The SOL Group is subject to taxation in Italy and in several other foreign jurisdictions.

The various companies of the Group are subject to the assessment of the income tax returns by the competent tax authorities of the countries in which they operate.

As already occurred in the past, any findings reported in the tax audits are carefully assessed and, when necessary, challenged in the appropriate venues.

At present, a dispute is in progress in Italy for findings - considered groundless - on Transfer pricing.

The opening of the MAP (Mutual Agreement Procedure) between Italy and four other European countries has been requested and has not yet been completed.

However, at Group level, this should not have a significant effect on profitability, given that the level of taxation in the countries involved is very similar.

NOTES

INCOME STATEMENT

1. Net sales

Balance as at 12.31.2022 1,379,187
Balance as at 12.31.2021 1,112,909
Change 266,278

Revenues by type of business break down as follows:

Description 12.31.2022 12.31.2021 Change
Technical gases 762,439 558,423 204,016
Home-care 616,748 554,486 62,262
Total 1,379,187 1,112,909 266,278

Reference should be made to the Directors' Report and the analysis of the results by type of business for comments regarding the trend in revenues.

Net sales achieved by the SOL Group as at December 31, 2022 amounted to Euro 1,379.2 million (up by 23.9% compared to the previous year, at Euro 1,112.9 million).

The effect of applying IAS 29 "Financial Reporting in Hyperinflationary Economies" to companies in Turkey led to an increase in revenue of Euro 2.0 million.

In particular, during 2022, the home-care business showed an 11.2% growth in sales (up by Euro 62.3 million) compared to the same period last year.

The technical gases sector experienced a 36.5% increase in revenues (up by Euro 204.0 million) over December 31, 2021.

2. Other revenues and income

Balance as at 12.31.2022 83,904
Balance as at 12.31.2021 11,060
Change 72,845

The item "Other revenues and income" breaks down as follows:

Description 12.31.2022 12.31.2021 Change
Capital gains on disposal 1,254 1,118 136
Extraordinary income 35,212 7,561 27,650
Grants received 1,370 1,539 (169)
Real estate rentals 384 384 -
Royalties income 4 - 4
Other 45,681 457 45,224
Total 83,904 11,060 72,845

Contingent assets include Euro 28.5 million of tax credits granted in some countries to energy-intensive companies for the abnormal increase in electricity procurement costs.

The item "Other" includes Euro 43.5 million related to the different treatment of electricity sales and purchases abroad. The costs if purchasing this energy are included in material purchases.

3. Internal works and collections

Balance as at 12.31.2022 26,718
Balance as at 12.31.2021 18,933
Change 7,785

The item "Internal works and collections" breaks down as follows:

Description 12.31.2022 12.31.2021 Change
Transfers to assets 25,750 17,276 8,474
Time work 968 1,657 (689)
Total 26,718 18,933 7,785

The item "Transfers to assets" includes the collection from the warehouse, mainly for equipment not intended for sale, but to rent, transferred to assets.

The item "Time work" is related to costs incurred for the internal construction of fixed assets.

4. Total costs

Balance as at 12.31.2022 901,894
Balance as at 12.31.2021 647,915
Change 253,979

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Purchase of materials 520,650 306,023 214,627
Services rendered 366,030 319,511 46,519
Change in inventories (13,232) (2,380) (10,852)
Other costs 28,446 24,761 3,685
Total 901,894 647,915 253,979

The item "Purchase of materials" includes purchases of gas and materials, electricity, water, diesel and methane for production.

The item "Services rendered" includes costs of transports, maintenance, third-party services, consultancy and insurances.

The item "Other costs" includes rentals, taxes other than income tax, contingent liabilities and capital losses.

Reference should be made to the Directors' Report for comments regarding the trend in costs.

5. Payroll and related costs

Balance as at 12.31.2022 259,657
Balance as at 12.31.2021 234,209
Change 25,448

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Wages and salaries 202,957 182,631 20,326
Social security charges 54,598 49,214 5,384
Employee severance indemnities 2,102 2,364 (262)
Total 259,657 234,209 25,448

The composition of the workforce is analysed below by category:

Description 12.31.2022 12.31.2021 Change
Managers 138 121 17
Clerks 4,204 3,506 698
Factory workers 1,409 1,474 (65)
Total 5,751 5,101 650

6. Amortisation/depreciations, provisions and write-downs, non-recurring expenses

Balance as at 12.31.2022 135,797
Balance as at 12.31.2021 125,007
Change 10,790

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Depreciation/amortisation 128,950 119,296 9,654
Provisions and write-downs 6,847 5,711 1,136
Total 135,797 125,007 10,790

The breakdown of the item "Amortisation and depreciation" of intangible and tangible fixed assets by asset category, is presented below:

Depreciation of tangible fixed assets and rights of use

Description 12.31.2022 12.31.2021 Change
Land 339 313 26
Buildings 15,138 13,419 1,720
Plant and machinery 19,206 18,530 676
Industrial and commercial equipment 72,597 67,560 5,037
Other assets 15,016 13,801 1,215
Total 122,296 113,623 8,673

The increase in depreciation is linked to investments made during the period, amounting to Euro 121.3 million.

Amortisation of other intangible fixed assets

Description 12.31.2022 12.31.2021 Change
Costs of research, development and advertising 216 204 12
Patents and rights to use patents of others 198 276 (78)
Concessions, licences and trademarks 5,975 4,812 1,163
Other 265 381 (116)
Total 6,654 5,674 981

The breakdown of the item "Provisions and write-downs" is as follows:

Description 12.31.2022 12.31.2021 Change
Provisions for bad debts 5,252 4,882 370
Provisions for risks 975 776 199
Write-downs of goodwill and consolidation differences 104 - 104
Write-downs of intangible fixed assets 9 - 9
Write-downs of tangible fixed assets and ROU 507 53 455
Total 6,847 5,711 1,136

7. Financial income / (expenses)

Balance as at 12.31.2022 (12,593)
Balance as at 12.31.2021 (9,843)
Change (2,750)

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Financial income 2,930 2,406 524
Financial expense (15.891) (11.472) (4.419)
Results from equity investments 368 (777) 1,146
Total (12,593) (9,843) (2,750)

The breakdown of the item "Financial income" is as follows:

Description 12.31.2022 12.31.2021 Change
From long-term receivables 48 17 31
Interest on investment securities 39 25 14
Interests on securities not held as fixed assets 80 34 46
Interest on banks and postal accounts 108 98 10
Interest from customers 450 160 290
Exchange rate gains 1,478 1,666 (188)
Other financial income 726 405 321
Total 2,930 2,406 524

The item "Other financial income" includes the positive change in mark to market derivatives to hedge the fair value of the hedged item (Fair Value Hedge - FVH), equal to Euro 39.5 thousand.

For further information on derivatives, see paragraph "Payables and other financial liabilities".

The breakdown of the item "Financial expense" is as follows:

Description 12.31.2022 12.31.2021 Change
Interest payable to banks (118) (117) (2)
Supplier interest (4) - (4)
Interest payable on loans (4,794) (5,239) 445
Interest on bonds (3.398) (2.742) (656)
Exchange rate losses (2.599) (2.058) (541)
Other financial expense (4.978) (1.315) (3.663)
Total (15.891) (11.472) (4.419)

"Other financial expenses" include Euro 1.5 million related to lease contracts and Euro 2.7 million related to the effect of applying IAS 29 "Financial Reporting in Hyperinflationary Economies".

The breakdown of the item "Results from equity investments" is as follows:

Description 12.31.2022 12.31.2021 Change
Revaluations of equity investments 464 29 435
Write-downs of equity investments (96) (807) 711
Total 368 (777) 1,146

The item "Revaluations of equity investments" refers to the measurement at equity of the jointly controlled companies CT BIOCARBONIC GmbH (Euro 353 thousand) and CONSORZIO ECODUE (Euro 2 thousand) and the associated company SHANGHAI JIAWEI MEDICAL GAS Co. Ltd (Euro 109 thousand).

The item "Write-downs of equity investments" refers to the measurement at equity of the associates CONSORGAS Srl (Euro 67 thousand) and NEMO LAB Srl (Euro 10 thousand) and to the write-down of the equity investment in the company ULJANIK BRODOGRADNJA 1856 doo by the subsidiary UTP doo (Euro 19 thousand).

8. Income taxes

Balance as at 12.31.2022 42,294
Balance as at 12.31.2021 32,170
Change 10,124

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Income taxes 37,533 29,072 8,461
Deferred tax liabilities 2,517 1,534 983
Deferred tax assets 2,244 1,564 680
Total 42,294 32,170 10,124

The reconciliation between the tax liability recorded in the financial statements and the theoretical tax liability, calculated on the basis of the theoretical tax rates in force in Italy, is as follows:

Description 12.31.2022 12.31.2021
Theoretical taxation 43,169 30,223
Tax effect permanent differences (847) 3,345
Tax effect deriving from foreign tax rates other than Italian theoretical tax rates (3,000) (3,375)
Income taxes recognised in the financial statements, excluding IRAP (current and deferred) 39,322 30,193
IRAP (Regional Business Tax) 2,972 1,977
Income taxes recognised in the financial statements (current and deferred) 42,294 32,170

BALANCE SHEET

9. Tangible fixed assets

Balance as at 12.31.2022 694,164
Balance as at 12.31.2021 615,329
Change 78,835

Breakdown of tangible fixed assets and rights of use

Changes in tangible fixed assets and rights of use, with reference to their historical cost, depreciation and net value are as follows:

Historical cost Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 24,718 180,379 349,322 1,000,161 99,344 32,442
Increases 1,339 19,609 22,869 79,102 14,009 30,880
Revaluations 112 689 - 63 159 -
Write-downs - - - (54) - -
Other changes 2,421 8,376 65,020 27,291 4,905 (31,032)
Exchange differences (52) 225 590 2,874 284 (160)
(Disposals) (4) (3,265) (632) (9,935) (5,973) -
Balance as at 12.31.2021 28,534 206,014 437,170 1,099,502 112,729 32,129
Increases 474 28,753 15,445 93,331 15,861 23,823
Revaluations 1,011 5,322 1,118 4,740 1,585 -
Write-downs - - (520) (7) - -
Other changes (33) 12,202 27,208 7,732 6,150 (29,590)
Exchange differences (77) (463) 1,167 (3,833) (412) (89)
(Disposals) (69) (3,183) (616) (11,119) (5,669) -
Balance as at 12.31.2022 29,840 248,645 480,973 1,190,346 130,245 26,273
Historical cost Total
Balance as at 01.01.2021 1,686,366
Increases 167,808
Revaluations 1,023
Write-downs (54)
Other changes 76,981
Exchange differences 3,762
(Disposals) (19,808)
Balance as at 12.31.2021 1,916,077
Increases 177,687
Revaluations 13,775
Write-downs (527)
Other changes 23,668
Exchange differences (3,705)
(Disposals) (20,656)
Balance as at 12.31.2022 2,106,321
Accumulated depreciation Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 3,362 89,609 239,697 730,562 68,562 -
Depreciation charges 313 13,419 18,530 67,560 13,801 -
Revaluations - - - - - -
Write-downs - - - - - -
Other changes - 4,420 45,274 17,699 3,744 -
Exchange differences (23) 52 245 1,731 215 -
(Disposals) - (3,364) (621) (8,305) (5,734) -
Balance as at 12.31.2021 3,652 104,136 303,125 809,247 80,588 -
Depreciation charges 339 15,138 19,206 72,597 15,017 -
Revaluations - - - - - -
Write-downs - - - - - -
Other changes (6) 1,352 (7,507) 9,804 4,673 -
Exchange differences (1) (79) 342 (2.287) (352) -
(Disposals) - - (1.670) (526) (9.189) (5.443)
Balance as at 12.31.2022 3,984 118,877 314,640 880,172 94,483 -
Accumulated depreciation Total
Balance as at 01.01.2021 1,131,792
Depreciation charges 113,623
Revaluations -
Write-downs -
Other changes 71,137
Exchange differences 2,220
(Disposals) (18,025)
Balance as at 12.31.2021 1,300,748
Depreciation charges 122,297
Revaluations -
Write-downs -
Other changes 8,316
Exchange differences (2.377)
(Disposals) (16.829)
Balance as at 12.31.2022 1,412,157
Net value Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 21,356 90,770 109,625 269,598 30,782 32,442
Increases 1,339 19,609 22,869 79,102 14,009 30,880
(Depreciations and write-downs) (313) (13,419) (18,530) (67,560) (13,801) -
Other changes 2,533 4,645 19,746 9,601 1,320 (31,032)
Exchange differences (29) 173 346 1,144 69 (160)
(Disposals) (4) 99 (10) (1.630) (238) -
Balance as at 12.31.2021 24,881 101,878 134,045 290,254 32,140 32,129
Increases 474 28,753 15,445 93,331 15,861 23,823
(Depreciations and write-downs) (339) (15,138) (19,206) (72,597) (15,017) -
Other changes 984 16,172 35,314 2,660 3,062 (29,590)
Exchange differences (75) (384) 825 (1.546) (59) (89)
(Disposals) (69) (1.513) (89) (1.930) (226) -
Balance as at 12.31.2022 25,856 129,767 166,333 310,173 35,761 26,273
Net value Total
Balance as at 01.01.2021 554,573
Increases 167,808
(Depreciations and write-downs) (113,623)
Other changes 6,812
Exchange differences 1,542
(Disposals) (1.784)
Balance as at 12.31.2021 615,329
Increases 177,687
(Depreciations and write-downs) (122,297)
Other changes 28,601
Exchange differences (1.329)
(Disposals) (3.827)
Balance as at 12.31.2022 694,164

Analysis of tangible fixed assets

Changes in tangible fixed assets, with reference to their historical cost, depreciation and net value are as follows:

Historical cost Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 22,066 131,016 349,228 999,959 74,703 32,442
Increases 1,318 14,047 22,869 79,023 6,193 30,880
Revaluations - - - 63 - -
Write-downs - - - (54) - -
Other changes 2,421 8,376 65,020 27,291 4,905 (31,032)
Exchange differences 22 88 590 2,874 294 (160)
(Disposals) - (1,617) (632) (9,931) (1,831) -
Balance as at 12.31.2021 25,826 151,911 437,076 1,099,225 84,264 32,129
Increases 349 9,534 15,445 93,219 8,549 23,823
Revaluations - 175 1,032 4,740 579 -
Write-downs - - (520) (7) - -
Other changes (26) 12,221 27,208 7,771 6,023 (29,590)
Exchange differences (36) (383) 1,167 (3,833) (266) (89)
(Disposals) (69) (1,919) (616) (10,922) (1,263) -
Balance as at 12.31.2022 26,045 171,539 480,793 1,190,195 97,886 26,273
Historical cost Total
Balance as at 01.01.2021 1,609,414
Increases 154,329
Revaluations 63
Write-downs (54)
Other changes 76,981
Exchange differences 3,708
(Disposals) (14,010)
Balance as at 12.31.2021 1,830,431
Increases 150,919
Revaluations 6,527
Write-downs (527)
Other changes 23,607
Exchange differences (3,439)
(Disposals) (14,788)
Balance as at 12.31.2022 1,992,730
Accumulated depreciation Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 2,809 75,117 239,643 730,451 58,233 -
Depreciation charges - - 5,107 18,505 67,492 5,916
Revaluations - - - - - -
Write-downs - - - - - -
Other changes - 4,420 45,274 17,699 3,744 -
Exchange differences - 24 245 1,731 256 -
(Disposals) - (1,574) (621) (8,300) (1,596) -
Balance as at 12.31.2021 2,809 83,094 303,046 809,073 66,553 -
Depreciation charges - - 5,617 19,175 72,488 6,789
Revaluations - - - - - -
Write-downs - - - - - -
Other changes - 1,391 (7,507) 9,831 4,760 -
Exchange differences - (18) 342 (2.287) (257) -
(Disposals) - (460) (526) (8.992) (1.097) -
Balance as at 12.31.2022 2,809 89,625 314,529 880,113 76,747 -
Accumulated depreciation Total
Balance as at 01.01.2021 1,106,253
Depreciation charges 97,020
Revaluations -
Write-downs -
Other changes 71,137
Exchange differences 2,255
(Disposals) (12,092)
Balance as at 12.31.2021 1,264,574
Depreciation charges 104,068
Revaluations -
Write-downs -
Other changes 8,475
Exchange differences (2.219)
(Disposals) (11.075)
Balance as at 12.31.2022 1,363,824
Net value Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 19,257 55,900 109,585 269,508 16,470 32,442
Increases 1,318 14,047 22,869 79,023 6,193 30,880
(Depreciations and write-downs) - (5,107) (18,505) (67,492) (5,916) -
Other changes 2,421 3,956 19,746 9,600 1,161 (31,032)
Exchange differences 22 64 346 1,144 38 (160)
(Disposals) - (43) (10) (1,630) (235) -
Balance as at 12.31.2021 23,017 68,817 134,030 290,152 17,711 32,129
Increases 349 9,534 15,445 93,219 8,549 23,823
(Depreciations and write-downs) - (5,617) (19,175) (72,488) (6,789) -
Other changes (26) 11,005 35,228 2,673 1,842 (29,590)
Exchange differences (36) (366) 825 (1.546) (9) (89)
(Disposals) (69) (1.460) (89) (1.930) (165) -
Balance as at 12.31.2022 23,236 81,913 166,264 310,081 21,139 26,273
Net value Total
Balance as at 01.01.2021 503,161
Increases 154,329
(Depreciations and write-downs) (97,020)
Other changes 5,852
Exchange differences 1,453
(Disposals) (1,919)
Balance as at 12.31.2021 565,857
Increases 150,919
(Depreciations and write-downs) (104,068)
Other changes 21,132
Exchange differences (1.220)
(Disposals) (3.713)
Balance as at 12.31.2022 628,906

The breakdown of major changes for the period relating to tangible fixed assets is shown below.

Investments made during the period with regard to the item "Lands" were mainly investments made by the parent company.

Investments made during the period with regard to the item "Buildings" are mainly investments made by the parent company (Euro 1,898 thousand) and the subsidiary companies SOL GAS PRIMARI Srl (Euro 153 thousand), SOL FRANCE Sas (Euro 767 thousand), VIVISOL Srl (Euro 252 thousand), IL POINT Srl (Euro 681 thousand), TPJ doo (Euro 1,178 thousand), TAE HELLAS Sa (Euro 519 thousand) and VIVISOL DEUTSCHLAND GmbH (Euro 3,104 thousand).

Acquisitions made during the period under the item "Plant and machinery" were mainly due to the purchase of equipment at the factories of the parent company (Euro 9,161 thousand) and by the subsidiaries SOL GAS PRIMARI Srl (Euro 544 thousand), SOL BULGARIA Ead (Euro 784 thousand), TAE HELLAS Sa (Euro 1,086 thousand) and to a lesser extent to other investments at all other Group companies.

The item "Industrial and commercial equipment" comprises commercial equipment (supplying devices, cylinders, base units, concentrators and medical appliances) as well as other small and sundry equipment. The increase recorded for the financial year was due to investments in commercial equipment in the form of cylinders, dispensing devices and tanks, made by companies in the technical gases sector in the amount of Euro 32,408 thousand (including Euro 12,521 by the parent company) and to investments made by companies operating in the home-care sector in the amount of Euro 60,811 thousand (including Euro 16,173 thousand by VIVISOL Srl) for base units and other medical appliances.

The item "Other assets" includes motor vehicles and motor cars, electric office equipment, furniture and fixtures, EDP systems. The increase recorded for the period refers to investments made for motor vehicles, laboratory equipment, hardware, furniture and fixtures, including Euro 2,864 thousand by the parent company, the subsidiaries DOLBY MEDICAL HOME RESPIRATORY CARE Ltd (Euro 367 thousand), IL POINT Srl (Euro 557 thousand) and to a lesser extent to other investments carried out by all other Group companies.

The "Assets under construction" item mainly refers to amounts relating to investments in progress made by the parent company (Euro 8,261 thousand) and by the subsidiaries GTH GAZE INDUSTRIALE Sa (Euro 3,352 thousand), SOL KOHLENSÄURE WERK GmbH & Co. KG (Euro 1,479 thousand), SOL GAS PRIMARI Srl (Euro 1,326 thousand), VIVISOL Srl (Euro 2,603 thousand) and CTS Srl (Euro 2,615 thousand).

Please note that the Mantua, Verona, Jesenice and Varna plants have mortgages and liens governed by mediumterm mortgage agreements between financial institutions and several group companies.

As at December 31, 2022, mortgages amounted to Euro 67,450 thousand. As at December 31, 2022, liens amounted to Euro 68,788 thousand.

The item "Other changes" includes the effects of the application of hyperinflation in Turkey as summarised below:

Description Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Historical cost - 175 1,312 4,505 530 -
Accumulated depreciation - (118) (480) (2,221) (313) -
Total - 58 832 2,284 216 -
Description Total
Historical cost 6,522
Accumulated depreciation (3,132)
Total 3,390

Breakdown of rights of use

Changes in tangible fixed assets, with reference to their historical cost, depreciation and net value are as follows:

Historical cost Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 2,652 49,362 94 202 24,641 -
Increases 22 5,562 - 79 7,816 -
Revaluations 112 689 - - 159 -
Write-downs - - - - - -
Other changes - - - - - -
Exchange differences (74) 138 - - (10) -
(Disposals) (4) (1.648) - (4) (4.142) -
Balance as at 12.31.2021 2,708 54,103 94 276 28,465 -
Increases 125 19,218 - 112 7,312 -
Revaluations 1,011 5,146 86 - 1,006 -
Write-downs - - - - - -
Other changes (8) (19) - (39) 128 -
Exchange differences (41) (79) - - (146) -
(Disposals) - (1.264) - (197) (4.407) -
Balance as at 12.31.2022 3,795 77,106 180 151 32,358 -
Historical cost Total
Balance as at 01.01.2021 76,952
Increases 13,479
Revaluations 960
Write-downs -
Other changes -
Exchange differences 54
(Disposals) (5.798)
Balance as at 12.31.2021 85,647
Increases 26,768
Revaluations 7,249
Write-downs -
Other changes 61
Exchange differences (266)
(Disposals) (5.868)
Balance as at 12.31.2022 113,590
Accumulated depreciation Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 553 14,492 54 111 10,329 -
Depreciation charges 313 8,311 25 68 7,886 -
Revaluations - - - - - -
Write-downs - - - - - -
Other changes - - - - - -
Exchange differences (23) 28 - - (41) -
(Disposals) - (1.790) - (4) (4.139) -
Balance as at 12.31.2021 843 21,042 79 174 14,036 -
Depreciation charges 339 9,521 32 109 8,228 -
Revaluations - - - - - -
Write-downs - - - - - -
Other changes (6) (39) - (27) (87) -
Exchange differences (1) (61) - - (95) -
(Disposals) - (1,211) - (197) (4,346) -
Balance as at 12.31.2022 1,175 29,252 111 59 17,736 -
Accumulated depreciation Total
Balance as at 01.01.2021 25,540
Depreciation charges 16,603
Revaluations -
Write-downs -
Other changes -
Exchange differences (35)
(Disposals) (5.933)
Balance as at 12.31.2021 36,174
Depreciation charges 18,229
Revaluations -
Write-downs -
Other changes (159)
Exchange differences (158)
(Disposals) (5,754)
Balance as at 12.31.2022 48,333
Net value Land Buildings Plant and machinery Industrial and commercial equipment Other assets Assets under construction and advances
Balance as at 01.01.2021 2,099 34,870 40 91 14,312 -
Increases 22 5,562 - 79 7,816 -
(Depreciations and write-downs) (313) (8,311) (25) (68) (7,886) -
Other changes 112 689 - - 159 -
Exchange differences (51) 110 - - 31 -
(Disposals) (4) 142 - - (3) -
Balance as at 12.31.2021 1,864 33,062 15 102 14,429 -
Increases 125 19,218 - 112 7,312 -
(Depreciations and write-downs) (339) (9,521) (32) (109) (8,228) -
Other changes 1,009 5,167 86 (12) 1,220 -
Exchange differences (40) (18) - - (51) -
(Disposals) - (53) - - (61) -
Balance as at 12.31.2022 2,620 47,854 69 92 14,622 -
Net value Total
Balance as at 01.01.2021 51,412
Increases 13,479
(Depreciations and write-downs) (16,603)
Other changes 960
Exchange differences 89
(Disposals) 135
Balance as at 12.31.2021 49,472
Increases 26,768
(Depreciations and write-downs) (18,229)
Other changes 7,469
Exchange differences (109)
(Disposals) (114)
Balance as at 12.31.2022 65,258

10. Goodwill and consolidation differences

Balance as at 12.31.2022 216,811
Balance as at 12.31.2021 170,313
Change 46,498

The breakdown of the item is as follows:

Description Goodwill Consolidation difference Total
Balance as at 01.01.2021 10,006 129,862 139,868
Increases - 29,786 29,786
Revaluations (Write-downs) - - -
Other changes 154 - 154
Exchange differences 192 313 504
(Amortisation) - - -
Balance as at 12.31.2021 10,352 159,960 170,313
Increases - 34,277 34,277
Revaluations (Write-downs) - (104) (104)
Other changes 12,683 - 12,683
Exchange differences (154) (204) (358)
(Amortisation) - - -
Balance as at 12.31.2022 22,881 193,929 216,811

The increase for the period in the item "Consolidation differences" is related to the acquisition of BLA SERVICOS HOSPITALARES Ltda, JML SERVICOS HOSPITALARES Ltda, PROFI GESUNDHEITS - SERVICE GmbH, WIP WEITERBILDUNG IN DER PFLEGE GmbH, ITOP Spa OFFICINE ORTOPEDICHE and its subsidiaries ITOP ORTOPEDIE ASSOCIATE Srl, ITOP SERVIZI Srl, ITOP SICILIA Srl and ORTHOHUB Srl, POLAR ICE and the adjustment of the goodwill of ISIMED Srl acquired in the last quarter of 2021 and merged by incorporation into VIVISOL Srl during this financial year.

In April 2022, the subsidiary P PAR PARTICIPACOES Ltda acquired 60% of BLA SERVICOS HOSPITALARES Ltda, a company governed by Brazilian law active in the hospital sector. If the acquisition had occurred on January 1, 2022, the group's revenues and the profit would have increased by Euro 614 thousand and by Euro 208 thousand, respectively, for the 12-month period ending December 31, 2022.

In April 2022, the subsidiary P PAR PARTICIPACOES Ltda acquired 60% of JML SERVICOS HOSPITALARES Ltda, a company governed by Brazilian law active in the hospital sector. If the acquisition had occurred on January 1, 2022, the estimated revenues and profit of the Group would have been higher by Euro 192 thousand and lower by Euro 229 thousand, respectively, for the 12-month period ended December 31, 2022.

In July 2022, the subsidiary VIVISOL DEUTSCHLAND GmbH acquired 100% of the shares of PROFI GESUND- HEITS -SERVICE GmbH, a German company operating in the home-care sector. If the acquisition had occurred on January 1, 2022, the group's revenues and the profit would have increased by Euro 1,681 thousand and by Euro 213 thousand, respectively, for the 12-month period ending December 31, 2022.

In August 2022, the subsidiary VIVICARE HOLDING GmbH acquired 100% of the shares of WIP WEITERBIL- DUNG IN DER PFLEGE GmbH, a German company operating in the home-care sector. If the acquisition had occurred on January 1, 2022, Group profit would have decreased by Euro 7 thousand for the 12-month period ended December 31, 2022.

In September 2022, the subsidiary AIRSOL Srl acquired 51% of the shares of ITOP Spa OFFICINE ORTOPEDICHE and its subsidiaries ITOP ORTOPEDIE ASSOCIATE Srl, ITOP SERVIZI Srl, ITOP SICILIA Srl and ORTHOHUB Srl, Italian companies operating in the field of orthopaedic prostheses. If the acquisition had occurred on January 1, 2022, the group's revenues and the profit would have increased by Euro 9,790 thousand and by Euro 1,378 thousand, respectively, for the 12-month period ending December 31, 2022.

In November 2022, the subsidiary AIRSOL Srl acquired 61% of the POLAR ICE Ltd, an Irish company that produces and sells dry ice. If the acquisition had occurred on January 1, 2022, the group's revenues and the profit would have increased by Euro 3,257 thousand and by Euro 828 thousand, respectively, for the 12-month period ending December 31, 2022.

In December 2022, the parent company acquired 52.56% of the shares of GREEN ASU PLANT PRIVATE Ltd, an Indian company operating in the technical gas and renewable energy sectors.

In December 2022, the parent company acquired 45.60% of the shares of BHORUKA SPECIALTY GASES PRIVATE Ltd, an Indian company operating in the technical gas sector.

The result of the acquisitions on the assets and liabilities of the Group is set below:

Description Values recorded during acquisition Adjustments to fair value Book values before acquisition
Tangible fixed assets 49,783 - 49,783
Intangible fixed assets 12,854 - 12,854
Long-term investments 355 - 355
Inventories 3,083 - 3,083
Trade and other receivables 10,510 - 10,510
Prepayments and accrued income 321 - 321
Cash and cash at bank 9,132 - 9,132
Minority interests (17,377) - (17,377)
Suppliers (4,460) - (4,460)
Other payables (12,112) - (12,112)
Risk provisions - - -
Employee severance indemnities (401) - (401)
Accrued expenses and deferred income (1,410) - (1,410)
Identifiable net assets and liabilities 50,279 - -
Goodwill deriving from acquisition (34,269) - -
Amount paid (84,547) - -
Available funds acquired 9,132 - -
Net outlays of available funds (75,416) - -

The Group checks the recoverability of goodwill at least annually or more frequently if specific events or changed circumstances indicate the possibility of having suffered an impairment loss, at Cash Generating Unit level to which the Company's management charges said goodwill, in accordance with the matters anticipated by IAS 36 "impairment of assets".

Impairment test

As provided by IAS 36 Impairment of assets, the value of intangible assets with an indefinite useful life is not amortised, but instead subject to an Impairment test at least once per year. The Group does not record intangible assets with an indefinite useful life other than goodwill.

IAS 36 also requires a company to assess at each reporting date the existence of indications of impairment in relation to any other asset.

The recoverability of the book values is tested by comparing the book value of the asset with its fair value (for example, using market multiples obtained from comparable transactions) or its value in use, whichever is greater. The methodology used to identify the recoverable amount (value in use) consists of discounting future cash flows generated by activities directly attributed to the entity to which the goodwill (CGU) is allocated, as well as the value expected from its divestment or transfer upon the end of its useful life. Value in use is calculated as the sum of the current value of expected future cash flows based on the forecasts issued for every CGU and approved by the Board of Directors of the Company.

The business plans cover a time span of five years or, in some cases, given the type of business involving investments with medium-term returns, of 7 or 10 years and were implemented based on the 2023 budget drawn up by the Management. The growth rates considered in the plan's timeframe were calculated based on experience in the relative sectors.

The rate used to discount cash flows was calculated using the Weighted Average Cost Of Capital (WACC). The WACC was calculated on an ad-hoc basis for each CGU subject to impairment, taking into consideration the specific parameters of the geographical area: market risk premium and sovereign debt yields and parameters relating to the sector of activity).

To ensure that changes to the main hypotheses would not significantly influence the results of the impairment tests, sensitivity analyses were carried out in the event of a change in WACC and growth rates of +/- 0.5.

The outcomes of these simulations reasonably supported the measurement obtained.

None of the impairment tests carried out as at December 31, 2022 identified any impairment losses except that of HYDROENERGY ShpK. However, since the value in use is determined on the basis of estimates, the Group cannot guarantee that the value of goodwill or other intangible assets will not be subject to impairment in the future.

11. Other intangible fixed assets

Balance as at 12.31.2022 26,550
Balance as at 12.31.2021 22,752
Change 3,799

The breakdown of the item is as follows:

Net value Costs of research, development and advertising Patents and rights to use patents of others Concessions, licences, trademarks and similar rights Other Assets under construction and advances Total
Balance as at 01.01.2021 2,611 735 10,349 533 4,378 18,606
Increases 571 24 6,911 803 3,210 11,519
Revaluations (Write-downs) - - - (18) - (18)
Other changes (454) - 994 272 (2.527) (1.715)
Exchange differences - - 32 - - 33
(Amortisation) (204) (276) (4.812) (381) - (5.674)
Balance as at 12.31.2021 2,524 483 13,473 1,211 5,061 22,752
Increases 698 68 8,550 434 2,705 12,455
Revaluations (Write-downs) - - 80 - - 80
Other changes - - 431 89 (2.586) (2.067)
Exchange differences - - (18) 1 3 (15)
(Amortisation) (216) (198) (5.975) (265) - (6.654)
Balance as at 12.31.2022 3,006 352 16,541 1,469 5,182 26,550

The item "Other changes" includes the effects of the application of hyperinflation in Turkey as summarised below:

Description Costs of research, development and advertising Patents and rights to use patents of others Concessions, licences, trademarks and similar rights Other Assets under construction and advances Total
Historical cost - - 89 - - 89
Accumulated amortisation - - (50) - - (50)
Total - - 39 - - 39

12. Equity investments

Balance as at 12.31.2022 13,082
Balance as at 12.31.2021 12,704
Change 378

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
BT GASES Ltd - 1 (1)
FLOSIT PHARMA Sa 450 476 (26)
GTE Sl 23 21 2
ZDS JESENICE doo 8 8 -
Non-consolidated subsidiary companies 481 506 (25)
CONSORZIO ECODUE 407 405 3
CT BIOCARBONIC GmbH 5,514 5,161 353
Jointly controlled companies 5,921 5,566 356
CONSORGAS Srl 13 79 (66)
NEMO LAB Srl 190 200 (10)
NIPPON SANSO SHENWEI GASES Co. Ltd 788 - 788
SHANGHAI JIAWEI MEDICAL GAS Co. 2,153 2,015 138
SHANGHAI SHENWEI GAS FILLING Co. Ltd 76 - 76
Associated companies 3,219 2,294 925
Other minority interests 3,461 4,339 (878)
Other companies 3,461 4,339 (878)
Total 13,082 12,704 378

Except for:

Euro 458 thousand recognised as non-consolidated subsidiaries (in the portfolio of the subsidiary SPG - SOL PLIN GORENJSKA doo of Euro 8 thousand, SOL FRANCE Sas of Euro 46 thousand and FLOSIT Sa of Euro 404 thousand);

Euro 407 thousand recognised as jointly controlled companies (in the portfolio of the subsidiary SOL GAS PRIMARI Srl);

Euro 2,215 thousand recognised as associated companies (in the portfolio of the subsidiaries SHANGHAI SHENWEI MEDICAL GAS Co. Ltd of Euro 864 thousand, VIVISOL Srl of Euro 190 thousand and AIRSOL Srl of Euro 2,153 thousand);

Euro 3,442 thousand recognised as other minority interests (relating to investments in local companies by the subsidiaries SOL GAS PRIMARI Srl of Euro 2,729 thousand, SOL INDIA PRIVATE Ltd of Euro 353 thousand, UTP doo of Euro 326 thousand, ITOP SICILIA Srl of Euro 11 thousand, ITOP Spa OFFICINE ORTOPEDICHE of Euro 9 thousand, ITOP ORTOPEDIE ASSOCIATE Srl of Euro 1 thousand, TGS Ad of Euro 2 thousand, TPJ doo of Euro 2 thousand, ICOA Srl of Euro 8 thousand, CRYOS Srl of Euro 1 thousand and VIVISOL SILARUS Srl of Euro 1 thousand),

all of the above investments are held by the parent company.

Non-consolidated subsidiaries and other minority interests are measured at fair value.

The following table shows the main economic and financial data of jointly controlled companies consolidated with the net equity method:

Jointly controlled companies CT BIOCARBONIC GmbH CONSORZIO ECODUE
Total assets 6,486 1,207
Total liabilities 567 392
Revenues 3,961 1,054
Result for the year 706 3

13. Other financial assets

Balance as at 12.31.2022 22,015
Balance as at 12.31.2021 10,484
Change 11,531

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Amounts receivable from third parties 21,331 9,406 11,925
Securities 684 1,077 (394)
Total 22,015 10,484 11,531

The breakdown of the item "Amounts receivable from third parties" is as follows:

Description 12.31.2022 12.31.2021 Change
Guarantee deposits 12,372 4,910 7,462
Derivatives 7,771 1,509 6,263
Tax receivables 759 2,889 (2,130)
Other receivables 428 99 329
Total 21,331 9,406 11,925

For further information on derivatives, see paragraph "Payables and other financial liabilities".

The item "Other receivables" mainly refers to long-term financial receivables to group companies not consolidated on a full line-by-line basis.

The breakdown for the item "Securities" is as follows:

Description 12.31.2022 12.31.2021 Change
CRYOS Srl 67 61 6
ISIMED Srl - 1 (1)
SOL HELLAS Sa 611 1,009 (398)
SOL TG GmbH 5 6 (1)
VIVISOL Srl 1 - 1
Total 684 1,077 (393)

The item "Securities" relating to SOL HELLAS refers to government securities of Greece, with maturity exceeding 12 months issued in payment of receivables claimed by the subsidiary SOL HELLAS from public bodies.

14. Deferred tax assets

Balance as at 12.31.2022 18,557
Balance as at 12.31.2021 21,031
Change (2,473)

The breakdown of the above item is as follows:

Description Bad debts Risk provisions Internal profits Prior losses Other Total
Balance as at 01.01.2021 1,263 156 853 1,371 18,053 21,695
Provisions/Uses (144) 118 (78) 1,181 (2,641) (1,564)
Other changes - - - - 872 872
Exchange differences - - - 23 4 27
Balance as at 12.31.2021 1,118 274 774 2,576 16,288 21,031
Provisions/Uses (36) (127) (35) 1,005 (3,052) (2,245)
Other changes (83) - - 43 (95) (135)
Exchange differences - - - (104) 10 (94)
Balance as at 12.31.2022 999 148 740 3,520 13,151 18,557

Deferred tax assets were measured in the case of probable realisation and tax recoverability considering the limited time horizon based on the business plans of the companies.

Deferred tax assets of Euro 3,520 thousand were recognised against prior losses in that there exists the probability of obtaining, in future financial years, taxable income sufficient to absorb the tax losses carried forward. The item "Other" includes the tax effect related to asset revaluations carried out by some Italian companies of the Group of Euro 9,328 thousand, which, although eliminated in the consolidated financial statements, allow the Group to receive the related tax benefits.

15. Inventories

Balance as at 12.31.2022 84,144
Balance as at 12.31.2021 67,303
Change 16,841

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Raw, subsidiary and consumable materials 5,652 6,336 (684)
Work in progress and semi-finished goods 2,821 1,913 908
Finished products and goods for resale 75,670 59,054 16,617
Total 84,144 67,303 16,841

16. Trade receivables

Balance as at 12.31.2022 431,054
Balance as at 12.31.2021 340,023
Change 91,031

The breakdown of the item is as follows:

Description Within 12 months Beyond 12 months Allowance for doubtful accounts 12.31.2022 12.31.2021
Trade receivables 456,597 - (25,543) 431,054 340,023
Total 456,597 - (25,543) 431,054 340,023

The "Allowance for doubtful accounts" changed as follows:

Description 12.31.2021 Provisions Uses Other changes 12.31.2022
Allowance for doubtful accounts 25,935 5,252 (4,882) (762) 25,543
Total 25,935 5,252 (4,882) (762) 25,543

The item "Other changes" refers to exchange rate differences of Euro 54 thousand and to reversals of the fund of Euro 708 thousand.

17. Other current assets

Balance as at 12.31.2022 64,377
Balance as at 12.31.2021 36,197
Change 28,181

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Amounts receivable from employees 830 813 17
Amounts receivable in respect of income tax 18,741 8,246 10,494
VAT receivables 23,597 11,642 11,955
Other amounts receivable from the tax authorities 3,850 1,478 2,372
Other receivables 4,641 3,023 1,618
Prepayments and accrued income 12,719 10,994 1,725
Total 64,377 36,197 28,181

"Prepayments and accrued income" represent the harmonising items for the period calculated on an accrual basis.

This item breaks down as follows:

Description 12.31.2022 12.31.2021 Change
Accrued income
Interest 23 44 (22)
Other accrued income 1,140 772 369
Total accrued income 1,163 816 347
Prepayments
Insurance premiums 1,006 782 224
Rents 667 519 148
Other prepayments 9,882 8,876 1,005
Total prepayments 11,555 10,178 1,377
Total prepayments and accrued income 12,719 10,994 1,725

The item "Other prepayments" mainly comprises purchase invoices referring to maintenance agreements or other expenses.

18. Current financial assets

Balance as at 12.31.2022 13,187
Balance as at 12.31.2021 8,671
Change 4,516

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Financial receivables from jointly controlled companies 200 350 (150)
Derivatives 5,225 1,443 3,782
Short-term time deposits 7,561 6,834 728
Other financial receivables 200 44 157
Total 13,187 8,671 4,516

The breakdown for the item "Short-term time deposits" is as follows:

Company 12.31.2022 12.31.2021 Change
BLA SERVICOS HOSPITALARES Ltda 221 - 221
DN GLOBAL HOMECARE Ltda 422 326 96
FLOSIT Sa 644 2,140 (1,496)
GLOBAL CARE Ltda 700 896 (196)
JML SERVICOS HOSPITALARES Ltda 5 - 5
PORTARE Lda 15 2 13
SICGILSOL GASES PRIVATE Ltd - 68 (68)
SOL INDIA PRIVATE Ltd 3,194 496 2,698
TGT Ad 2,336 2,008 328
UNIT CARE Ltda 20 893 (873)
VIVISOL BRASIL Sa 4 5 (1)
Total 7,561 6,834 727

19. Cash and cash at bank

Balance as at 12.31.2022 134,642
Balance as at 12.31.2021 139,642
Change (5,000)

The breakdown for this item is as follows:

Description 12.31.2022 12.31.2021 Change
Bank and postal deposits 134,011 139,140 (5,130)
Cash and cash equivalents on hand 631 501 130
Total 134,642 139,642 (5,000)

20. Shareholders' equity

Balance as at 12.31.2022 862,630
Balance as at 12.31.2021 721,452
Change 141,179

The share capital of SOL Spa as at December 31, 2022 comprised 90,700,000 ordinary shares with a par value of Euro 0.52 each, fully subscribed and paid up.

The breakdown of and changes in shareholders' equity at year-end are detailed below:

Description 12.31.2021 Transfer of result Dividends paid Translation differences Other changes Profit (loss)
Pertaining to the Group:
Share capital 47,164 - - - - -
Share premium reserve 63,335 - - - - -
Revaluation reserves - - - - - -
Legal reserve 10,459 - - - - -
Statutory reserves - - - - - -
Treasury share reserves - - - - - -
Other reserves 486,904 67,781 - (3,244) 13,818 -
Profits/(Losses) carried forward 845 21,768 (21,768) - (142) -
Net Profit 89,549 (89,549) - - - 133,693
Shareholders' equity - Group 698,257 - (21,768) (3,244) 13,677 133,693
Minority interests:
Shareholders' equity - Minority interests 18,987 4,208 (2,491) 61 17,369 -
Profit pertaining to minority interests 4,208 (4,208) - - - 3,882
Shareholders' equity Minority interests 23,194 - (2,491) 61 17,369 3,882
Shareholders' equity 721,452 - (24,259) (3,183) 31,046 137,574
Description 12.31.2022
Pertaining to the Group:
Share capital 47,164
Share premium reserve 63,335
Revaluation reserves -
Legal reserve 10,459
Statutory reserves -
Treasury share reserves -
Other reserves 565,261
Profits/(Losses) carried forward 704
Net Profit 133,693
Shareholders' equity - Group 820,615
Minority interests:
Shareholders' equity - Minority interests 38,134
Profit pertaining to minority interests 3,882
Shareholders' equity Minority interests 42,015
Shareholders' equity 862,630

The item "Other reserves" mainly includes extraordinary reserves, the Cash Flow Hedge (CFH) reserve, the effects of hyperinflation in Turkey and unallocated profits.

As at December 31, 2022, the CFH reserve, gross of the tax effect, was positive and amounted to Euro 12,994 thousand (positive for Euro 1,278 thousand as at December 31, 2021). The change in the period is reported in the Consolidated Statement of Comprehensive Income.

For further information on derivatives, see paragraph "Payables and other financial liabilities".

The effects of hyperinflation in Turkey amounted to Euro 5,944 thousand, of which Euro 361 thousand were third parties.

Reconciliation of Parent Company's Financial Statements with the Consolidated Financial statements

12.31.2022 12.31.2021
Description Shareholders' equity Net income Shareholders' equity Net income
Financial Statements of SOL Spa 314,141 41,594 284,910 31,221
Elimination of consolidated inter-company transactions, net of tax effects:
- Internal profit on tangible fixed assets (2,576) 158 (2.733) 182
- Internal profit on long-term investments - - (1.727)
- Reversal of adjustments to investments in subsidiary companies - 141 - 105
- Dividends paid by consolidated companies - (85.007) - (79.009)
Adjustment of accounting policies to achieve consistent Group accounting policies, net of tax effects:
- Adjustment to achieve a consistent accounting policy regarding intangible assets 7,810 (921) 15,870 (833)
- Application of IFRS 16 and IAS 17 (398) (267) (135) (67)
- Valuation at equity of companies reported at cost 1,556 720 806 (138)
Book value of consolidated equity investments (868.112) - (774.198) -
Shareholders' Equity and profit for the year of consolidated companies 1,174,265 177,379 1,013,777 139,815
Allocation of the difference to the assets of the
consolidated companies and relative depreciation, amortisation and write-downs:
- Goodwill from consolidation 193,929 (104) 159,960 -
Group consolidated financial statements 820,615 133,693 698,257 89,549

21. Employee severance indemnities and benefits

Balance as at 12.31.2022 15,143
Balance as at 12.31.2021 18,696
Change (3,553)

The breakdown for this item is as follows:

Description 12.31.2022 12.31.2021
Balance as at 1 January 18,696 18,536
Provisions 2,102 2,364
(Uses) (1,531) (1,047)
Financial expense (16) (25)
Other changes (4,098) (1,122)
Exchange differences (9) (11)
Balance at the end of the period 15,143 18,696

Employee benefits are calculated on the basis of the following actuarial assumptions:

Description Interest rate
Annual discount rate 0.58%
Inflation rate 1.50%
Annual severance indemnity increase rate 2.18%
Annual wage increase rate 2.00%

Sensitivity analysis

The effects of the variation of the assumptions used are presented here below:

Balance as at December 31, 2022 Amount
Inflation rate + 0.5% 216
Inflation rate - 0.5% (209)
Discount rate + 0.5% (395)
Discount rate - 0.5% 426
Turnover rate +0.5% 165

Employee severance indemnities

The item "Employee severance indemnity" reflects the indemnity provided to employees during their working relationship which is paid at the time the employee leaves the company. In the presence of specific conditions, the employee may obtain a partial advance on said indemnity during their working relationship.

Other

The item "Other" comprises benefits such as the loyalty bonus, which accrues on attainment of a specific length of service within the company.

22. Provision for deferred taxes

Balance as at 12.31.2022 12,163
Balance as at 12.31.2021 7,362
Change 4,801

The item "Provision for deferred taxes" represents the net balance of deferred tax liabilities provided for in the consolidated financial statements as at December 31, 2022 with regard to tax items present in the financial statements of the Group companies (accelerated depreciation), and the deferred tax liabilities referring to the other consolidation entries; the item comprises.

Description Capital gains Accelerated depreciations Leasing Other minor Total
Balance as at 01.01.2021 22 960 31 3,248 4,261
Provisions/Uses 9 1,255 (25) 295 1,534
Other changes - - - 1,434 1,434
Exchange differences - 76 5 52 133
Balance as at 12.31.2021 32 2,290 11 5,029 7,362
Provisions/Uses (7) 1,877 (100) 747 2,517
Other changes - - (2) 2,497 2,495
Exchange differences - (180) 4 (34) (210)
Balance as at 12.31.2022 24 3,987 (87) 8,238 12,163

23. Provisions for risks and charges

Balance as at 12.31.2022 3,309
Balance as at 12.31.2021 3,070
Change 239

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Other minor provisions 3,309 3,070 239
Total other provisions 3,309 3,070 239
Total 3,309 3,070 239

Provisions for risks and charges are allocated exclusively in the presence of a current obligation assessable in a reliable way, as a result of past events, which may be legal, contractual or derive from declarations or behaviour of the company such as to create in third parties a reasonable expectation that the company is responsible or assumes the responsibility of fulfilling an obligation. If the financial effect of time is significant, the liability is discounted, the discounting effect is recorded under financial expense.

The provisions underwent the following changes:

Description 12.31.2021 Provisions Uses Other changes 12.31.2022
Other minor provisions 3,070 975 (787) 51 3,309
Total 3,070 975 (787) 51 3,309

24. Payables and other financial liabilities

Balance as at 12.31.2022 454,496
Balance as at 12.31.2021 378,471
Change 76,025

The breakdown of the item is as follows:

Description 12.31.2022 12.31.2021 Change
Bonds 172,764 109,796 62,969
Amounts due to other lenders 214,490 231,577 (17,086)
Lease liabilities 47,732 34,573 13,159
Derivatives - 1,135 (1,135)
Other 19,509 1,390 18,119
Total 454,496 378,471 76,025

The item "Bonds" refers:

to the issue of two bond loans taken out by two American institutional investors. The original amount of these issues totals US$95 million converted to Euro 75,011 thousand by means of two cross currency swap (CCS) contracts for a duration equal to the original bond loans (12 years);

to the issue of a bond subscribed by three American institutional investors. The original amount of this issue was Euro 40 million;

to the issue of a bond subscribed by two American institutional investors. The original amount of this issue was Euro 70 million;

to the issue of a bond subscribed by five American institutional investors. The original amount of this issue was Euro 75 million.

The item "Amounts due to other lenders" comprises medium- and long-term loans granted by credit institutions. Some of these loans are backed by liens on movable assets and mortgages on real property, as already mentioned in the notes regarding tangible fixed assets.

The item ʺOthers" includes Euro 18 million in payables to SIMEST Spa for the repurchase of shares in the companies BHORUKA SPECIALTY GASES PRIVATE Ltd and GREEN ASU PLANT PRIVATE Ltd.

The detailed breakdown of the item "Bonds", "Amounts due to other lenders", "Lease liabilities" and "Derivatives" is as follows (with values expressed in thousands of euro:

Lending institution Amount Long-term portion Short-term portion Interest rate Maturity
MISE 62 - 62 Fixed 0,17% 12.31.2022
CREDEM 11 - 11 Fixed 0.85% 01/21/2023
MEDIOBANCA * 536 - 536 Fixed 2.90% 06/20/2023
UNICREDIT BULBANK 1,000 - 1,000 Fixed 4,50% 10/11/2023
UNICREDIT 10 - 10 Floating 1,00% 11/30/2023
PSA 4 - 4 Fixed 3.99% 12/31/2023
INTESA SAN PAOLO * 5,625 1,875 3,750 Floating 2.07% 03/31/2024
MEDIOCREDITO ITALIANO 2,222 741 1,481 Floating 1,40% 03/31/2024
UNICREDIT * 1,875 625 1,250 Floating 1.20% 05/31/2024
BNL - BNP PARIBAS 79 29 50 Floating 2.00% 07/22/2024
MONTE PASCHI SIENA 2,083 1,250 833 Fixed 4.21% 06/15/2025
INTESA SAN PAOLO * 9,375 5,625 3,750 Fixed 1.44% 06/30/2025
CREDITO VALTELLINESE 3,811 2,549 1,262 Floating 0.73% 07/05/2025
CREDITO VALTELLINESE 1,905 1,274 631 Floating 0,73% 07/05/2025
INTESA SAN PAOLO 105 65 40 Fixed 1,00% 07/13/2025
BNL - BNP PARIBAS 583 371 212 Floating 3,05% 09/01/2025
UBI BANCA 7,664 5,157 2,507 Fixed 1.00% 09/14/2025
BANK OF IRELAND 99 62 37 Floating 4.28% 11/19/2025
BANCA IMI * 2,384 1,700 684 Fixed 6.50% 01/26/2026
UNICREDIT 466 327 139 Floating 2,50% 03/31/2026
BCC CARATE 4,473 3,211 1,262 Floating 3.50% 06/13/2026
INTESA SAN PAOLO * 17,500 12,500 5,000 Fixed 1.10% 06/30/2026
BNL - BNP PARIBAS * 13,500 10,500 3,000 Fixed 1.69% 11/25/2026
BCC ROMA 74 55 19 Fixed 1,50% 11/25/2026
UNICREDIT BOSNIA 946 738 208 Floating 3,80% 12/31/2026
HDFC 1,368 1,019 349 Floating 9,50% 12/31/2026
CARIGE 157 122 35 Fixed 1,55% 04/30/2027
UBI BANCA * 23,126 18,129 4,997 Fixed 1.60% 06/26/2027
MEDIOBANCA 27,500 22,500 5,000 Fixed 1.66% 01/28/2028
BANK OF IRELAND 554 465 89 Floating 3,87% 05/16/2028
BCC ROMA 1,188 969 219 Floating 2,73% 05/31/2028
UBI BANCA 602 503 99 Floating 2,20% 09/24/2028
INVITALIA 8,524 7,217 1,307 Fixed 0.11% 06/30/2029
BANCO BPM 38,180 32,313 5,867 Fixed 1.90% 06/30/2029
BNL - BNP PARIBAS * 34,960 29,970 4,990 Fixed 1.73% 12/31/2029
BNL - BNP PARIBAS * 21,875 18,656 3,219 Fixed 1.32% 05/06/2030
BCC CARATE 4,460 3,919 541 Fixed 0,85% 12/17/2030
BANCA DI CARAGLIO 157 141 16 Floating 1,80% 11/30/2031
BCC CARATE * 9,989 9,989 Floating 2.43% 10/06/2032
BANCO BPM * 19,920 19,924 (4) Floating 4.00% 12/31/2032
Derivatives 3 - 3
Lease liabilities 66,063 47,732 18,331
Total amounts due to other lenders 335,018 262,222 72,796
Bonds 184,693 172,764 11,929
Total 519,711 434,986 84,725
Lending institution Original amount
MISE Euro 289,820
CREDEM Euro 500,000
MEDIOBANCA * Euro 15,000,000
UNICREDIT BULBANK Euro 8,000,000
UNICREDIT Euro 27,000
PSA Euro 18,850
INTESA SAN PAOLO * Euro 30,000,000
MEDIOCREDITO ITALIANO Euro 20,000,000
UNICREDIT * Euro 10,000,000
BNL - BNP PARIBAS Euro 200,000
MONTE PASCHI SIENA Euro 10,000,000
INTESA SAN PAOLO * Euro 30,000,000
CREDITO VALTELLINESE Euro 10,000,000
CREDITO VALTELLINESE Euro 5,000,000
INTESA SAN PAOLO Euro 200,000
BNL - BNP PARIBAS Euro 900,000
UBI BANCA Euro 20,000,000
BANK OF IRELAND Euro 290,000
BANCA IMI * Euro 7,000,000
UNICREDIT Euro 500,000
BCC CARATE Euro 10,000,000
INTESA SAN PAOLO * Euro 40,000,000
BNL - BNP PARIBAS * Euro 30,000,000
BCC ROMA Euro 100,000
UNICREDIT BOSNIA Euro 2,000,000
HDFC Euro 1,367,648
CARIGE Euro 180,000
UBI BANCA * Euro 40,000,000
MEDIOBANCA Euro 40,000,000
BANK OF IRELAND Euro 600,000
BCC ROMA Euro 1,500,000
UBI BANCA Euro 1,000,000
INVITALIA Euro 12,643,000
BANCO BPM Euro 50,000,000
BNL - BNP PARIBAS * Euro 40,000,000
BNL - BNP PARIBAS * Euro 30,000,000
BCC CARATE Euro 5,000,000
BANCA DI CARAGLIO Euro 250,000
BCC CARATE * Euro 10,000,000
BANCO BPM * Euro 40,000,000
Derivatives
Lease liabilities
Total amounts due to other lenders
Bonds
Total

Covenants

The loan agreements marked by an asterisk ( *) contain financial restrictions (covenants) that envisage the maintenance of certain ratios between net financial indebtedness and shareholders' equity, between net financial indebtedness and cash-flow, and between net financial indebtedness and EBITDA referable to the consolidated financial statements.

To date, these parameters were complied with and are complied with as at December 31, 2022.

Derivatives

Some loan agreements were covered by derivative contracts, as defined below.

1. The loan agreement outstanding with Mediobanca whose residual debt amounts to Euro 536 thousand was hedged by an IRS agreement entered into on May 19, 2010, which anticipates the payment of a fixed rate of 2.9% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was negative in the amount of Euro 1 thousand (negative in the amount of Euro 55 thousand as at December 31, 2021).

2. The loan agreement outstanding with BNL - BNP Paribas, the residual debt of which amounts to Euro 34,960 thousand, was hedged by a fixed rate of 1.45% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 3,605 thousand (negative in the amount of Euro 351 thousand as at December 31, 2021).

3. The bond whose residual debt amounts to Euro 9,588 thousand was hedged by a CCS contract entered into with Intesa San Paolo on June 15, 2012. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 1,529 thousand (at December 31, 2021 positive in the amount of Euro 1,407 thousand).

4. The bond whose residual debt amounts to Euro 8,121 thousand was hedged by a CCS contract entered into with Intesa San Paolo on May 29, 2013. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 1,614 thousand (at December 31, 2021 positive in the amount of Euro 1,478 thousand).

5. The loan outstanding with Unicredit Bulbank whose residual debt amounts to Euro 1,000 thousand was hedged by a fixed rate of 2.40% against a floating 3-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 2 thousand (negative in the amount of Euro 67 thousand as at December 31, 2021).

6. The loan agreement outstanding with Intesa San Paolo whose residual debt amounts to Euro 9,375 thousand was hedged by a fixed rate of 0.44% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 390 thousand (negative in the amount of Euro 178 thousand as at December 31, 2021).

7. The loan agreement outstanding with Banca Popolare di Bergamo, the residual debt of which amounts to Euro 7,664 thousand, was hedged by a fixed rate of 0.10% against a floating 3-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 332 thousand (negative in the amount of Euro 95 thousand as at December 31, 2021).

8. The loan agreement outstanding with Intesa San Paolo whose residual debt amounts to Euro 17,500 thousand was hedged by a fixed rate of 0.10% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 1,069 thousand (negative in the amount of Euro 145 thousand as at December 31, 2021).

9. The loan agreement outstanding with BNL - BNP Paribas, the residual debt of which amounts to Euro 13,500 thousand, was hedged by a fixed rate of 0.535% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 685 thousand (negative in the amount of Euro 278 thousand as at December 31, 2021).

10. The loan agreement outstanding with Mediobanca, the residual debt of which amounts to Euro 27,500 thousand, was hedged by a fixed rate of 0.759% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 1,618 thousand (negative in the amount of Euro 560 thousand as at December 31, 2021).

11. The loan agreement outstanding with BNL - BNP Paribas, the residual debt of which amounts to Euro 21,875 thousand, was hedged by a fixed rate of -0.13% against a floating 6-month Euribor rate. The fair value as at December 31, 2022, calculated by the same bank, was positive in the amount of Euro 2,154 thousand (at December 31, 2021 positive in the amount of Euro 67 thousand).

The Group, where possible, applies hedge accounting, verifying compliance with the requirements of IAS 39. From January 1, 2018, the Group decided to continue to use the hedge accounting rules set out in IAS 39 and not IFRS 9 for all hedges already designated in hedge accounting at December 31, 2017 and for new hedges designated in subsequent periods.

Derivative instruments that qualify as hedges pursuant to IFRS 9 and IAS 39 comprise transactions put in place to hedge the fluctuations in cash flows (Cash Flow Hedge - CFH) and to hedge the fair value of the hedged element (Fair Value Hedge - FVH).

The contract numbered 1. was assessed at fair value hedge, while contracts numbered from 2. to 11. were assessed at cash flow hedge.

Hierarchical levels of fair value measurement

As regards the financial instruments recorded in the statement of financial position at fair value, the IFRS 7 requires that such values be classified on the basis of a hierarchical level that reflects the importance of the inputs used when determining the fair value.

The levels are broken down as follows:

Level 1 - prices recorded on an active market for measured assets or liabilities;

Level 2 - inputs other than the prices set forth above, which are directly (prices) or indirectly (derived from the prices) observable on the market;

Level 3 - inputs that are based on observable market figures.

The following table shows the fair value as at December 31, 2022 of financial instruments by hierarchical level of fair value measurement:

Payables and other financial liabilities Notes Level 1 Level 2 Level 3 Total
Negative measurement
MEDIOBANCA (1) (1)
UNICREDIT (2) (2)
Total negative measurement - (3) - (3)
Positive measurement
BNL - BNP PARIBAS 685 685
BNL - BNP PARIBAS 2,154 2,154
BNL - BNP PARIBAS 3,605 3,605
MEDIOBANCA 1,618 1,618
BANCA POPOLARE DI BERGAMO 332 332
INTESA SAN PAOLO 1,529 1,529
INTESA SAN PAOLO 1,614 1,614
INTESA SAN PAOLO 390 390
INTESA SAN PAOLO 1,069 1,069
Total positive measurement - 12,996 - 12,996
Overall total - 12,993 - 12,993

Fair value Calculation models used

The fair value of the item "Due to banks" and of the item "Due to other lenders" was calculated on the basis of the interest rate curve at the end of the reporting period.

The fair value of the financial instruments listed on an active market is based on market prices at the end of the reporting period. The market prices used are bid /ask prices depending on the active/passive position held. The fair value of financial instruments not listed in an active market and of derivative instruments is determined using measurement techniques and models prevailing on the market, using inputs that are observable on the market. It should be noted that - for the items trade receivables and payables, other financial assets - fair values have not been calculated as their book value approximates them.

The fair value of finance lease payables and due to other lenders is not materially different from their book value.

25. Current liabilities

Balance as at 12.31.2022 370,842
Balance as at 12.31.2021 315,398
Change 55,444

This item breaks down as follows:

Description 12.31.2022 12.31.2021 Change
Amounts due to banks 6,860 1,643 5,216
Trade accounts payable 175,114 150,290 24,824
Other financial liabilities 84,814 82,098 2,716
Tax payables 32,552 19,216 13,335
Other current liabilities 71,502 62,150 9,352
Total 370,842 315,398 55,444

The item "Other financial liabilities" represents the short-term portions of the amounts due to other lenders, for which reference is made to the breakdown reported previously in the section "Payables and other financial liabilities".

The breakdown of the item "Tax payables" comprises:

Description 12.31.2022 12.31.2021 Change
Income tax payables 15,399 7,185 8,214
VAT payables 13,031 6,101 6,930
Other tax payables 4,122 5,930 (1,808)
Total 32,552 19,216 13,335

"Other current liabilities" comprise:

Description 12.31.2022 12.31.2021 Change
Amounts due to social security institutions 9,846 8,678 1,168
Amounts due to employees 15,056 15,432 (376)
Amounts due to shareholders for dividends 73 34 38
Guarantee deposits payable 1,862 1,903 (41)
Other payables 1,308 3,262 (1,954)
Accrued expenses and deferred income 43,357 32,841 10,516
Total 71,501 62,150 9,351

The breakdown of the item "Accrued expenses and deferred income" is as follows:

Description 12.31.2022 12.31.2021 Change
Accrued expenses
Interest payable on loans 1,220 765 455
Other 13,903 7,597 6,306
Total accrued expenses 15,123 8,362 6,762
Deferred income
Sink funds granted 998 591 407
Rentals receivable 45 44 -
Other 27,191 23,844 3,347
Total deferred income 28,234 24,479 3,754
Total accrued expenses and deferred income 43,357 32,841 10,516

REVENUES BY TYPE OF BUSINESS SOL GROUP

(amounts in thousands of Euro)

12.31.2022
Technical gas sector % Home-care service sector % Write downs
Technical gas sector 796,862 100.0% - - (34,423)
Home-care service sector - - 618,199 100.0% (1,451)
Net sales 796,862 100.0% 618,199 100.0% (35,874)
Other revenues and income 78,247 9.8% 6,365 1.0% (707)
Internal works and collections 5,118 0.6% 19,659 3.2% 1,940
Revenues 880,227 110.5% 644,223 104.2% (34,641)
Purchase of materials 393,780 49.4% 150,106 24.3% (23,236)
Services rendered 205,069 25.7% 171,013 27.7% (10,052)
Change in inventories (7,869) -1.0% (5,363) -0.9% -
Other costs 13,539 1.7% 16,209 2.6% (1,302)
Total costs 604,519 75.9% 331,965 53.7% (34,591)
Added value 275,708 34.6% 312,257 50.5% (50)
Payroll and related costs 109,784 13.8% 149,873 24.2%
Gross operating margin 165,924 20.8% 162,385 26.3% (50)
Depreciation/amortisation 61,832 7.8% 66,499 10.8% 620
Provisions and write-downs 5,547 0.7% 1,308 0.2% (8)
Non-recurring (income)/expenses - - - - -
Operating result 98,545 12.4% 94,579 15.3% (662)
Financial income 29,318 3.7% 1,996 0.3% (28,384)
Financial expense (13,389) -1.7% (5,297) -0.9% 2,795
Results from equity investments 269 - 38 - 61
Total financial income/(expense) 16,198 2.0% (3,262) -0.5% (25,528)
Profit (Loss) before income taxes 114,743 14.4% 91,317 14.8% (26,191)
Income taxes 18,500 2.3% 23,797 3.8% (3)
Net result from business activities 96,243 12.1% 67,519 10.9% (26,188)
Net result from discontinued operations - - - - -
(Profit)/Loss pertaining to minority interests (910) -0.1% (2,995) -0.5% 24
Net Profit/(Loss) 95,333 12.0% 64,524 10.4% (26,164)
12.31.2022
Consolidated figures %
Technical gas sector 762,439 55.3%
Home-care service sector 616,748 44.7%
Net sales 1,379,187 100.0%
Other revenues and income 83,904 6.1%
Internal works and collections 26,718 1.9%
Revenues 1,489,809 108.0%
Purchase of materials 520,650 37.8%
Services rendered 366,030 26.5%
Change in inventories (13,232) -1.0%
Other costs 28,446 2.1%
Total costs 901,894 65.4%
Added value 587,915 42.6%
Payroll and related costs 259,657 18.8%
Gross operating margin 328,259 23.8%
Depreciation/amortisation 128,950 9.3%
Provisions and write-downs 6,847 0.5%
Non-recurring (income)/expenses - -
Operating result 192,462 14.0%
Financial income 2,930 0.2%
Financial expense (15,891) -1.2%
Results from equity investments 368 -
Total financial income/(expense) (12,593) -0.9%
Profit (Loss) before income taxes 179,869 13.0%
Income taxes 42,294 3.1%
Net result from business activities 137,574 10.0%
Net result from discontinued operations - -
(Profit)/Loss pertaining to minority interests (3,882) -0.3%
Net Profit/(Loss) 133,693 9.7%
12.31.2021
Technical gas sector % Home-care service sector % Write downs
Technical gas sector 590,036 100.0% - - (31,613)
Home-care service sector 555,935 100.0% (1,449)
Net sales 590,036 100.0% 555,935 100.0% (33,062)
Other revenues and income 7,467 1.3% 4,204 0.8% (611)
Internal works and collections 3,921 0.7% 13,049 2.3% 1,962
Revenues 601,424 101.9% 573,188 103.1% (31,711)
Purchase of materials 199,972 33.9% 123,779 22.3% (17,728)
Services rendered 185,476 31.4% 146,684 26.4% (12,649)
Change in inventories (1,913) -0.3% (467) -0.1% -
Other costs 13,627 2.3% 12,413 2.2% (1,279)
Total costs 397,161 67.3% 282,409 50.8% (31,656)
Added value 204,263 34.6% 290,779 52.3% (55)
Payroll and related costs 104,107 17.6% 130,102 23.4%
Gross operating margin 100,156 17.0% 160,677 28.9% (55)
Depreciation/amortisation 58,297 9.9% 60,505 10.9% 494
Provisions and write-downs 3,994 0.7% 1,717 0.3% -
Non-recurring (income)/expenses - - - - -
Operating result 37,866 6.4% 98,454 17.7% (549)
Financial income 25,336 4.3% 2,009 0.4% (24,939)
Financial expense (10,455) -1.8% (2,977) -0.5% 1,960
Results from equity investments (777) -0.1% (52) - 52
Total financial income/(expense) 14,104 2.4% (1,020) -0.2% (22,928)
Profit (Loss) before income taxes 51,970 8.8% 97,434 17.5% (23,476)
Income taxes 7,455 1.3% 24,701 4.4% 15
Net result from business activities 44,515 7.5% 72,733 13.1% (23,491)
Net result from discontinued operations - -
(Profit)/Loss pertaining to minority interests (1,353) -0.2% (2,879) -0.5% 25
Net Profit/(Loss) 43,162 7.3% 69,853 12.6% (23,466)
12.31.2021
Consolidated figures %
Technical gas sector 558,423 50.2%
Home-care service sector 554,486 49.8%
Net sales 1,112,909 100.0%
Other revenues and income 11,060 1.0%
Internal works and collections 18,933 1.7%
Revenues 1,142,901 102.7%
Purchase of materials 306,023 27.5%
Services rendered 319,511 28.7%
Change in inventories (2,380) -0.2%
Other costs 24,761 2.2%
Total costs 647,915 58.2%
Added value 494,987 44.5%
Payroll and related costs 234,209 21.0%
Gross operating margin 260,778 23.4%
Depreciation/amortisation 119,296 10.7%
Provisions and write-downs 5,711 0.5%
Non-recurring (income)/expenses - -
Operating result 135,771 12.2%
Financial income 2,406 0.2%
Financial expense (11,472) -1.0%
Results from equity investments (777) -0.1%
Total financial income/(expense) (9,843) -0.9%
Profit (Loss) before income taxes 125,928 11.3%
Income taxes 32,170 2.9%
Net result from business activities 93,757 8.4%
Net result from discontinued operations -
(Profit)/Loss pertaining to minority interests (4,208) -0.4%
Net Profit/(Loss) 89,549 8.0%

OTHER INFORMATION SOL GROUP

(amounts in thousands of Euro)

12.31.2022
Technical gas sector % Home-care service sector %
Total assets 1,334,261 899,538
Total liabilities 754,861 317,356
Investments 53,046 68,287
12.31.2022
Write downs Consolidated figures %
Total assets (515,215) 1,718,583
Total liabilities (216,265) 855,952
Investments - 121,334
12.31.2021
Technical gas sector % Home-care service sector %
1,129,848 802,749
658,782 260,337
58,230 65,067
12.31.2021
Write downs Consolidated figures %
(488,151) 1,444,447
(196,124) 722,996
- 123,297

BREAKDOWN OF REVENUES BY TYPE OF BUSINESS: TECHNICAL GAS SECTOR

The income statement of the Technical Gas Sector is shown below:

(amounts in thousands of Euro)

12.31.2022 % 12.31.2021 %
Net sales 796,862 100.0% 590,036 100.0%
Other revenues and income 78,247 9.8% 7,467 1.3%
Internal works and collections 5,118 0.6% 3,921 0.7%
Revenues 880,227 110.5% 601,424 101.9%
Purchase of materials 393,780 49.4% 199,972 33.9%
Services rendered 205,069 25.7% 185,476 31.4%
Change in inventories (7,869) -1.0% (1,913) -0.3%
Other costs 13,539 1.7% 13,627 2.3%
Total costs 604,519 75.9% 397,161 67.3%
Added value 275,708 34.6% 204,263 34.6%
Payroll and related costs 109,784 13.8% 104,107 17.6%
Gross operating margin 165,924 20.8% 100,156 17.0%
Depreciation/amortisation 61,832 7.8% 58,297 9.9%
Provisions and write-downs 5,547 0.7% 3,994 0.7%
Non-recurring (income)/expenses - - - -
Operating result 98,545 12.4% 37,866 6.4%
Financial income 29,318 3.7% 25,336 4.3%
Financial expense (13,389) -1.7% (10,455) -1.8%
Results from equity investments 269 - (777) -0.1%
Total financial income/(expense) 16,198 2.0% 14,104 2.4%
Profit (Loss) before income taxes 114,743 14.4% 51,970 8.8%
Income taxes 18,500 2.3% 7,455 1.3%
Net result from business activities 96,243 12.1% 44,515 7.5%
Net result from discontinued operations - - - -
(Profit)/Loss pertaining to minority interests (910) -0.1% (1,353) -0.2%
Net Profit/(Loss) 95,333 12.0% 43,162 7.3%

Sales in the Technical Gas Sector registered a 35.1% increase.

Gross operating margin increased by 65.7% compared to the previous year.

Operating result increased by 160.2% compared to the previous year.

The statement of financial position of the Technical Gas sector is presented below:

(amounts in thousands of Euro)

12.31.2022 12.31.2021
Tangible fixed assets 456,541 411,126
Goodwill and consolidation differences 58,036 29,477
Other intangible fixed assets 15,105 13,072
Equity investments 200,127 199,898
Other financial assets 16,129 8,842
Deferred tax assets 12,895 14,901
Non-current assets 758,833 677,316
Non-current assets held for sale - -
Inventories 40,917 31,133
Trade receivables 292,464 213,765
Other current assets 41,617 26,719
Current financial assets 117,623 101,408
Cash and cash at bank 82,807 79,507
Current assets 575,427 452,532
TOTAL ASSETS 1,334,261 1,129,848
Share capital 47,164 47,164
Share premium reserve 63,335 63,335
Legal reserve 10,459 10,459
Reserve for treasury shares in portfolio - -
Other reserves 334,643 294,338
Retained earnings (accumulated loss) - -
Net Profit 95,333 43,162
Shareholders' equity - Group 550,934 458,459
Shareholders' equity - Minority interests 27,555 11,254
Profit pertaining to minority interests 910 1,353
Shareholders' equity - Minority interests 28,465 12,608
Shareholders' equity 579,399 471,067
Employee severance indemnities and benefits 10,383 13,875
Provision for deferred taxes 6,968 4,170
Provisions for risks and charges 2,313 1,557
Payables and other financial liabilities 416,938 354,131
Non-current liabilities 436,601 373,734
Non-current liabilities held for sale - -
Amounts due to banks 5,528 1,230
Trade accounts payable 115,509 100,916
Other financial liabilities 151,378 148,268
Tax payables 13,890 7,583
Other current liabilities 31,956 27,051
Current liabilities 318,260 285,048
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 1,334,261 1,129,848

BREAKDOWN OF REVENUES BY TYPE OF BUSINESS: HOME-CARE SERVICE SECTOR

The income statement of the Home-care Service sector is shown below:

(amounts in thousands of Euro)

12.31.2022 % 12.31.2021 %
Net sales 618,199 100.0% 555,935 100.0%
Other revenues and income 6,365 1.0% 4,204 0.8%
Internal works and collections 19,659 3.2% 13,049 2.3%
Revenues 644,223 104.2% 573,188 103.1%
Purchase of materials 150,106 24.3% 123,779 22.3%
Services rendered 171,013 27.7% 146,684 26.4%
Change in inventories (5,363) -0.9% (467) -0.1%
Other costs 16,209 2.6% 12,413 2.2%
Total costs 331,965 53.7% 282,409 50.8%
Added value 312,257 50.5% 290,779 52.3%
Payroll and related costs 149,873 24.2% 130,102 23.4%
Gross operating margin 162,385 26.3% 160,677 28.9%
Depreciation/amortisation 66,499 10.8% 60,505 10.9%
Provisions and write-downs 1,308 0.2% 1,717 0.3%
Non-recurring (income)/expenses - - - -
Operating result 94,579 15.3% 98,454 17.7%
Financial income 1,996 0.3% 2,009 0.4%
Financial expense (5,297) -0.9% (2,977) -0.5%
Results from equity investments 38 - (52) -
Total financial income/(expense) (3.262) -0.5% (1.020) -0.2%
Profit (Loss) before income taxes 91,317 14.8% 97,434 17.5%
Income taxes 23,797 3.8% 24,701 4.4%
Net result from business activities 67,519 10.9% 72,733 13.1%
Net result from discontinued operations - - - -
(Profit)/Loss pertaining to minority interests (2,995) -0.5% (2,879) -0.5%
Net Profit/(Loss) 64,524 10.4% 69,853 12.6%

Sales in the Home care Service sector reported an increase of 11.2%. Operating result decreased by 3.9% compared to the previous year.

The statement of financial position of the Home-care Service sector is presented below:

(amounts in thousands of Euro)

12.31.2022 12.31.2021
Tangible fixed assets 225,387 191,297
Goodwill and consolidation differences 120,187 105,530
Other intangible fixed assets 11,445 9,679
Equity investments 162,825 153,131
Other financial assets 7,474 2,952
Deferred tax assets 5,547 6,017
Non-current assets 532,865 468,606
Non-current assets held for sale - -
Inventories 43,227 36,169
Trade receivables 157,898 139,562
Other current assets 23,553 10,156
Current financial assets 90,183 88,121
Cash and cash at bank 51,812 60,135
Current assets 366,673 334,143
TOTAL ASSETS 899,538 802,749
Share capital 7,750 7,750
Share premium reserve 20,934 20,934
Legal reserve 1,550 1,550
Reserve for treasury shares in portfolio - -
Other reserves 449,292 407,157
Retained earnings (accumulated loss) 24,577 24,577
Net Profit 64,524 69,853
Shareholders' equity - Group 568,627 531,821
Shareholders' equity - Minority interests 10,559 7,712
Profit pertaining to minority interests 2,995 2,880
Shareholders' equity - Minority interests 13,555 10,591
Shareholders' equity 582,181 542,412
Employee severance indemnities and benefits 4,760 4,820
Provision for deferred taxes 5,168 3,165
Provisions for risks and charges 1,004 1,513
Payables and other financial liabilities 134,228 121,849
Non-current liabilities 145,161 131,347
Non-current liabilities held for sale - -
Amounts due to banks 1,332 413
Trade accounts payable 77,625 62,374
Other financial liabilities 32,981 18,468
Tax payables 18,662 11,633
Other current liabilities 41,595 36,102
Current liabilities 172,195 128,990
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 899,538 802,749

INFORMATION BY GEOGRAPHIC AREA

The breakdown of revenues by geographic area is presented below:

Description 12.31.2022 12.31.2021 Change
Italy 600,702 462,405 138,297
Other Countries 778,485 650,504 127,981
Total 1,379,187 1,112,909 266,278

The breakdown of investments by geographic area is presented below:

Description 12.31.2022 12.31.2021 Change
Italy 42,808 44,505 (1,697)
Other Countries 78,526 78,792 (266)
Total 121,334 123,297 (1,963)

INTRA-GROUP TRANSACTIONS AND TRANSACTIONS WITH RELATED PARTIES

The parent company SOL Spa is controlled by GAS AND TECHNOLOGIES WORLD Bv, in turn controlled by STICHTING AIRVISION; the Group has not entered into any transaction with the latter.

INTRA-GROUP TRANSACTIONS

All the intra-group transactions fall within the ordinary operations of the Group, they are conducted on an arms' length basis, and there were no atypical or unusual transactions or transactions causing potential conflicts of interest.

Intra-group sales and services carried out during 2022 amounted to Euro 339.3 million.

As at December 31, 2022, receivable and payable transactions between Group companies came to Euro 484.9 million, of which Euro 314.5 million of a financial nature and Euro 170.4 million of a trade nature.

The breakdown of intercompany financial receivables is as follows:

Financial receivables granted by SOL Spa Euro 188.8 million
Financial receivables granted by AIRSOL BV Euro 26.5 million
Financial receivables granted by other companies Euro 999.2 million

The transactions of the SOL Group with non-consolidated subsidiary companies, jointly controlled companies and associated companies comprised:

Sales and services to CT BIOCARBONIC GmbH Euro 38 thousand
Purchases from CT BIOCARBONIC GmbH Euro 3,888 thousand
Amounts due to CT BIOCARBONIC GmbH Euro 323 thousand
Sales and services to ZDS JESENICE doo Euro 3,735 thousand
Purchases from ZDS JESENICE doo Euro 8,058 thousand
Trade receivables from ZDS JESENICE doo Euro 564 thousand
Amounts due to ZDS JESENICE doo Euro 735 thousand
Trade receivables from CONSORGAS Srl Euro 3 thousand
Financial receivables from CONSORGAS Srl Euro 35 thousand
Amounts due to CONSORGAS Srl Euro 6 thousand
Sales and services to CONSORZIO ECODUE Euro 130 thousand
Purchases from CONSORZIO ECODUE Euro 580 thousand
Trade receivables from CONSORZIO ECODUE Euro 75 thousand
Amounts due to CONSORZIO ECODUE Euro 195 thousand
Amounts due to SHANGHAI SHENWEI MEDICAL GAS Co. Ltd Euro 1 thousand
Sales and services to SHANGHAI SHENWEI MEDICAL GAS Co. Ltd Euro 230 thousand

COMMITMENTS, GUARANTEES AND POTENTIAL LIABILITIES

The Sol Group obtained sureties totalling Euro 89,829 thousand.

NET FINANCIAL POSITION

(amounts in thousands of Euro)

12.31.2022 12.31.2021
A. Cash and cash equivalents 134,642 139,642
B. Cash and cash equivalents 7,561 6,834
C. Other current financial assets 5,648 1,882
D. Liquidity (A + B + C) 147,851 148,357
E. Current financial debt (including debt instruments, but excluding the current portion of non-current financial debt) (26,503) (18,393)
F. Current portion of non-current financial debt (66,391) (66,113)
G. Current borrowing (E + F) (92,894) (84,506)
H. Net current borrowing (G - D) 54,957 63,851
I. Non-current financial debt (excluding the current portion and debt instruments) (426,604) (373,503)
J. Debt instruments 0 (1,135)
K. Trade payables and other non-current debts (18,100) (100)
L. Non-current borrowing (I + J + K) (444,704) (374,738)
M. Total net borrowing (H + L) (389,747) (310,887)

Letter E "Current financial debt" includes Euro 18,331 related to the short-term portion arising from the application of IFRS 16, while letter I "Non-current financial debt" includes Euro 47,732 related to the long-term portion.

After deduction of lease portions, net indebtedness amounted to Euro 323,684 thousand (Euro 261,025 as at December 31, 2021).

DISCLOSURE PURSUANT TO ARTICLE 1 PARAGRAPH 125 OF ITALIAN LAW NO. 124 OF 4 AUGUST 2017

With reference to Article 1 paragraph 125 of Italian Law 124/2017, the subsidies received by public administrations are summarised below:

Contribution of Euro 201 thousand from the Ministry of Economic Development (MiSE) for the CHEAPH2 Project, PON I&C 2014-2020 "Horizon 2020" Funds granted to the parent company

Contribution of Euro 1 thousand for the BIOSET Project for the development of services and products for a more efficient and safer blood transfusion chain granted to the Parent company

Aid for investment in Research, Development and Innovation Euro 114 thousand - Apulia Regional Regulation for exempted aid (no. 17 of September 30, 2014 - Burp October 06, 2014) to the company VIVISOL Srl

Contribution of the Lazio Region of Euro 19 thousand for the W-Shield project - public notice "2019 Strategic Projects" (managing body Lazio Innova) paid to CRYOLAB Srl

European contribution of Euro 53 thousand for Katy project (Horizon 2020 programme - Artificial Intelligence and Bioinformatics in the fight against tumours) granted to the company PERSONAL GENOMICS Srl

European contribution of Euro 120 thousand for Eclipse project (Horizon programme - for the production of a nanobiotechnological platform for the detection of pathogens with a high level of sensitivity and reliability) granted to the company PERSONAL GENOMICS Srl

Contribution from the Marche Region for Progetto Bando Piattaforme Euro 155 thousand (of which Euro 65 thousand paid to the project partners) to the company DIATHEVA Srl.

ADJUSTMENTS PURSUANT TO ART.S 15 AND 18 OF THE MARKET REGULATIONS

Pursuant to Article 18 (former 39) of the Market Regulation issued by Consob with reference to "Conditions for the share prices of companies controlling companies set-up and governed by the law of non-EU Countries" referred to in Article 15 (former 36) of the above Regulation (issued in order to implement Article 62 sub-paragraph 3 bis of Italian Legislative Decree 58/1998 as amended on December 28, 2017 with resolution no. 20249), it is stated that in the SOL Group there are twelve companies based in four non-EU Countries that are important pursuant to subparagraph 2 of the said article 15.

The current procedures of the SOL Group already allow to conform with what is required by the standard.

INFORMATION PURSUANT TO ARTICLE 149 DUODECIES OF THE CONSOB ISSUER REGULATION

The following table, drawn up pursuant to Article 149 duodecies of the Consob Issuer Regulation, shows the considerations pertaining to the 2022 financial year for the auditing services and for those other than auditing supplied by the auditing company and by bodies belonging to its network.

(amounts in thousands of Euro)

Subject who supplied the service Recipient Considerations pertaining to the 2022 financial year
External auditing Deloitte Parent Company SOL Spa 128
Deloitte Subsidiary companies 100
Deloitte network Subsidiary companies 282
Quarterly audit Deloitte Parent Company SOL Spa 6
Deloitte Subsidiary companies 9
Deloitte network Subsidiary companies 4
Other services Deloitte Parent Company SOL Spa (1) 39
Deloitte Subsidiary companies (1) 28
Deloitte network Subsidiary companies 10
Total 606

(1) Fiscal aid services and others

NON-RECURRING SIGNIFICANT EVENTS AND TRANSACTIONS

Pursuant to Consob (Italian Securities and Exchange Commission) communication no. DEM/6064296 of July 28, 2006, the SOL Group did not carry out non-recurring significant events and transactions during 2022.

TRANSACTIONS DERIVING FROM ATYPICAL AND/OR UNUSUAL OPERATIONS

Pursuant to Consob communication no. DEM/6064296 of July 28, 2006, the SOL Group did not carry out atypical and/or unusual operations since 2022, as defined by the Communication itself.

SIGNIFICANT EVENTS THAT TOOK PLACE AT THE REPORTING DATE AND FORESEEABLE BUSINESS DEVELOPMENTS

In this regard, please refer to the specific section in the management report.

 

Monza, March 30, 2023

The Chairman of the Board of Directors

Aldo Fumagalli Romario

CERTIFICATE OF THE CONSOLIDATED FINANCIAL STATEMENTS PURSUANT TO ARTICLE 154-BIS OF ITALIAN LEGISLATIVE DECREE 58/1998

The undersigned Aldo Fumagalli Romario and Marco Annoni, as Managing directors, and Marco Filippi, as Manager in charge of drawing up company accounting documents for SOL Spa, certify, also considering the provisions of Article 154-bis, paragraphs 3 and 4, of Italian Legislative Decree no. 58 of February 24, 1998:

the adequacy in relation to the characteristics of the business and

actual application

of the administrative and accounting procedures for the drawing up of the consolidated financial statements during the 2022 financial year.

We also certify that:

1. The consolidated financial statements:

a) were prepared in accordance with the International Financial Reporting Standards recognised by the European Union pursuant to Regulation (EC) no. 1606/2002 of the European Parliament and of the Council of July 19, 2002;

b) correspond to the results of the accounting books and records;

c) give a true and fair view of the financial position, the results of the operations and of the cash flows of the issuer and of the consolidated companies;

2. The directors' report includes a reliable analysis of the business trend and operating result as well as of the situation of issuing company and of the consolidated companies, together with a description of the main risks and uncertainties they incur.

 

Monza, March 30, 2023

The Managing directors

Aldo Fumagalli Romario

Marco Annoni

Manager in charge of drawing up company accounting documents

Marco Filippi

Subject definition
Name of reporting entity or other means of identification SOL Spa
Explanation of change in name of reporting entity or other of identification from end of preceding reporting period There were no changes compared to the previous year means
Domicile of entity Monza (Italy)
Legal form of entity Joint-stock company
Country of registration Italy
Address of registered office of entity Via Borgazzi 27, 20900 Monza
Main place of business SOL is an Italian multinational group operating in Europe, Turkey, Morocco, India, China and Brazil
Description of the nature of the entity's business and its main operations SOL is an Italian multinational group operating in two main sectors: production, applied research and marketing of technical, pure and medical gases (Technical Gas sector) and home care (Home Care sector).
Name of parent entity SOL Spa
Name of the parent company SOL Spa

REPORT OF THE AUDITING COMPANY SOL GROUP

INDEPENDENT AUDITOR'S REPORT

PURSUANT TO ARTICLE 14 OF LEGISLATIVE DECREE No. 39 OF JANUARY 27, 2010 AND ARTICLE 10 OF THE EU REGULATION 537/2014

To the Shareholders of SOL S.p.A.

REPORT ON THE AUDIT OF THE CONSOLIDATED FINANCIAL STATEMENTS

Opinion

We have audited the consolidated financial statements of SOL S.p.A. and its subsidiaries (the "Group"), which comprise the consolidated statement of financial position as at December 31, 2022, and the consolidated statement of income, consolidated statement of comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies.

In our opinion, the accompanying consolidated financial statements give a true and fair view of the consolidated financial position of the Group as at December 31, 2022, and of its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with International Financial Reporting Standards as adopted by the European Union and the requirements of national regulations issued pursuant to art. 9 of Italian Legislative Decree no. 38/05.

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (ISA Italia). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of SOL S.p.A. (the "Company") in accordance with the ethical requirements applicable under Italian law to the audit of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements of the current period. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Impairment test on Intangible Assets with an Indefinite Useful Life

Description of the key audit matter

The Group recognizes intangible assets with indefinite useful lives ("goodwill and consolidation differences") for Euro 216,811 thousand, which, in accordance with the applicable accounting standards, and as described in the notes to the financial statements, are not amortized, rather they are subjected to an impairment test at least annually.

As required by the "IAS 36 Impairment of Assets," the Company's Directors have carried out the impairment test in order to determine that intangible assets with indefinite useful lives are accounted for in the consolidated financial statements at December 31, 2022 at a value not higher than their recoverable values. The amounts subject to impairment test do not include intangible assets with indefinite useful lives relating to the companies acquired by the Group during the year, equal to Euro 34,277 thousand, the value of which was subject to verification upon initial registration.

The recoverable amounts of these assets were estimated by determining their economic values, based on the cash flows that the assets are able to generate.

Based on the strategic and organizational choices made, the Directors identified the Cash Generating Units ("CGU") in the individual legal entities, which represent the smallest units generating financial flows identifiable within the Group.

The recoverability of the amounts recorded in the financial statements was verified by comparing the carrying amounts of the assets attributable to the CGUs with the values in use of the same.

The value in use, defined as Enterprise Value, was determined considering the expected cash flows for an explicit projection period (in some cases even longer than 5 years in relation to the specificity of some businesses) for the individual CGUs, the terminal value, determined after the last year of the explicit projection period through the application of a perpetual annuity, and an appropriate discount rate (Weighted Average Cost of Capital -WACC). In particular, the WACC was calculated for each CGU subjected to the impairment test, taking into account the specific parameters of the geographical area: market risk premium and sovereign debt yields.

Future expectations about market conditions influence these assumptions.

Based on the impairment test approved by the Board of Directors on March 30, 2023, the Directors assessed that the carrying values of the intangible assets with indefinite useful lives are lower than the recoverable values and, therefore, no impairment losses were recognized in relation to the intangible assets with indefinite useful lives with the exception of the Albanian company Hydroenergy for which a devaluation of Euro 604 thousand was recorded.

Considering the relevant values of the intangible assets with indefinite useful lives accounted for in the consolidated financial statements, the subjectivity of the estimates related to the determination of cash flows (DCF) and the key variables of the impairment tests, we considered the impairment test as a key audit matter of the Group consolidated financial statements.

Note 10 "Goodwill and consolidation differences" of the consolidated financial statements states the disclosures on the impairment test, including a sensitivity analysis performed by the Directors, which shows the effects that may occur on the recoverable value of intangible assets resulting from changes in certain key assumptions used for the impairment test.

Audit procedures performed

As part of our audit, we have, among others, carried out the following procedures, also with the support of experts:

review of the methods adopted by the Directors for the determination of the value in use of the CGUs, analyzing the methods and assumptions used and considered for the development of the impairment test and its compliance with the applicable accounting standards;

understand and evaluate the Group's relevant internal controls over the impairment test process related to intangible assets with indefinite useful lives;

analysis of the reasonableness of the key assumptions underlying the cash flow calculation; also, through the review of historical data available on the sector and on the Group (such as growth and average sector margins) as well as through the review of information obtained from the Directors;

analysis of the actual figures compared to the planned amounts in order to assess the nature of the deviations and the reliability of the planning process;

analysis of the reasonableness of the discount rate (WACC), of the calculation of the terminal value (TV) and of the long-term growth rate (grate);

review of the mathematical accuracy of the model used to estimate the value in use of the CGUs;

review of the correct calculation of the book value of the CGUs;

review of the sensitivity analysis aimed at understanding the effects on the impairment test when certain assumptions change;

analysis of the adequacy and compliance of the disclosure related to the impairment test.

Responsibilities of the Directors and the Board of Statutory Auditors for the Consolidated Financial Statements

The Directors are responsible for the preparation of consolidated financial statements that give a true and fair view in accordance with International Financial Reporting Standards as adopted by the European Union and the requirements of national regulations issued pursuant to art. 9 of Italian Legislative Decree no. 38/05, and, within the terms established by law, for such internal control as the Directors determine is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Directors are responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless they have identified the existence of the conditions for the liquidation of the Company or the termination of the business or have no realistic alternatives to such choices.

The Board of Statutory Auditors is responsible for overseeing, within the terms established by law, the Group's financial reporting process.

Auditor's Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with International Standards on Auditing (ISA Italia) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with International Standards on Auditing (ISA Italia), we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group's internal control.

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Directors.

Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group to cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance, identified at an appropriate level as required by ISA Italia, regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence applicable in Italy, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, actions taken to eliminate threats or safeguards applied.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors' report.

Other information communicated pursuant to art. 10 of the EU Regulation 537/2014

The Shareholders' Meeting of SOL S.p.A. appointed us on May 12, 2016 as auditors of the Company for the years from December 31, 2016 to December 31, 2024.

We declare that we have not provided prohibited non-audit services referred to in art. 5 (1) of EU Regulation 537/2014 and that we have remained independent of the Company in conducting the audit.

We confirm that the opinion on the financial statements expressed in this report is consistent with the additional report to the Board of Statutory Auditors, in its role of Audit Committee, referred to in art. 11 of the said Regulation.

REPORT ON OTHER LEGAL AND REGULATORY REQUIREMENTS

Opinion on the compliance with the provisions of the Delegated Regulation (EU) 2019/815

The Directors of SOL S.p.A. are responsible for the application of the provisions of the European Commission Delegated Regulation (EU) 2019/815 with regard to the regulatory technical standards on the specification of the single electronic reporting format (ESEF - European Single Electronic Format) (hereinafter referred to as the "Delegated Regulation") to the consolidated financial statements as at December 31, 2022, to be included in the annual financial report.

We have carried out the procedures set forth in the Auditing Standard (SA Italia) n. 700B in order to express an opinion on the compliance of the consolidated financial statements with the provisions of the Delegated Regulation.

In our opinion, the consolidated financial statements as at December 31, 2022 have been prepared in XHTML format and have been marked up, in all material respects, in accordance with the provisions of the Delegated Regulation.

Due to certain technical limitations, some information contained in the explanatory notes to the consolidated financial statements, when extracted from XHTML format in an XBRL instance, may not be reproduced in the same way as the corresponding information displayed in the consolidated financial statements in XHTML format.

Opinion pursuant to art. 14 paragraph 2 (e) of Legislative Decree 39/10 and art. 123-bis, paragraph 4, of Legislative Decree 58/98

The Directors of SOL S.p.A. are responsible for the preparation of the report on operations and the report on corporate governance and the ownership structure of SOL Group as at December 31, 2022, including their consistency with the related consolidated financial statements and their compliance with the law.

We have carried out the procedures set forth in the Auditing Standard (SA Italia) n. 720B in order to express an opinion on the consistency of the report on operations and some specific information contained in the report on corporate governance and the ownership structure set forth in art. 123-bis, n. 4 of Legislative Decree 58/98, with the consolidated financial statements of SOL Group as at December 31, 2022 and on their compliance with the law, as well as to make a statement about any material misstatement.

In our opinion, the above-mentioned report on operations and some specific information contained in the report on corporate governance and the ownership structure is are consistent with the consolidated financial statements of SOL Group as at December 31, 2022 and are prepared in accordance with the law.

With reference to the statement referred to in art. 14, paragraph 2 (e), of Legislative Decree 39/10, made on the basis of the knowledge and understanding of the entity and of the related context acquired during the audit, we have nothing to report.

Statement pursuant to art. 4 of the Consob Regulation for the implementation of Legislative Decree December 30, 2016, no. 254

The Directors of SOL S.p.A. are responsible for the preparation of the non-financial statement pursuant to Legislative Decree December 30, 2016, no. 254.

We verified the approval by the Directors of the non-financial statement.

Pursuant to art. 3, paragraph 10 of Legislative Decree December 30, 2016, no. 254, this statement is subject of a separate attestation issued by us.

 

Milan, Italy April 18, 2023

DELOITTE & TOUCHE S.p.A.

Signed by

Riccardo Raffo, Partner

This independent auditor's report has been translated into the English language solely for the convenience of international readers. Accordingly, only the original text in Italian language is authoritative.

Design

M Studio, Milano

Photo

Denis Allard

Renato Cerisola

Alberto Giuliani

Sol Photo Archive

Printing

Tipografia Fratelli Verderio, Milano

SOL Spa

Via Borgazzi, 27 20900 Monza

• Italy

Tel. +39 039 23961

Fax +39 039 2396375

diaf@sol.it

www.solgroup.com

Nachrichten & Medien

Insolvenzbekanntmachungen

Aktuelle Insolvenzverfahren

Prüfen, ob Insolvenzverfahren für dieses Unternehmen vorliegen

Handelsregister Dokumente

Gesellschafterliste
Aktueller Abdruck
Chronologischer Abdruck

Organisationen an dieser Adresse

16 nahegelegene Organisationen

Liste von Unternehmen und Organisationen an oder in der Nähe dieser Geschäftsadresse. Die Daten umfassen Firmennamen, Adressen, Registrierungsdetails und Branchenklassifikationen.
Die Informationen auf dieser Seite stammen aus öffentlichen Quellen, offiziellen Registern oder werden von Drittanbietern bereitgestellt. Fusionbase übernimmt keine Garantie für die Richtigkeit, Vollständigkeit oder Aktualität der Daten. Melde dich bei Fragen oder Anregungen über unser Kontaktformular.